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Oxazoloporphyrins, Oxazolochlorins and Oxazolobacteriochlorins 
Junichi Kent Ogikubo, Ph.D.  
University of Connecticut, 2012 
Since the serendipitous discovery of oxazole-containing porphyrins over 30 years 
ago, this class of porphyrinoid macrocycles remained largely unexplored.  This thesis is 
the first systematic study of the syntheses and optical properties of this class of macro-
cycles. Specifically, this thesis investigates the scope and limits of synthesizing various 
oxazole containing chlorin and bacteriochlorin chromophores.  The multi-step syntheses 
described are based on the OsO4-mediate dihydroxylation of meso-tetraphenylporphyrin 
(TPP) to form diolchlorin A. This diol is converted into various oxazolones and/or α-
substituted oxazolines (B/C/D) via one of two principal pathways; through MnO4— 
mediated oxidation or NaIO4-mediated oxidative cleavage. Similar reaction sequence also 
takes place on the opposing pyrrole unit for the formation of bis-oxazolochlorins and -
bacteriochlorins (E/F/G). These oxazole(s)-containing macrocycles are optically tunable 
in 20-30 nm increments in the range of 650-810 nm.   
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1.  General Introduction 
1.1.  Porphyrins, Chlorins, and Bacteriochlorins 
Porphyrins are fully unsaturated macrocycles composed of four pyrrolic subunits 
linked by four methylene carbons. The chemical and physical properties of porphyrins 
are mainly determined by the presence of a closed conjugated aromatic 18 π system that 
is cross-conjugated to two β,β’-double bonds. These cross-conjugated double bonds can 
be successively reduced–and thereby removed from macrocycle conjugation, resulting in 
the formation of a chlorin (one bond reduced), a bacteriochlorin (both bonds on opposite 
pyrroles reduced), or its isomer, an isobacteriochlorin (both bonds reduced on adjacent 
pyrroles) (Figure 1-1).  
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Figure 1-1. Macrocycle structure, position numbering, and naming system used in 
porphyrins, chlorins, bacteriochlorins, and isobacteriochlorins. The macrocycle-aromatic 18 π 
system inherent to all is shown in bold 
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The ‘reduction’ of the bond can also be an oxidation or addition reaction, as long 
as at least one of the β-carbons is converted into an sp3-carbon in the process. All reduced 
macrocycles still maintain a central 18 π system. The reductions result in a number of 
changes in their chemical and physical properties. Most profoundly, the UV-visible 
spectra of the chromophores change in a diagnostic fashion (for a more detailed dis-
cussion, see Section 1.2). Moreover, increasing reduction leads to increasing confor-
mational flexibility of the macrocycle. This also affects their electronic structure as, in 
general, the spectra of porphyrinoids are broadened upon increase of conformational 
flexibility and red-shifted with increasing deviation from planarity.1,2 Also, increasing 
reduction decreases significantly the basicity of the inner imine-type nitrogens. Thus, 
bacteriochlorins are less basic than chlorins that, in turn, are less basic than porphyrins.3  
In nature, porphyrins, chlorins and bacteriochlorins fulfill crucial roles in the 
metabolic network of all organisms. For example, heme, the iron complex of porphyrin, 
plays a vital role in nearly all vertebrae and some invertebrate, as it is responsible for 
oxygen transport through red blood cell.4 Chlorophyll, a magnesium chlorin complex, is 
essential for photosynthesis in all plants.  Similarly, bacteriochlorophyll a, a naturally 
occurring bacteriochlorin magnesium complex, is the photosynthetic pigments of photo-
autotrophic purple bacteria and cyanobacteria. Other examples of essential porphyrin 
natural products include cofactor F430, bacteriochlorophyll, and siroheme.4 
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Figure 1-2. Examples of porphyrins, chlorins and bacteriochlorins in nature 
1.2.  Optical Properties of Porphyrinic Chromophore 
The optical properties of porphyrins and hydroporphyrins are illustrated in Figure 
1-3. The spectra of regular porphyrins are well defined: A Soret band is followed by four 
Q bands in descending order of intensity. Owing to an increase of the chromophore 
symmetry (from two-fold symmetry to four-fold symmetry), metalation cuts the number 
of Q bands in half, and the longest wavelengths absorption band (λmax) is now 
hypsochromically shifted compared to the free-base. A free-base chlorin also exhibits the 
Soret band and four side bands, but the λmax band is now the most intense Q-band. The 
bands are also broadened, reflecting the larger conformational flexibility of this chromo-
phore. Depending on the particular chlorin, λmax may or may not be bathochromically 
shifted compared to the parent porphyrin. Insertion of a metal has the same principal 
effects on a chlorin as it has on a porphyrin (but the λmax band remains the most intense 
band). Metalation also rigidifies the chromophore, as seen in the sharpened optical 
spectrum. The Soret band of an isobacteriochlorin is hypsochromically shifted compared 
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to that of a chlorin, the spectrum is chlorin-like broadened, but with a changed Q-band 
intensity distribution, and a hypsochromically shifted λmax. The metalloisobacteriochlorin 
spectrum is a slightly hypsochromically shifted metallochlorin-like spectrum. The 
spectrum of free-base bacteriochlorin stands out for its diagnostic three-band shape, a 
hypsochromically shifted Soret band, and significantly bathochromically shifted λmax that 
possess an intensity of a similar magnitude as the Soret band (even though, in absolute 
terms, the extinction coefficient of the Soret band of a bacteriochlorin can be an order of 
magnitude lower than that of a porphyrin or chlorin).  
 
Figure 1-3. Comparison of the UV-visible spectra of the four principle porphyrin and 
hydroporphyrin classes, in their free-base form (solid trace) and metalated form (M = Zn; 
broken trace)  
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 The trends observed in the optical spectra of the porphyrins and their derivatives 
find their qualitative explanation in the relative position of the frontier orbitals of the 
chromophores.5 The longest wavelengths band (λmax) in the UV-visible of a porphyrin 
corresponds to a HOMO→LUMO transition (Figure 1-4).  
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Figure 1-4. Idealized relative position of the chromophore frontier orbitals. For sake of 
simplification, the Zn-complexes of higher symmetry, as compared to the free-bases, are 
shown. Adopted from Ref. 6 
Upon reduction of a porphyrin to a chlorin, the a1u is elevated and the relative 
order of the HOMO (a1u) and the HOMO-1 (a2u) become inverted relative to their order in 
porphyrins. The narrowed HOMO-LUMO gap results in a minor bathochromic shift of 
λmax for chlorins. The increased intensity of the chlorin λmax band is because the HOMO-
LUMO transition has become more symmetry-allowed. In the isobacteriochlorin case, 
both the HOMO and LUMO are lifted by about the same amount, thus the λmax of 
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isobacteriochlorins are very similar to those of chlorins. On the other hand, the HOMO is 
lifted and the LUMO is slightly lowered in bacteriochlorins relative to porphyrins and 
chlorins. Thus, the HOMO-LUMO gap in bacteriochlorins is the smallest, translating into 
the longest wavelengths λmax among all four chromophores. The degeneracy of LUMO 
and LUMO+1 remains to be lifted, the HOMO-LUMO transition remains being 
symmetry-allowed and is thus correspondingly intense. 
1.3.  Porphyrin Application 
Synthetic porphyrins and their analogues have demonstrated their value by 
contributing to a wide range of scientific fields such as material science (partial oxygen 
pressure-sensitive dyes),7-9 analytical science (high pH sensing)10 and environmental 
science (artificial light harvesting system).11 In biomedicine, porphyrins have shown 
promises as photosensitizers in photodynamic therapy (PDT) for cancer.12 
1.3.1.  Photodynamic Therapy 
Photodynamic therapy (PDT) is a non-invasive medical procedure in which a 
combination of light and drugs (photosensitizers) is used to remove cancerous or 
otherwise unwanted tissues.14 The process of PDT is depicted in Figure 1-5. First, a 
photosensitizer of negligible dark toxicity is injected systemically (A). When the 
preferential accumulation of the photosensitizer in tumor cells reaches the optimal level 
(B), the light is shone onto the target tissue for the drug activation (C).  The activated 
Chapter 1: General Introduction 
 7 
drug, through a series of photophysical processes, converts the molecular oxygen in cells 
to cytotoxic singlet oxygens, which eventually induces apoptosis in targeted areas (D).14  
 
Figure 1-5. Process of photodynamic therapy  
The ideal PDT drug will exhibit no significant biological activity until it is 
activated by light.  Light of longer wavelength penetrates deeper through tissues; 
however, at certain wavelengths, light penetration through tissues is limited due to light 
scattering and absorption by endogenous chromophores, mainly hemoglobin 
(Figure 1-6).15  
 
Figure 1-6. The wavelength dependence of depth of penetration of light into a tissue, 
adopted from Ref. 14 
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An efficient generation of singlet oxygen species is extremely crucial for the 
success of PDT. For this reason, ideal PDT drug is one in which can be activated at 
wavelength in the red or near-IR region.13   
A modified Jablonski diagram (Figure 1-7) outlines the underlying photophysical 
processes involved in PDT.13 Absorption of light by the photosensitizer excites the 
molecule to the excited states (route 1).  The excited species can relax back to the ground 
states via fluorescence (route 2) or non-radiatively through internal conversion (route 3).  
Alternatively, the excited photosensitizer can partake in a non-radiative inter-system 
crossing (ISC, route 4) to the triplet state. Although this is a “forbidden” process and is 
less likely than an “allowed” process, porphyrins have a unique ability to undergo this 
ISC pathway with high efficiency.  From the triplet state, a molecule has at least two 
pathways towards relaxation: radiatively via phosphorescence (route 5) and through non-
radiative spin exchange with another triplet state species (i.e. molecular oxygen, route 6). 
This spin exchange interaction is arguably the most important step for the success of 
PDT. The resulting singlet oxygen is an extremely reactive species with a lifetime (in 
water) of ~4 µs, it initiates a number of reactions with biological substrates.  For 
example, oxidation of cholesterol or cycloaddition with tryptophan and guanine are all 
quite disruptive to the biological processes.16   
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Figure 1-7. Modified Jablonski diagram for a typical photosensitizer. Adopted from Ref 13 
1.4.  Synthesis of Porphyrins 
 There are a number of ways to obtain porphyrinoids (and their derivatives). 
Notable methods include extraction from natural sources (i.e. blood, chloroplast), semi-
synthesis, and total synthesis. This thesis only focuses on the last approach, the total 
synthesis and manipulation of entirely synthetic porphyrin analogues. Unless mentioned 
otherwise, all of the syntheses described herein are based on meso-tetraphenylporphyrins 
(TPP).   
meso-Tetraarylporphyrins are a synthetic class of porphyrins with no biological 
counterparts.  The simplicity of their syntheses, however, makes them an excellent class 
of model compound for a wide range of porphyrin applications.  The popularity of meso-
tetraarylporphyrins also arises from their susceptibility towards a wide range of chemical 
modulations.  
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The one-step, one-pot tetaraarylporphyrin synthesis was first developed by 
Rothemund.17,18 In the mid-1960s, Adler and co-workers reported the acid-catalyzed 
modification of this reaction (Scheme 1-1).19 Several modifications of this synthesis have 
been reported in recent years.20 Most notably, the two-step, one-flask version, known as 
the Lindsey method, has been employed extensively for the syntheses of various meso-
tetraarylporphyrins using a number of arylaldehydes.20,21 
 
Scheme 1-1. Adler-type synthesis of meso-tetraarylporphyrin 6 
 The mechanism of Adler’s tetraarylporphyrin synthesis is straightforward.  An 
acid-catalyzed electrophilic aromatic substitution (EAS) reaction between a pyrrole and a 
benzaldehyde forms benzyl alcohol 1. Compound 1 is susceptible to a second EAS with 
another pyrrole, forming phenyldipyrromethane 2.  This sequence of reactions continues 
on until a ring closure provides tetrapyrrolic porphyrinogen 5. Compound 5 is then 
rapidly oxidized in situ until it becomes fully unsaturated, aromatic porphyrin 6, which 
generally crystallize out from the solution.  While this reaction is low in absolute yield 
(~20%), it has a number of advantages: 1) simplicity and swiftness; 2) ease of 
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purification as it requires no chromatography; 3) its scalability for the preparation of up 
to ~25 grams per reaction (for TPP, it requires a 5L flask).  
1.5.  Synthesis of Chlorins and Bacteriochlorins  
The syntheses of chlorins and bacteriochlorins are not as simple as porphyrins.  
There are four principal pathways to access chlorins and bacteriochlorins: firstly, they 
can be extracted from natural sources.22 Secondly, they can be made by semi-synthetic 
approaches. For example, the modification of chlorins and bacteriochlorins extracted 
from biological materials. Thirdly, a total synthesis which we consider only a synthesis 
that involves a porphyrinoid ring-closing step that directly results in the formation of a 
chlorin (Section 1.5.1) and/or bacteriochlorins (Section 1.5.2). Lastly, a synthesis in 
which pre-formed synthetic porphyrins are converted to chlorins (Section 1.5.3) and/or 
bacteriochlorins (Section 1.5.4). Hereon, we will refer to this last pathway as the pyrrole-
modified approach.  
1.5.1.  Total Syntheses of Chlorins  
The most significant progress in the total synthesis of chlorins and bacterio-
chlorins since the work by Woodward, Eschenmoser, or Battersby was presented in a 
series of publications beginning in 2000 by Lindsey and co-workers.23-34 The syntheses 
are based on the retrosynthetic analysis that a chlorin can be made in a [2+2] approach 
(Scheme 1-2) by fusion of a dipyrromethane with a gem-dimethyldihydrodipyrrin .35,36 
Utilizing complementary functionalities, a dipyrromethane and a gem-dimethyldihydro-
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dipyrrin can be ring-closed in a regioselective fashion to form, after an oxidation step, a 
chlorin.37-40 
Syntheses that followed this generalized scheme are characterized by several 
advantages: They gave access to asymmetric chlorins without any type of β,β’-double 
bond reduction step; they enabled the incorporation of inherent oxidation-protection by 
introducing the gem-dimethyl moiety at the pyrrolidine β-position; the syntheses allowed 
the preparation of chlorins with unsubstituted β- and meso-positions that could be 
modified in later steps. These advantages also translate to the related bacteriochlorin 
syntheses (see Section 1.5.2). 
 
Scheme 1-2. Retrosynthetic analyses for the total syntheses of chlorins and bacteriochlorins 
Synthesis of chlorins typically began from the functionalization of 5-aryldipyrrine 
7.30 For instance, simple formylation (Ar1 = H) was done under standard Vilsmeier-Haak 
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condition while the installment of aryl ketone (Ar1 = p-tolyl) was done by treating 7 with 
3 mol equiv. of EtMgBr followed by a reaction with pyridyl-methylbenzothioate at -
78°C.30 The resulting carbonyl 8 (of both Ar1 = H or p-tolyl) were subjected to further 
modulation, for instance regioselective NBS bromination, to complete the “eastern-half” 
9 of the chlorin. A fusion of 9 with the “western half” 10 under acidic condition (TFA or 
TsOH·H2O) results in, formation of free-base chlorins 11.  
 
 
Scheme 1-3. Lindseyʼs total synthesis of chlorins 
In addition to the various functionalization of dipyrrolic fragments, Lindsey and 
co-workers demonstrated that the functionalization, typically transition-metal mediated 
coupling reactions, could also take place after the tetrapyrrolic macrocycle 
formation.33,41,42 Depicted in Scheme 1-4 are two complementary functionalization 
approaches.  In the post-cyclization approach, regioselective NBS-bromination of 12 
takes place to give 5-bromochlorin 13. A Pd-mediated coupling then introduces a new 
Chapter 1: General Introduction 
 14 
substituent (i.e. phenyl in 14). 33,41,42 On the other hand, a ring-fusion between two 
bromine-containing dipyrrine halves (15 and 16) in the pre-cyclization approach directly 
provides dibromochlorin 17.  The two bromo-groups of 17 could then undergo Pd-
mediated coupling, introducing two new functional groups simultaneously (i.e. alkyne in 
18). 42 
 
Scheme 1-4. Two complementary approaches towards chlorin functionalizations 
The two approaches mentioned above can be used sequentially for the annulation 
of chlorins, enabling a formation of a macrocycle known as phorbine.  For example, 
monobromochlorin 19, made by modified pre-cyclization approach, is first acetylated via 
Stille coupling to provide 20.  Then the selective NBS bromination, the post-cyclization 
modulation, takes place to provide 5-bromochlorin 21.  Finally, the second palladium 
coupling completes the exocyclic fusion to provide phorbine 22.33 
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Scheme 1-5. 5-annulated chlorin (phorbine) 22 synthesis. 
1.5.2.  Total Syntheses of Bacteriochlorins  
Bacteriochlorins, particularly the two-fold symmetric bacteriochlorin shown 
(Scheme 1-2), can be made by a head-to-tail fusion of two identical gem-dimethyl-
dihydrodipyrrin building blocks. Even though this approach requires a multi-step 
synthesis of the dihydrodipyrrin building block, it is attractive in several respects: self-
condensation of a self-complementary dihydrodipyrrin requires only one dipyrrolic 
intermediate, thus significantly reducing the number of synthetic steps; it introduces two 
pyrroline moieties simultaneously, furnishing a bacteriochlorin chromophore in a single 
step without the need for further redox steps; it enables access to bacteriochlorins 
carrying few β- or meso-substituents, allowing broad post-synthetic functionalization but 
also allowing direct access to broadly derivatized bacteriochlorins by use of appropriately 
substituted pyrroles (that form the dihydrodipyrrin); the gem-dimethyl moieties provide 
oxidation protection in the bacteriochlorins; lastly, the synthesis of the starting materials 
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is scalable and the bacteriochlorin-forming reactions allow, arguably for the first time, 
access to significant (mmol range) quantities of synthetic regio- and stereo-chemically 
pure bacteriochlorins. 
 The bacteriochlorin macrocycle is formed by acid-catalyzed head-to-tail self-
condensation of two dihydrodipyrrin dimethyl acetals 23 (Scheme 1-6). In general, the 
reaction conditions resembled those of previous chlorin chemistry;35,36 the dihydro-
dipyrrin-acetals were stirred in moderately polar solvents at room temperature in the 
presence of an acid catalyst. Since the building blocks provide all framework atoms in 
their proper oxidation states, no oxidation step is required.25,34 
 
Scheme 1-6. Synthesis of bacteriochlorins and tetrahydrocorrin 
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 The reaction produces three major products: The desired 5-methoxybacterio–
chlorin 24, bacteriochlorin 25, and tetradehydrocorrin 26. The yields and product 
distributions vary widely and appear to be dependent on the combination of particular 
β-substituents and catalyst that were used.25,34 The cyclization reaction is also subject to a 
considerable amount of steric effects. 
Addition of functionalities onto porphyrins using transition metal-mediated 
coupling reactions has become standard methodology.43-47 Accordingly, meso- and 
β-brominated bacteriochlorins of type 27 and 29 are also susceptible to a number of 
reactions (Scheme 1-7). A variety of functionalities have been introduced at the 
15-position of 15-bromobacteriochlorin 27 using palladium-mediated coupling reactions: 
Mono- and di-substituted aryl groups were added using Suzuki protocols, while 
Sonogashira and Buchwald-Hartwig protocols were employed for the introduction of 
alkyl and amide functionalities, respectively.32 Functionality such as tethers to attach 
bacteriochlorins to a surface (for photophysical studies) were also introduced.31  
Similarly, β-bromobacteriochlorins such as 29 can also go through a variety of 
standard Pd-mediated coupling reactions to provide bis-substituted bacteriochlorins 30.29 
In addition, 3,13-biscyanation (concomitant with adventitious zinc insertion) was 
accomplished using zinc(II) cyanide,29 while a palladium-mediated carbonylation 
reactions in the presence of a number of nucleophiles furnished carbonyl derivatives such 
as acids (using sodium hydroxide as nucleophile), esters (using sodium methanolate) and 
aldehydes (using tri-tert-butyl tin hydride).29 Stoichiometric amounts of palladium 
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reagent were required to improve the yield of these reactions. In the presence of formic 
acid, a palladium-mediated hydrodehalogenation took place.29 Subsequently, the diacids 
of type 30 could also be converted into the acid chlorides, and the acid chlorides reacted 
with amines to provide amides.48 
 
Scheme 1-7. Pd-catalyzed modification of bacteriochlorins 
 Bacteriochlorins 31 with two, four, or six quaternized ammonium groups (Figure 
1-8) or two basic amine groups (not shown) were compared for light-mediated killing 
against a Gram-positive bacterium, a Gram-negative bacterium, a dimorphic fungal yeast, 
and human HeLa cancer cells.48 This report established cationic bacteriochlorins as 
extremely active and selective NIR-activated photoantimicrobials. 
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Figure 1-8. Examples of bacteriochlorins bearing quaternized ammonium groups 
 Both, the five- and six-membered annulated systems were synthesized using 
similar approaches mentioned above.49 Thus, regioselective bromination of diacetyl-
bacteriochlorin 32 forms bromobacteriochlorin 33 (Scheme 1-8). The subsequent 
palladium-mediated α-arylation of the adjacent 13-acetyl group give rise to the exocyclic 
cyclopentanone moiety, forming bacteriopheophorbide 34.  
 
Scheme 1-8. Synthesis of bacteriopheophorbide 
The synthesis of bacteriochlorindicarboxylimides 37 followed a similar approach 
(Scheme 1-9). In this case, however, the ester functionalities of 35 were introduced at the 
pyrrole stage of the synthesis. Selective meso-bromination gave 2,12-diethyl-3,13-
diethylester-15-bromobacteriochlorins 36. Finally, palladium-mediated carbamoylation 
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resulted in ring-closure to provide the exocyclic dicarboxylimide moiety of 
bacteriochlorins 37.  
 
Scheme 1-9. Synthesis of bacteriochlorindicarboxylimides 
1.5.3.  Syntheses of Pyrrole-Modified Chlorins and Chlorin Analogues 
In synthetic porphyrin chemistry, many principle approaches can be taken to 
achieve the conversion of porphyrins to chlorins.50 Conceptually, the most straight-
forward method for converting porphyrins to chlorins, or bacteriochlorins is by reduction. 
However, classic reduction conditions, such as H2/Pt or Pd-C, are unsuitable, as they tend 
to also reduce double bonds at the meso-positions.51  
 In 1969, Whitlock and co-workers reported a hydrogenation of porphyrins 6 using 
diimide (HN=NH), which is generated in situ by heating tosyl-hydrazine in base, to 
produce dihydrochlorin 38 and tetrahydrobacteriochlorin 39 (Scheme 1-10).3 This 
reaction accomplished regioselective β,β’-double bond reduction of porphyrins but the 
use of it was limited, largely due to extremely difficult product isolation.  Moreover, its 
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instability towards oxidation (facile conversion back to porphyrin 6) considerably limited 
the synthetic value of 38.  
 
Scheme 1-10. Bacteriochlorins via reduction of β,β’-double bonds 
 The osmium tetroxide-mediated dihydroxylation of a β,β’-bond of octaalkyl-
porphyrins was discovered by Fischer in 1940.52 This reaction highlights the pseudo-
olefinic nature of the porphyrin β,β’-bonds and has found widespread use in the 
formation of chorins, bacteriochlorins, and isobacteriochlorins.53-64 However, the reaction 
is slow compared to the osmylation/dihydroxylation of true olefins, and no system has 
been reported in which the dihydroxylation of porphyrins was performed using catalytic 
amounts of osmium tetroxide.  
Surprisingly, it took until 1995 before the application of this reaction to meso-
tetraarylporphyrins was reported.65-69 meso-Tetraaryldiolchlorins 40 is obtained by the 
dihydroxylation of meso-tetraarylporphyrin 6 (Scheme 1-12). The reaction is performed 
using a stoichiometric quantity (or even a stoichiometric excess) of osmium tetroxide in 
the presence of pyridine (as co-solvent and accelerator of the osmylation reaction).70 The 
initially formed osmate ester is reduced in a separate step with H2S.71 As in the diimide 
reduction, this oxidation is highly regioselective.65,72 The product, unlike 38, contains 
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functional groups that can be subjected to further synthetic modulations.50 Particularly, 
our group has utilized this functional group extensively to synthesize a number of unique 
chlorin-analogues.  This principle approach to the synthesis of chlorin analogue will be 
referred hereon as the “breaking and mending approach”.   
The breaking and mending approach begins by first converting simple porphyrins, 
typically tetraarylporphyrins 6, into diols via OsO4-mediated dihydroxylation.  The 
β,β’-carbon bond of diol is oxidatively cleaved using NaIO4 or Pb(OAc)4, initiating the 
“breaking” process, to form bisaldehyde secochlorins 41. This bisaldehyde sets the stage 
for a variety of multistep “mending” processes. For instance, a five-membered pyrrole in 
porphyrin can be contracted into four-membered azete in three steps (42 in Scheme 1-
11).73 On the other hand, the bisaldehyde can be expanded into six membered rings.  
These examples include formation of morpholine (43) and pyrazine (44). 74-77 In a more 
unique case, acid treatment of bisaldehyde causes the annulation to takes place with the 
flanking phenyl groups, giving rise to a seco-chlorin derivative known as indaphyrin 
(45).78 Alternatively, a replacement of a β-carbon atom by a heteroatom results in a 
formation of heterocyclic porphyrinoids.  Noteworthy examples here include formation 
porpholactam (46),79 imidazoloporphyrin (47),80 and porpholactone (48).75,81  
Chapter 1: General Introduction 
 23 
 
Scheme 1-11. Chlorin-analogue synthesis via the “Breaking and Mending” approach  
 All in all, this “breaking and mending” principle has proven to be a very effective 
way to construct a number of novel and unique synthetic porphyrinoid macrocycles.  In 
addition, the series of synthetic methodologies developed by Brückner and co-workers 
also highlights the importance and the unique chemical plasticity of bisaldehyde-
secochlorins.  
1.5.4. Syntheses of Pyrrole-Modified Bacteriochlorins and Bacteriohlorin Analogues 
 The synthesis of chlorins mentioned above can also be applied to synthesize 
bacteriochlorins.  For instance, diimide reduction of porphyrins can be pushed to form 
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bacteriochlorins 39 as the major product by using excess reducing agent. Likewise, meso-
tetraaryltetraolbacteriochlorins 49 can be obtained either by the dihydroxylation of meso-
tetraaryldiolchlorin 40 or by reaction of porphyrins 6 with (at least) a two-fold molar 
excess of osmium tetroxide. The product is a mixture of two isomeric bacteriochlorins in 
a 3:1 ratio with the higher polarity trans-isomer being the major product. The two 
isomers vary with the relative orientation of the two vic-diol functionalities (cis/trans-
isomers, shown in Scheme 1-12).  
 
Scheme 1-12. Bacteriochorin via OsO4—-mediated dihydroxylation of porphyrins 
 Analogous to the pyrrole-modified chlorin syntheses, bacteriochlorins such as 49 
can also be subjected to a “breaking and mending” protocol. Samankumara et al. recently 
reported on the expansion of one or two pyrrole(s) to form morpholine-containing 
bacteriochlorins 50 and 51 (Scheme 1-13). This mono- and bis-ring expansion of pyrroles 
can be controlled by simple methyl ether protection of the diol functional group. For 
instance, when one of the two diol moieties is protected (49 when R = Me), NaIO4-
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mediated cleavage results in selective formation of one morpholine ring, giving rise to 
dimethoxy-morpholinobacteriochlorin 50. On the other hand, when tetraolbacteriochlorin 
(49 when R = H) is treated with NaIO4, simultaneous oxidative cleave of two diol groups 
results in the formation of bismorpholinobacteriochlorin 51. Exposing the mono- and 
bismorpholinobacteriochlorin to acid (i.e. TFA) causes ring fusion with the nearby 
flanking phenyl group(s), forming mono- or bis-annulated morpholinobacteriochlorins, 
52 and 53 respectively.51 
  
Scheme 1-13. Expanded bacteriochlorins syntheses 
Two independent 1,3-dipolar cycloadditions to two β,β’-positions in porphyrins or 
a single 1,3-dipolar cycloaddition to a β,β’-position of a chlorin are another option for the 
conversion of porphyrins or chlorins into bacteriochlorins. For instance, a reaction of 
porphyrin 54 with 1,3-dipoles, such as azomethine ylides, give rise to a regio-isomeric 
mixtures of bacteriochlorins 55.82-85 Other examples of bacteriochlorin syntheses 
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involving 1,3-dipolar cycloaddition include reactions with nitrile oxides,86-89 nitrones,90 
nitrile imines,91 and carbonyl ylides92.  
Similarly, bacteriochlorins can also be derived via Diels-Alder reaction.  In 
principle, this can take place in two ways: porphyrin as dienes and as dienophiles. In 
either case, the porphyrin β,β’-double bond involved is transformed into a single bond, 
thus generating chlorin- and/or bacteriochlorin-type chomophores.51 One example, 
reported by Cavaleiro and co-workers, is the reaction of porphyrin 54 with diene-o-
benzoquinodimethane, generated in situ by thermal extrusion of SO2 from a sulfone, to 
form bacteriochlorin 56 (Scheme 1-14).93,94  
 
Scheme 1-14. Bacteriochlorins via 1,3-dipolar cycloaddition and Diels-Alder reaction 
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2.  Introduction to Oxazole-Containing Porphyrinoids 
2.1.  Nomenclature Conventions 
There is no firmly established trivial nomenclature for most porphyrinoids. Thus, 
we define oxazoloporphyrins to be porphyrin-like chromophores in which a single 
pyrrole was replaced by an oxazole moiety (i.e. porpholactone 5) and oxazolochlorins to 
be chlorin-type chromophores in which a single pyrrole was replaced by an oxazoline 
moiety (i.e. porpholactol 11H2).  
2.2.  Porpholactones 
In a seminal contribution by Crossley and King more than 25 years ago,1 it was 
recognized that oxidation of β-substituted porphyrins, such as dione 6 (prepared from 1 
via 2, 3, or 4), can lead to the loss of one β-carbon and the formal replacement of the 
porphyrinic β,β’-bond by a lactone moiety, forming porpholactone 5 (Scheme 2-1). One 
other serendipitous finding five years later identified strongly oxidizing reaction 
conditions (AgNO3 in refluxing acetic acid containing oxalate) that were suitable for 
converting porphyrin 1 (with Ar = C6F5) directly into a porpholactone.2,3 Additional 
specialized reaction pathways toward porpholactones have been discovered since, such as 
the singlet oxygen oxidation of β-aminoporphyrin 4 (Scheme 2-1).4 Select oxidations of 
dione 6 also lead to porpholactones, perhaps shedding light on a possible reaction 
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mechanism toward the formation of porpholactones 5.5 Porpholactones also appeared as 
adventitious products in a variety of oxidation reactions of β-derivatized porphyrins.5-7 
 
Scheme 2-1. Literature-known syntheses of porpholactone 5. Only free bases are shown but 
some transformations may require metal complexation, or metal insertion takes place during 
the transformation 
Since its discovery, porpholactones have been demonstrated to be of practical 
value: The Fe(III) and Fe(IV)=O+ complexes of meso-tetrakis(2,6-dichlorophenyl)-
substituted porpholactone were used as model compounds for naturally occurring chlorin-
type prosthetic groups.4 The catalytic activity of the Fe(III)Cl and Mn(III)Cl complexes 
of meso-tetrakis(phenyl)porpholactone with respect to olefin epoxidation and sulfide 
oxidation reactions were tested.8,9 [meso-Tetrakis(pentafluorophenyl)porpho-
lactonato]Pt(II) is a promising component in pressure sensitive paints,10-12 allowing the 
imaging of air flow around objects.13 This complex can also be utilized as a high pH 
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sensor in the range of pH 11.5–13.14 Despite their increasing utility and the emergence of 
their unique reactivity, a rational, general, and high-yielding synthesis of meso-tetraaryl-
porpholactones was only published recently.15,16  
2.3.  Rational Syntheses of Porpholactones  
The process of OsO4-mediated dihydroxylation of meso-tetraarylporphyrin 1 to 
produce dihydroxychlorin 7 was first reported by Brückner and Dolphin.17 Oxidation of 
this diol 7 with MnO4– produced porpholactone 5 in a single step (Scheme 2-2). The 
source of MnO4- can either be an excess of powdered KMnO4 suspended at ambient 
temperature in an organic solvent (toluene, CH2Cl2, CHCl3, THF) in the presence of the 
phase-transfer agent 18-crown-6, KMnO4 heterogenized on silica gel or in the form of 
cetyltrimethylammonium permanganate (CTAP). 
 
Scheme 2-2. Synthesis of porpholactones 5 by oxidation of 2,3-dihydroxychlorins 7 
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The osmate esters were also susceptible to CTAP oxidation to the corresponding 
porpholactones but the reaction was slower than the reaction of the corresponding 
alcohols, and the fate of the osmium remained unknown. Given the high toxicity of OsO4 
that potentially forms as a side product,18 the oxidation of the diol was given preference 
over the oxidation of the corresponding osmate ester. This methodology is considered to 
be fairly general as it was applicable to the oxidation of free base dihydroxychlorin 7, its 
Ni(II), Zn(II), Ag(II), and Pt(II) complexes, to diol chlorins carrying a variety of electron-
donating and -withdrawing meso-phenyl substituents.14 
The exact mechanism of formation of the porpholactones remains unclear. 
Permanganate oxidation of dihydroxychlorin 7 suggests the formation of secochlorin 
biscarboxylate 10. In fact, Crossley already surmised that the as yet unobserved 
secochlorin 10 is the immediate precursor to porpholactone 5.1 Other reactions that 
reasonably can be expected to produce the biscarboxylate species also generate porpho-
lactones. For instance, an attempted silver ion insertion into free base bisaldehyde 9 
(using excess Ag(I) in pyridine, heat) results in [porpholactonato]Ag(II) 5Ag in mediocre 
yield (~20%).6 Independent evidence points toward 2,3-dioxochlorins of type 6 to be the 
key intermediates in the conversion of porpholactones.5,19 Since porpholactones 
frequently also appear as adventitious (by)products in a number reactions that treat 
(β-derivatized) porphyrins under a variety of oxidizing conditions,1,2,5,6 one may regard 
porpholactones as the thermodynamic sink in the β,β’-oxidative degradation pathway of 
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porphyrins. As such, it can be reasonably assumed that multiple pathways lead to this 
product. 
2.4.  Reductions of Porpholactones 
The carbonyl moiety of the porpholactone is susceptible towards several types of 
functional group transformations.7,20-22 For instance, a DIBAl-H reduction of the 
porpholactone 5aZn produces 11Zn in relatively high yield. The reduction of free base 
porpholactones (5H2) is complicated by the formation of aluminum containing side 
products, as low valent aluminum species are known to metalate free base porphyrins.23 
As a result, the free base porpholactol 11H2 is prepared by the reduction of the zinc 
complex 5aZn, followed by an acid-mediated (HCl) demetallation. The hemiacetal 
moiety of porpholactol (freebase or metal-complex) can be further reduced. An acid-
catalyzed (BF3⋅OEt2 or Amberlyst 15, H+ form) hydro-dehydroxylation using silyl-
hydride (Et3SiH) converts porpholactol 11H2 to oxazolochlorin 12H2 (Scheme 2-3). 
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Scheme 2-3. Reduction of Porpholactone 5 
The methylene group of 12H2 is located in a benzylic position with respect to the 
porphyrinoid aromatic system and α to an oxygen atom in the oxazole moiety. For this 
reason, it is highly activated and extremely sensitive toward (photo-sensitized) oxidation 
back to porpholactol 11H2 
2.5.  Optical Properties of Oxazoloporphyrins and -chlorins 
Free base porpholactones possess UV-visible and fluorescence emission spectra 
that are almost indistinguishable from those of the corresponding porphyrins (Figure 2-1). 
The similarity of the porphyrin and porpholactone spectra, noted already upon their 
discovery,1,2 is surprising as the modified pyrrolic moiety has lost its cross-conjugated 
β,β’-double bond. Therefore, porpholactones could have been expected to possess 
chlorin-like spectra.24 Evidently, however, the electronic effects of the carbonyl double 
bond mimic the presence of a β,β’-double bond. On the basis of iterative extended 
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Hückel calculations, Gouterman and co-workers categorized porpholactones to lie 
between porphyrins and chlorins.2 
 
Figure 2-1. Normalized UV-visible (solid traces) and fluorescence spectra (broken traces) of 
the compounds drawn (all in CH2Cl2 at ambient temperature) 
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The reduced porpholactones, 3-hydroxy-2-oxachlorins 11H2 (λmax = 646 nm) and 
11Zn, both possess chlorin-like optical spectra (cf. to the spectra for 7aH2, (λmax = 648 
nm, and 7aZn). The influence of the 3-hydroxyl functionality on the 2-oxachlorin 
chromophore is profound. The removal of this group in the free base chromophore 12H2 
results in a 22 nm red-shift (λmax = 668 nm) in the UV-visible spectrum. The distinct 
blue-shifts caused by OH-substitution of chlorin pyrrolines has been previously 
reported.25 Most surprisingly, the removal of the hydroxy group also results in a 
significant enhancement of the extinction coefficient of the Qx band relative to its Soret 
band. Thus, replacement of the CH2CH2 group in chlorins by a CH2O group has an 
auxochromic effect, adding to the collection of groups that are known to substantially 
modify the chlorin chromophore.26 A rationalization for this observation through 
computational studies has also been reported.15 
2.6.  Other Oxazole-Containing Porphyrinoid Macrocycles 
In 2011, an example of a 3,3-dimethyl-oxazole-containing phthalocyanine-
analogue 15, made by total synthesis, was reported (Scheme 2-4).27 Mixed condensation 
of either phthalonitrile (13) (or phthalimide) and 5,5-dimethyl-1,3-oxazolidine-2,4-dione 
(14) in the presence of nickel chloride and a ammonium molybdate catalyst (MOA) in 
quinoline at 250 °C led to a mixture of [phthalocyaninato]Ni(II) (PcNi) as the main 
product and 2,2-dimethyl-3-oxa-tri(1,2-benzo)tetraazachlorin (15) as a sparingly soluble 
product in 4.2% yield that required HPLC purification.  
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Scheme 2-4. Synthesis of 2,2-dimethyl-3-oxa-tri(1,2-benzo)tetraazachlorin (15) according to 
Dudkin et al.27  
Pawlicki and Latos-Grazynski reported the total synthesis of 18, the 
carbaporphyrin analogue to 3-methoxy-2-oxachlorin 17 (Scheme 2-5).28,29-31 Carba-
porphyrins are porphyrin analogues containing a carbon atom in place of an inner 
nitrogen. This reaction is in contrast to our ‘breaking and mending of porphyrin’ strategy 
toward porpholactones 5. Multi-step oxidation of 18 led to the formation of 19, the 
carbaporphyrin analogue to porpholactone 5. 
 
Scheme 2-5. Synthesis of 2-oxa-21-carbaporphyrin 16, 2-oxa-3-ethoxy-21-carbachlorin 18, 
and 2-oxa-3-oxo-21-carbaporphyrin 19 
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Crossly and King have long been regarded as the pioneers of oxazole-containing 
porphyrins. However, we discovered recently that Gurinovich and co-workers in fact 
reported the first example of oxazole-containing porphyrins in 1977. Remarkably, a 
standard ozonolysis at -100°C converted the starting material 20 to product 23 in one 
step. Presumably, the pseudo-olefinic β,β’-double bond of 20 reacts with ozone to form 
molozonide intermediate 21 first. Then the series of rearrangements take place to form 
more stable ozonide intermediate 22. The peculiar loss of one β−carbon (and its ethyl 
substituent) likely occurs at this stage to form 23 (Scheme 2-6).32 
 
Scheme 2-6. Synthesis of alkyloxazolochlorin by the group of Gurinovich via ozonolysis of 
octaethylporphyrin  
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3.  Aim of this Thesis 
The overarching aim of this thesis is the study of the scope and limits of the 
syntheses of mono- and bisoxazole-containing chlorin- and bacteriochlorins-like 
chromophores.  
Previous work has shown that a replacement of a chlorin β-carbon with an oxygen 
drastically intensifies and red-shifts its optical spectra but their chemical stability was 
low. This prompted us to develop methodologies to synthesize a class of β-alkylated 
oxazolochlorins that were predicted to be more stable. Furthermore, we adopted known 
and novel techniques to the generation of hitherto unknown oxazole(s)-containing 
bacteriochlorin chromophores.  
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4.  Diphenylporpholactones 
4.1.  Introduction 
 During the single crystal X-ray structural evaluation of porpholactones, it was 
noticed that the oxazolone moiety of 1Zn, more specifically the carbonyl moiety, was not 
perfectly co-planar with the macrocycle.1 We proposed that the effect may originate from 
a steric interaction between the carbonyl oxygen and the flanking phenyl group. To test 
whether other experimental evidence can be found for a significant steric interaction 
between the lactone carbonyl and the flanking phenyl group, we set out to prepare 
porpholactones from the less sterically hindered 5,15-diphenylporphyrin DPP. We 
hypothesized that the key MnO4-mediated oxidation step will display regioselectivity 
towards formation of the less sterically hindered product (4-II).  
 
4.2.  Results and Discussion 
4.2.1.  Synthesis of 5,15-Diphenylporpholactone 
 The 5,15-diphenylporphyrin DPP, was synthesized in a step-wise manner, 
following the procedure described by Boyle and co-workers.2 Thus, 5-phenyldipyrro-
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methanes 2 were first synthesized by reacting benzaldehyde with excess pyrrole.  The 
phenyldipyrromethanes 2 are isolated from the side-products, namely their trimer and 
tetramer analogues, through sublimation at 120°C under high vacuum. These dipyrrolic 
fragments were then subjected to an acid-mediated condensation reaction with trimethyl-
orthoformate to form the tetrapyrrolic framework of 5,15-diphenylporphyrin DPP.  
OsO4-mediated dihydroxylation, followed by H2S-reductive cleavage transformed 
DPP into known 5,15-diphenyl-2,3-dihydroxychlorin 3 (Scheme 4-1).3,4   
 
Scheme 4-1. Synthesis of 5,15-diphenylporpholactone 4 I/II and its zinc complex 4-II-Zn 
The CTAP oxidation of dihydroxychlorin 3 proceeded smoothly and rapidly, 5 
producing pink non-polar product with a porphyrin like UV-vis spectrum. Based on the 
previously reported syntheses of meso-tetraphenylporpholactones 1,5 along with the HR-
MS data, the product was identified as the lactone 4. The 1H NMR of 4 indicated the 
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presence of two isomers in a ~1:5 ratio. Repeated preparative plate chromatographies and 
recrystallizations (CHCl3 → MeOH) allowed the isolation of a pure fraction of the 
majority product, but the minority product could not be isolated in pure form in high 
enough yields to perform a full analysis. 1D and 2D-NMR spectroscopy (see 
experimental section) allowed the unambiguous assignment of the majority product as the 
2-oxo-3-oxa isomer 4-II, that is unaffected by any steric interaction between the lactone 
carbonyl and a phenyl group. This was confirmed by single X-ray crystal structure 
elucidation of 4-II-Zn, as its pyridine adduct, formed by zinc insertion into the free-base 
(Figure 4-1). 
Alternatively, DPP can be directly converted into 4 at room temperature upon 
treatment with excess CTAP (30% combined yield). This direct-oxidation route change 
the regioisomeric ratio as it maintained the ~5:1 regioselectivity (favoring 4-II).  This 
consistency of the diastereomeric ratio hints at the possibility of this reaction following a 
similar mechanistic path to that of the original reaction sequence (DPP→3→4). To our 
surprise, over-oxidations to form diphenylporphodilactone were not observed even with 
the excessive use of oxidant and/or extended reaction time. Despite numerous attempts, 
direct oxidations of meso-tetraphenylporphyrins to form 1 were unsuccessful using this 
method. The direct oxidation to form 1, however, can be accomplished using the Ru-
catalyzed system as recently reported by the group of Zhang.6 
The fact that the seemingly less sterically inhibited isomer forms in preference 
over the other isomer serves as an indication for the existence of a small but noticeable 
steric interaction between the carbonyl and the phenyl group. Most significantly, the 
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macrocycle conformation (Figure 4-1) shows that the lactone moiety is near-perfectly co-
planar with the oxazole moiety and that the macrocycle of 4-II-Zn is overall significantly 
more planar than that of the tetraaryl analogue 1Zn. This provides the most convincing 
proof for the rationalization of the non-planar arrangements of the lactone moiety with 
the porphyrins in 1 and 1Zn on steric grounds.  
 
Figure 4-1. Single crystal X-ray structures of 1-Zn (left) and 4-II-Zn (right) 
We observed reduced disorder in the structure of 4-II-Zn versus that observed in 
porpholactone 1, and thus can more reliably determine the bond lengths in the oxazolone 
ring (Figure 4-1). The C=O lengths in 4-II-Zn range from 1.106(3) to 1.228(3) Å, while 
the C-O lengths vary between 1.357(3) to 1.486(8) Å (there are two independent 
molecules per unit cell). Compared to the free-base porpholactones 1, these bond length 
changes compared to the porpholactone free-base support a chlorin rather than a 
porphyrin-like electronic structure.  
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4.2.2.  Optical Properties of 5,15-Diphenylporpholactone 
Generally, the absorption spectra of 5,15-diphenylporphyrin derivatives are 
slightly blue-shifted compared to their tetraphenyl analogues.1,4 This also translated to the 
diphenyldihydroxychlorins and diphenylporpholactones (Figure 4-2).  
  
Figure 4-2. Normalized UV-vis absorption spectra comparison of 1-Zn and 4-II-Zn free-base 
(top) and zinc complexes (bottom) 
 The UV-visible absorption spectra of diphenylporpholactone 4-II and its zinc 
complex 4-II-Zn, when compared to their tetraphenyl analogues, possessed ~10 nm blue-
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shift at all Q-bands.  Overall, the absorption spectra of 4-II and 4-II-Zn closely 
resembled those of their corresponding tetraphenyl analogues.   
4.3.  Conclusion 
5,15-diphenylporpholactones were synthesized and structurally characterized, 
displaying their structural relationship to the corresponding porphyrins but also 
suggesting the presence of a steric interaction between the oxazolidone moiety with the 
flanking phenyl group. As hypothesized, the lactone-forming reaction displayed 
regioselectivity towards the formation of less-sterically hindered isomer. The similarity 
of the optical properties of porphyrins and porpholactones highlight their close electronic 
relationship.  
4.4.  Experimental Section  
4.4.1.  Instruments and Materials 
Column chromatography was performed using preparatory plate or manual glass 
column using normal phase silica. The fluorescence quantum yields(φ) were determined 
relative to those of meso-tetraphenylporphyrin (φ = 0.11 in benzene, calculated to be 0.09 
in CH2Cl2); λexcitiation = λSoret. For details of the instruments used, see List of Instruments. 
4.4.2.  Preparation and Characterization 
5,15-Diphenylporpholactones 4-I and 4-II. In a 50 mL round bottom flask 
shielded from light with aluminum foil, diphenyldihydroxychlorin 3 (50 mg, 5.7 × 
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10-5 mol) was dissolved in CHCl3 (20 mL). The solution was stirred magnetically and 
cetytrimethylammonium permanganate (CTAP) was added (69 mg, 0.17 mmol, ~3 equiv) 
at ambient temperature. TLC was used to monitor the formation of a bright pink, non-
polar spot. UV-visible spectroscopy was used to monitor the disappearance of the chlorin 
peak (at ~650 nm) and the formation of porphyrin-like peaks. The reaction was stirred 
until the full consumption of 3 was observed (~2 h). The products were then isolated by 
flash chromatography (silica, CH2Cl2), providing an isomeric mixture (approximate ratio 
5:1 by 1H NMR; see ESI) of the diphenylporpholactones in high (~80%) yield. The 
isomers were separated by preparative TLC (silica-50% petroleum ether 30-60/CHCl3) 
but compound 4-I could not be isolated in high purity in large enough quantity for its full 
characterization. 4-II. Rf (silica–CH2Cl2) = 0.84; 1H NMR (300 MHz, CDCl3, δ): 10.10 
(s, 1H), 10.03 (s, 1H), 9.34 (dd, 3J = 4.9 Hz, 4J = 1.8 Hz, 1H), 9.21 (d, J = 4.6 Hz, 1H), 
9.09 (d, J = 4.5 Hz, 1H), 9.03 (dd, 3J = 4.8 Hz, 4J = 1.8 Hz, 1H), 8.96 (d, J = 8.0, 4.7 Hz 
1H), 8.85 (d, J = 8.0, 4.5 Hz, 1H), 8.18-8.22 (m, 4 H), 7.77–7.85 (m, 6H), –1.99 (s, 1H), 
–2.58 (s, 1H) ppm; 13C NMR (100 MHz, CDCl3, δ): 170.2, 155.2, 154.9, 154.7, 141.4, 
140.8, 137.6, 137.4, 137.0, 136.7, 135.4, 134.7, 134.6, 132.9, 131.8, 131.1, 129.9, 129.0, 
128.4, 128.3, 128.25, 127.5, 127.3, 126.3, 124.3, 107.0, 102.6, 101.1 ppm; UV-vis 
(CHCl3) λmax (log ε): 409 (5.23), 511 (3.92), 549 (4.00), 581 (3.76), 633 (3.81) nm; HR-
MS (ESI+, 100% CH3CN, TOF): m/z calc’d for C31H21N4O2 (MH+): 481.1665, found 
481.1629. 
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Figure 4-3. 1H NMR (400 MHz, CDCl3) of a mixture of the two regio-isomers of 5,15-
diphenylporpholactones, 4-I and 4-II 
 
 
Figure 4-4. 1H NMR (300 MHz, CDCl3) of 4-II. Assignment of proton signals as shown, and 
based on the 2D spectra shown below 
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Figure 4-5. 13C NMR (100 MHz, CDCl3) of 4-II 
 
 
Figure 4-6. NOESY Spectrum (300 MHz, CDCl3) of 4-II 
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Figure 4-7. FT-IR spectrum (neat, diffuse reflectance) of 4-II 
[5,15-Diphenylporpholactonato]Zn(II) (4-II-Zn). To a stirring solution of 4-II 
(30 mg, 6.3 × 10-5 mol) in CHCl3 (~5 mL), was added a solution of Zn(OAc)2·4 H2O in 
MeOH (27 mg, 1.3 × 10-4 mol, ~2 equiv). The mixture was heated to reflux for ~1 h. TLC 
was used to monitor the formation of a more polar green product. Upon completion, the 
solvents were evaporated using rotary evaporation and the product was isolated by 
column chromatography (silica, 1% MeOH/CH2Cl2) to provide 4-II-Zn in near 
quantitative yield (33 mg). Rf (silica, 1% MeOH/CH2Cl2) = 0.46; 1H NMR (300 MHz, 
CDCl3, δ): 9.84 (s, 1H), 9.69 (s, 1H), 9.16 (d, J = 4.7 Hz, 1H), 9.08 (d, J = 4.5 Hz, 1H), 
8.95 (d, J = 4.3 Hz, 1H), 8.83-8.87 (m, 3H), 8.08-8.15 (m, 4 H), 7.76-7.79 (m, 6H) ppm; 
UV-vis (CH2Cl2) λmax (log ε): 416 (5.81), 514 (3.76), 553 (4.33), 597 (4.79) nm; MS 
(ESI+, 100% CH3CN, 30 V cone voltage): m/z = 543.1 (MH+); HR-MS (ESI+ of MH+, 
100% CH3CN, TOF): m/z calc’d for C31H19N4O2Zn: 543.0799, found 543.0833. 
N
NH
O
N
HN
Ph
Ph
O
3
2
Chapter 4: Diphenylporpholactone 
 59 
 
 
Figure 4-8. 1H NMR (300 MHz, CDCl3) of 4-II-Zn 
 
 
Figure 4-9. FT-IR spectrum (neat, diffuse reflectance) of 4-II-Zn 
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4.4.3.  X-ray Crystallography Data 
X-ray crystallographic analysis (provided by Dr. Christopher Ziegler, University 
of Akron):  X-ray intensity data were measured at 100 K (Bruker KYRO-FLEX) on a 
Bruker SMART APEX CCD-based X-ray diffractometer system equipped with a Mo-
target X-ray tube (λ = 0.71073 Å) operated at 2000 W power.  The crystals were mounted 
on a cryoloop using Paratone N-Exxon oil and placed under a stream of nitrogen at 100 
K.  The detector was placed at a distance of 5.009 cm from the crystals. The data were 
corrected for absorption with the SADABS program.  The structures were refined using 
the Bruker SHELXTL Software Package (Version 6.1), and were solved using direct 
methods until the final anisotropic full-matrix, least squares refinement of F2 converged.  
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 Crystal Structure Report for 4-II-Zn·py. Purple crystals of 4-II-Zn·py. were 
grown by diffusion of MeOH into a CH2Cl2 solution of the complex.  A 0.10 × 0.20 × 
0.20 crystal was mounted. 
 
Figure 4-10. ORTEP representation and numbering scheme used in the crystal structure of 
4-II-Zn·py. Minor disordered moieties are omitted for clarity 
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Table 4-1. Crystallographic and structure refinement data for 4-II-Zn·py. 
Chemical formula C36H23N5O2Zn 
Mr 622.96 
Cell setting, space group Triclinic, P  
Temperature (K) 100 (2) 
a, b, c (Å) 10.4629(19) 
13.445(2) 
20.798(4) 
α, β, γ (°) 91.532(3) 
91.461(3) 
108.916(3) 
V (Å3) 2764.9(9) 
Z 4 
Dx (Mg m–3) 1.494 
Radiation type Mo Ka 
m (mm–1) 0.933 
Crystal form, colour block, dark green 
Crystal size (mm) 0.20 × 0.20 × 0.10 
Diffractometer CCD area detector 
Data collection method φ and w scans 
Absorption correction Multi-scan  
 Tmin 0.3844 
 Tmax 0.9124 
No. of measured, independent  
& observed reflections 
23458, 12485, 10192 
Criterion for observed reflections I > 2s(I) 
Rint 0.0250 
qmax (°) 28.40 
Refinement on F2 
R[F2 > 2s(F2)], wR(F2), S 0.0404, 0.1137, 0.1096 
No. of relections 12485 reflections 
No. of parameters 
No. of restraints 
826 
0 
H-atom treatment Constrained to parent 
site 
Weighting scheme Calculated    w = 
1/[s2(Fo2)  
+ (0.0617P)2 + 0.7753P]  
where P = (Fo2 + 2Fc2)/3 
(D/s)max <0.01 
Drmax, Drmin (e Å–3) 1.199, –0.525 
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5.  Oxazolochlorins 
5.1.  Introduction 
Perez and co-workers reported a high photo-toxicities of porpholactols 1 towards 
several cancer cell lines in 2005.1 This raised a question of whether modulating the 
hemiacetal moiety of 1 can further increase their biological activities. In this chapter, we 
first describe our effort to expand on the study conducted by Perez et al. thorough various 
functional group conversion of the hemiacetal 1. The latter part of this chapter describes 
the details of the improved synthesis of α-substituted oxazolochlorins. 
 
5.2.   Results and Discussion 
5.2.1. –OR, -SR, and –NR Substituted Oxazolochlorins  
The hydride reduction of porpholactone to form porpholactol 1 was previously 
described (Chapter 2). The lactol hydroxy group of 4 is susceptible to facile acid-
catalyzed nucleophilic substitutions by a range of O-, N-, and S-nucleophiles, providing 
access to a number of stable chlorin-like derivatives of graded lipophilicity (Scheme 5-1). 
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Scheme 5-1. O-, N-, and S-substition of porpholactol 4 
A marked nucleophile-dependent reactivity difference is noted. Exposure of 1 to 
primary, secondary, and tertiary alcohols results in a rapid reaction that is essentially 
quantitative after 30 min to 1 h at ambient temperature. The resulting acetals 4-OR 
showed all the expected spectroscopic data. Diagnostic for the successful formation of 
acetals containing an α-methylene group, this group shows a diastereotopic splitting. This 
can be rationalized by its relative position with respect to the macrocycle plane, exposing 
one of the methylene protons to a much larger degree to the diatropic ring current than 
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the other. Alkoxy-substituted morpholinochlorins show a very similar effect. Bulky 
alcohols like cholesterol or pregnenolone can also be attached to the chromophore with 
ease. 
Secondary amines required a longer reaction time and azeotropic removal of the 
water formed (reflux in benzene with 3 Å mol sieves placed in a Soxhlet apparatus over 
several days) to push the reaction to completion. The hemiaminals 4-NR2 showed all of 
the expected spectroscopic and analytical properties, including the diastereotopic split of 
the α-methylene protons. We did not succeed in reacting primary amines with the 
porpholactols under these or other conditions tested. 
The reactivity of primary thiols was similar to the reactivity of the corresponding 
alcohols. Over time, however, the formation of side products with spectroscopic data 
suggestive of being the corresponding sulfoxides appeared (m/z = +16 compared to the 
expected compound; essentially identical 1H and 13C NMR spectra). 
This high reactivity of lactol 1 with respect to acetal, aminal, and thioacetal 
formation is of immediate interest for the potential application of the 2-oxachlorins as 
photochemotherapeutics.  The efficacy of 1 when incorporated into a biodegradable 
nanoparticle for the photodynamic treatment of a tumor in a mouse model has been 
reported previously.1 The facile acetalization demonstrated here suggests that the 
biodistribution of the hemiacetal may also be modulated by its ability to undergo 
derivatization with biomolecules containing alcohol and thiol groups. Such promiscuity 
may allow achievement of a biodistribition of the drug it would not have as a single and 
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stable compound. Inversely, the facile derivatization of 1 suggests the preparation of 
amphiphilic (pro)drugs using PEGs, carbohydrates, or similarly suitable moieties. 
5.2.2.  Alternative Synthesis of –OR/NR2 Substituted Oxazolochlorins  
In total, the transformation of diol 2 to oxazolochlorins 4-OR/NR2/SR requires 
five discrete synthetic steps: 1. oxidation to the lactone; 2. zinc insertion; 3. hydride 
reduction; 4. zinc removal–the zinc is required as a protecting group for the reduction to 
take place; 5. acetal/aminal/thioacetal formation (Scheme 5-2). Chromatographic 
purification of every intermediate is necessary, with overall yields of 10-33%. Notably, 
the formation of aminals required forcing conditions (molecular sieve-driven water 
removal from the reaction taking an excess of 3 days).2 
 
Scheme 5-2. Step-wise synthesis of oxazolochlorins 4-OR/NR2/SR 
This section describes an alternative pathway that converts chlorin diol 2 in a two-
step, one-pot reaction directly to a number of α-substituted oxazolochlorin derivatives of 
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type 4-OR/NR2, thus eliminating multiple reaction and chromatographic purification 
steps, and improving the overall yield of the reactions. 
5.2.2.1.  Synthesis of –NR2, and –OR substituted oxazolochlorins from diolchlorins 
It is known that the oxidation of diol 5 with NaIO4 heterogenized on silica gel, in 
the presence of a Brønsted base (Et3N), generates a secochlorin bisaldehyde 7.3 Further, 
this reaction performed in the presence of a nucleophile (alcohol, secondary amine) leads 
to an in situ ring-closure reaction of the bisaldehyde, forming morpholinochlorins 8 in 
high yields.4 We found that treatment of the crude mixture of 8 with MnO4–, in the form 
of cetyltrimethylammonium permanganate (CTAP), formed, depending on the 
nucleophile used, oxazolochlorin acetals or aminals 4-OR/NR2, respectively. The 
reaction proceeded in good to acceptable isolated yields with a range of alcohols and 
secondary amines (Scheme 5-3). The reaction is completed within 2 h for the meso-
phenyl derivative and within 10 min for the meso-pentafluorophenyl derivative at 
ambient temperature using ~2 equivalents oxidant. Extended reaction time or excessive 
stoichiometric ratios of CTAP resulted in increased decomposition of the intermediates 
and reduced yields of 4-OR/NR2.  
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Scheme 5-3. Direct synthesis of –NR2, and –OR substituted oxazolochlorins 4OR/NR2 
Reactions between secondary amines and diolchlorins 2 in the absence of Et3N 
led to poor conversion of the intermediate bisaldehyde 7 to morpholinochlorin 8, and the 
formation of substantial amounts of porpholactone 3 were noted. Aminals 4-NR2 are 
susceptible to hydrolysis to the corresponding hemiacetals 1; thus slow eluting column or 
plate chromatography was not suited for the purification of aminal 4-NR2. The best 
purification with minimal associated hydrolysis was observed on an automated flash 
chromatography system using a high-performance silica column (CH2Cl2) at rates that 
eluted the product within minutes. 
5.2.2.2. Mechanistic Considerations 
The mechanism of the single β-carbon loss from morpholinochlorin 8 remains 
unclear. However, it is reasonable to assume that MnO4– oxidizes 8 to form morpho-
linone 9. Evidently, this species extrudes a framework carbon to form oxazolochlorin 4-
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OR/NR2. Notably, the corresponding anhydride 10 is considerably more stable though it 
is also capable of fragmentation to the corresponding porpholactone 3.5,6 
 
There are other examples in which similar β-carbon losses take place. For 
instance, the CTAP oxidation of diol 2 presumably forms the corresponding secochlorin 
biscarboxylate that, upon decarboxylation, (oxidatively) ring-closes to form porpho-
lactone 3 (Scheme 5-2).2,7 Also, when the use of AgII as a template was studied during the 
synthesis of morpholinochlorins under mildly acidic conditions (Scheme 5-4), 
oxazolochlorin AgII complex 4Ag-OEt formed as a major product, along with 
diethoxymorpholinochlorin 11Ag and porpholactone 6Ag.8 
 
Scheme 5-4. First example of a reaction that suggests that the oxidation of hydroxy-
substituted morpholinochlorins leads to a formation of oxazolochlorin 
Another relevant observation was made in more recent years: Free base 
secochlorin bisaldehyde 7 underwent an intramolecular Cannizzaro reaction 
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(Scheme 5-5). This reaction mechanism was determined based on the general reactivity 
of aromatic aldehydes as well as an analysis of the reaction products.3  
The, bisaldehyde 7, when treated with strong base, formed products 1, porpho-
lactone 3, and dimer 1-O-1 (Scheme 5-6, Route A). Their formation was rationalized by 
presuming that bisaldehyde 7 underwent an intramolecular disproportionation to form 
acid-benzyl alcohol intermediate 12. The latter was then assumed to decarboxylate and 
(oxidatively) ring-close to form oxazolochlorin 13. The latter primary product 13, 
however, was not directly observed at any point of the reaction. 2  
 
Scheme 5-5. Second example of a reaction that suggests that the oxidation of hydroxy-
substituted morpholinochlorins leads to a formation of oxazolochlorin 
With the outcome of the oxidation reactions reported in Scheme 5-5 in mind, 
another rationalization of the reaction products offers itself (Scheme 5-5, Route B). 
Secochlorin bisaldehyde, when exposed to wet conditions, was noted to form a water 
adduct, 11-(OH)2, which was, based on its UV-vis spectrum, assigned the bis-hydroxy-
morpholinochlorin structure shown.3 Under the strongly basic and wet conditions of the 
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Cannizzaro reaction (an aqueous Et4NOH solution was used) this compound may well 
have been a major intermediate before air elicited an oxidation reaction that lead to the 
formation of the observed product 1. In fact, similarly to bisaldehyde 7 forming acetal 
4a-OEt in the presence of EtOH (Scheme 5-3), bisaldehyde 7 would directly form acetal 
dimer 1-O-1 in the presence of alcohol 1, indeed without evoking a Cannizzaro reaction. 
5.3.  Optical Properties 
 As expected, the –OR, -NR and -SR substitution of phorpholactol 1 did not affect 
the optical property in any significant manner as all derivatives maintained their charac-
terristic chlorin-like absorption spectra. Various –OR substituted oxazolochlorins were 
near indistinguishable from each other as all spectra contained the λmax of ~647 nm (4a-
OiPr: λmax = 647 nm, 4a-OtBu: λmax = 647 nm, 4a-OnOct: λmax = 646 nm, 4a-OCHex: 
λmax = 647 nm, 4a-OChol: λmax = 655 nm, 4a-OPreg:, λmax = 647 nm).  A replacement of 
the hydroxy groups of porpholactol 4 with 2° amines caused slight bathochormic shift of 
~10 nm (4a-Nmorph: λmax =654 nm, 4a-N(Bn)2: λmax =655 nm). Likewise, a substitution of 
hydroxy group by thioxy group caused ~15 nm bathochromic shift (4a-SnHex: λmax = 
660 nm, 4a-SEt: λmax = 655 nm).  Shown in Figure 5-1 are the normalized (at λsoret) 
comparisons of representative –OR, -NR and –SR substituted oxazolochlorins.  
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Figure 5-1. Normalized UV-vis spectra comparison of –OR, -SR and –NR2 derivatives 
5.4.  Crystal structures 
The crystal structure of 4a-OMe, as its Ag(II) complex9 and a phorpholactol 
acetal dimer3 were previously characterized by single crystal X-ray diffraction. The 
crystal structure of 4a-OMe is disordered to a point that a conformational analysis is 
meaningless however, it is shown here as a proof of connectivity. 
 
Figure 5-2. Single crystal X-ray structures of 4a-OMe. 
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5.5.  Conclusion 
Efficent syntheses of various meso-tetraphenyloxazolochlorins from meso-tetra-
phenylporpholactol (1) and  meso-tetraphenyldiolchlorins (2) were described. These 
methodologies can be regarded to be general. As a result, we have further expanded the 
synthetic methodologies of converting a porphyrin to pyrrole-modified porphyrins along 
the ‘breaking and mending of porphyrins’ strategy.  
5.6.  Experimental Section  
5.6.1.  Instruments and Materials 
meso-Tetraphenyl-3-methoxy-2-oxachlorin 4a-OMe,  and meso-tetraphenyl-3-
ethoxy-2-oxachlorin, 4a-OEt were prepared as described previously.9,10 Flash column 
chromatography was performed on an automated flash chromatography system, on 
normal-phase silica columns (sizes of columns and solvents used are indicated; isochratic 
elution modes). The crude products were dry-packed onto silica gel in a pre-column. The 
fluorescence quantum yields(φ) were determined relative to those of meso-tetraphenyl-
porphyrin (φ = 0.11 in benzene, calculated to be 0.09 in CH2Cl2); λexcitiation = λSoret. For 
details of the instruments used, see List of Instruments. 
5.6.2.  Preparation and Characterization 
meso-Tetraphenyl-3-isopropoxy-2-oxachlorin (4-OiPr). General procedure 
for the conversion of hemiacetals to acetals. Isopropanol (1 mL) was added to a stirring 
solution of 1 (11.5 mg, 1.9 × 10-5 mol) in CHCl3 (3 mL) at room temperature. Traces of 
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TFA vapors (from a TFA bottle head space, delivered via pipette) were added, and the 
reaction was monitored by TLC. The reaction was complete within in 3 h. Upon 
completion, the acid was neutralized with Et3N (1 drop), the solution washed, dried over 
anhydrous MgSO4, evaporated to dryness using rotary evaporation, and purified by flash 
column chromatography (DCM) or preparative plate. Yield >95% (12 mg). Rf (silica–
CH2Cl2) = 0.96; 1H NMR (300 MHz, CDCl3, δ): 8.60 (d, 3J = 4.2 Hz, 1H), 8.51 (d, 3J = 
4.2 Hz, 1H), 8.47 (d, 3J = 4.2 Hz, 1H), 8.43 (d, 3J = 4.2 Hz, 1H), 8.35 (d, 3J = 4.2 Hz, 1H), 
8.04–8.19 (m, 7H), 7.89 (br, 1H), 7.66–7.73 (m, 14H), 3.96 (m, 1 H), 1.27 (d, 3J = 6.0 Hz, 
3H), 0.91 (d, 3J = 6.0 Hz, 3H), –0.73 (s, 1H), –1.09 (s, 1H) ppm; UV-vis (CH2Cl2) λmax 
(log ε): 418 (5.38), 516 (4.21), 550 (4.26), 593 (3.97), 647 (4.63) nm; LR-MS (ESI+, 
100% CH3CN, 30 V cone voltage, TOF): m/z 677.1 (MH+), 634.7 (MH+ –C3H7); HR-MS 
(ESI+ of M+, 100% CH3CN): m/z calc’d for C46H36N4O2: 677.2917, found 677.3018. 
 
Figure 5-3. 1H NMR spectrum (300 MHz, CDCl3) of 4a-OiPr 
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meso-Tetraphenyl-3-cyclohexanoxy-2-oxachlorin (4a-OcHex). Prepared 
according to the general procedure from 1 (10 mg, 0.016 mmol) and cyclohexanol (1 mL) 
in >95% isolated yields 11 mg): Rf (silica–CH2Cl2) = 0.98; 1H NMR (300 MHz, CDCl3, 
δ): 8.59 (dd, 3J = 4.9, 4J =1.5Hz, 1H) 8.51 (dd, 3J = 3.8, 4J =1.7Hz, 1H), 8.46 (dd, 3J = 4.9, 
4J =1.7Hz, 1H), 8.43 (d, 3J = 4.5 Hz, 1H), 8.35 (d, 3J = 4.5 Hz, 1H), 7.88–8.19 (m, 8H), 
7.69–7.72 (m, 13H), 3.59–3.66 (m, 1H), 0.89–1.72 (m, 10H), –0.71 (s, 1H), –1.08 (s, 1H) 
ppm; 13C NMR (100 MHz, CDCl3, δ): 165.5, 154.9, 151.8, 151.4, 142.9, 142.1, 142.0, 
141.1, 140.1, 139.1, 136.7, 135.3, 134.5, 134.0, 133.9, 131.7, 131.1, 129.7, 127.9, 127.85, 
127.8, 127.7, 127.6, 127.5, 127.0, 126.9, 125.9, 125.0, 121.9, 121.3, 112.2, 105.1, 100.4, 
79.4, 33.7, 31.9, 25.8, 24.1 ppm; UV-vis (CH2Cl2) λmax (log ε): 418 (5.31), 516 (4.14), 
550 (4.19), 594 (3.88), 647 (4.55) nm; HR-MS (ESI+ of M+, 100% CH3CN, TOF): m/z 
calc’d for C49H41N4O2: 717.3230, found 717.3212. 
 
Figure 5-4. 1H NMR spectrum (300 MHz, CDCl3) of 4a-OcHex 
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Figure 5-5. 13C NMR spectrum (100 MHz, CDCl3) of 4a-OcHex 
meso-Tetraphenyl-3-tert-butoxy-2-oxachlorin (4a-OtBu). Prepared according 
to the general procedure from 1 (12 mg, 0.019 mmol) and tert-butanol (1 mL) in 80% 
isolated yields (9.8 mg): Rf (silica–CH2Cl2) = 0.92; 1H NMR (300 MHz, CDCl3, δ): 8.58 
(d, 3J = 4.7 Hz, 1H), 8.44–8.49 (m, 2H), 8.41 (d, 3J = 4.5 Hz, 1H), 8.34 (d, 3J = 4.5 Hz, 
1H), 8.03–8.19 (m, 8H), 7.84–7.89 (m, 2H), 7.63–7.72 (m, 12H), 1.09 (s, 9H), –0.71 (s, 
1H), –1.07 (s, 1H) ppm; 13C NMR (100 MHz, CDCl3, δ): 165.3, 154.8, 152.1, 151.7, 
142.9, 142.2, 142.1, 142.0, 141.2, 140.4, 139.1, 136.7, 135.5, 134.4, 134.3, 134.1, 134.0, 
133.9, 133.3, 131.6, 131.4, 129.6, 128.0, 127.96, 127.92, 127.8, 127.7, 127.6, 127.54, 
127.51, 127.0, 126.9, 125.9, 125.0, 121.7, 121.2, 112.0, 105.8, 100.6, 100.4, 64.8, 28.5 
ppm; UV–vis (CH2Cl2) λmax (log ε): 418 (5.20), 514 (4.05), 550 (4.08), 594 (3.79), 647 
(4.46) nm; HR-MS (DART+, 20 V orifice voltage, 100% CH3CN, TOF): m/z calc’d for 
C47H39N4O2 (MH+): 691.3037, found 691.3056. 
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Figure 5-6. 1H NMR spectrum (300 MHz, CDCl3) of 4a-OtBu 
 
Figure 5-7. 13C NMR spectrum (100 MHz, CDCl3) of 4a-OtBu 
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meso-Tetraphenyl-3-octoxy-2-oxachlorin (4a-OnOct). Prepared according to 
the general procedure from 1 (10 mg, 0.016 mmol) and n-octanol (1 mL) in 92% isolated 
yields (11.4 mg): Rf (silica–CH2Cl2) = 0.92; 1H NMR (300 MHz, CDCl3, δ): 8.59 (dd, 3J 
= 4.5, 4J = 1.5 Hz, 1H), 8.52 (dd, 3J = 4.6, 4J =1.7 Hz, 1H), 8.45 (dd, 3J = 5.8, 4J =1.7 Hz, 
1H), 8.43 (d, 3J = 4.6 Hz, 1H), 8.35 (d, 3J = 4.5 Hz, 1H), 8.21 (dd, 3J = 5.8, 4J =1.7Hz, 
1H), 7.85–8.18 (m, 8H), 7.64–7.77 (m, 12H), 7.59 (s, 1H), 3.64–3.67 (m, 1H), 3.42–3.45 
(m, 1H), 1.24–1.28 (m, 17H), –0.73 (s, 1H), –1.09 (s, 1H) ppm; 13C NMR (100 MHz, 
CDCl3) δ 165.0, 154.9, 151.9, 151.0, 143.0, 142.1, 142.0, 140.9, 139.9, 139.0, 136.8, 
135.0, 134.5, 134.2, 134.1, 134.0, 133.9, 133.5, 131.8, 131.2, 129.7, 128.1, 128.0, 127.9, 
127.8, 127.7, 127.6, 127.65, 127.0, 126.9, 125.9, 125.1, 121.9, 121.4, 112.2, 105.9, 100.3, 
69.4, 32.0, 29.9, 29.5, 29.4, 26.3, 22.9, 14.3 ppm; UV-vis (CH2Cl2) λmax (log ε): 417 
(5.23), 515 (4.06), 550 (4.11), 593 (3.79), 646 (4.48) nm; HR-MS (ESI+ of M+, 100% 
CH3CN, TOF): m/z calc’d for C51H47N4O2: 747.3699, found 747.3705. 
 
Figure 5-8. 1H NMR spectrum (300 MHz, CDCl3) of 4a-OnOct 
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Figure 5-9. 13C NMR spectrum (100 MHz, CDCl3) of 4a-OnOct 
meso-Tetraphenyl-3-(+)cholesteroxy-2-oxachlorin (4a-OChol). Prepared 
according to the general procedure from 1 (33.9  mg, 0.053 mmol) and cholesterol (20.7 
mg, 2 eq.) in 88% isolated yield (47 mg): Rf (silica–CH2Cl2) = 0.96; 1H NMR (300 MHz, 
CDCl3, δ): 8.63 (d, 3J = 4.8 Hz, 1H), 8.55 (m, 1H), 8.51 (d, 3J = 1.5 Hz, 1H), 8.47 (d, 3J = 
4.5 Hz, 1H), 8.39 (d, 3J = 4.5 Hz, 1H), 8.10–8.25 (m, 8H), 7.9 (d, 3J = 0.3 Hz, 2H), 7.66–
7.76 (m, 13H), 5.29–5.36 (m, 1H), 3.55–3.63 (m, 1H), 2.32–2.64 (m, 1H), 2.12–1.72 (m, 
6H), 1.28–1.62 (m, 15H), 0.99–1.22 (m, 12H), 0.96 (s, 3H), 0.98 (s, 3H), 0.71 (s, 3H), 
-0.74 (s, 1H), –1.06 (s, 1H) ppm; 13C NMR (100 MHz, CDCl3, δ): 165.1, 165.0, 155.0, 
154.9, 151.9, 151.2, 151.1, 143.0, 142.2, 142.1, 141.2, 141.1, 141.0, 140.2, 140.1, 139.1, 
139.0, 136.8, 136.7, 135.4, 135.3, 134.6, 134.2, 134.1, 134.0, 133.5, 131.8, 131.1, 131.0, 
129.8, 128.2, 128.1, 128.0, 128.0, 127.9, 127.9, 127.9, 127.7, 127.6, 127.1, 126.9, 126.0, 
125.1, 125.1, 122.1, 122.0, 122.0, 121.9, 121.4, 121.4, 112.2, 105.3, 105.2, 100.5, 100.4, 
81.1, 81.0, 57.0, 56.4, 50.3, 42.6, 40.8, 40.0, 39.8, 38.6, 37.6, 37.4, 36.9, 36.8 36.5, 36.1, 
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32.3, 32.2, 32.1, 30.1, 28.5, 28.3, 28.2, 24.6, 24.1, 23.1, 22.9, 21.4, 21.3, 19.6, 19.0, 12.1 
ppm; UV-vis (CH2Cl2) λmax (log ε): 419 (5.24), 515 (4.16), 552 (4.18), 594 (3.95) 655 
(3.79) nm; HR-MS (ESI+, 100% CH3CN, TOF): m/z calc’d for C70H75N4O2 (MH+): 
1003.5890, found 1003.5893. 
 
Figure 5-10. 1H NMR spectrum (400 MHz, CDCl3) of 4a-OChol 
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Figure 5-11. 13C NMR spectrum (100 MHz, CDCl3) of 4a-OChol 
 
Figure 5-12. FT-IR spectrum (neat, diffuse reflectance) of 4a-OChol 
meso-Tetraphenyl-3-pregnenolonoxy-2-oxachlorin (4a-OPreg). Prepared 
according to the general procedure from 1 (33.5 mg, 0.053 mmol) and pregnenolone 
(33.4 mg, 2 equiv) in 83% isolated yield (41 mg): Rf (silica–CH2Cl2) = 0.55; 1H NMR 
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(300 MHz, CDCl3, δ): 8.61 (d, 3J = 4.5 Hz, 1H), 8.53 (d, 3J = 4.5 Hz, 1H), 8.47 (t, 3J = 4.5 
Hz, 1H), 8.44 (d, 3J = 4.5 Hz, 1H), 8.36 (d, 3J = 4.5 Hz, 1H), 7.89–8.22 (m, 9H), 7.65–
7.74 (m, 13H), 5.30 (dd, 3J = 23.3 Hz, 4.5 Hz, 1H), 3.55–3.61 (m, 1H), 2.29–2.62 (m, 
2H), 2.20 (m, 1H), 2.14 (s, 3H), 2.02–2.013 (m, 3H), 1.04–1.94 (m, 14H), 0.96 (s, 3H), 
0.63 (s, 3H), –0.74 (s, 1H), –1.08 (s, 1H) ppm; 13C NMR (100 MHz, CDCl3) δ  209.8, 
151.9, 142.9, 142.1, 142.0, 141.1, 141.1, 141.0, 140.9, 136.8, 136.7, 135.4, 135.3, 134.5, 
134.2, 134.1, 134.0, 133.5, 131.8, 131.1, 131.0, 129.8, 128.2, 128.1, 128.0, 127.9, 127.8, 
127.7, 127.1, 126.9, 126.0, 125.1, 125.0, 122.0, 121.9, 121.7, 121.6, 112.2, 105.3, 105.2, 
100.4, 80.9, 80.7, 63.9, 57.1, 50.1, 44.2, 40.7, 39.0, 38.5, 37.5, 37.4, 36.9, 36.8, 32.1, 
31.8, 30.0, 28.1, 24.7, 23.0, 21.3, 21.2, 19.6, 19.5, 13.4 ppm; UV-vis (CH2Cl2) λmax (log 
ε): 419 (5.28), 517 (4.13), 550 (4.17), 593 (3.88) 647 (4.52) nm; HR-MS (ESI+, 100% 
CH3CN, TOF): m/z calc’d for C64H61N4O3 (MH+): 933.4744, found 933.4733. 
 
Figure 5-13. 1H NMR spectrum (400 MHz, CDCl3) of 4a-OPreg 
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Figure 5-14. 13C NMR spectrum (100 MHz, CDCl3) of 4a-OPreg 
 
Figure 5-15. FT-IR spectrum (neat, diffuse reflectance) of 4a-OPreg 
meso-Tetraphenyl-3-N-morpholinyl-2-oxachlorin (4a-Nmorph). General 
procedure for the conversion of hemiacetals to aminals. A small-scale Soxhlet 
containing 3 Å molecular sieves was attached to a 50 mL round bottom flask.  Excess 
amine (5 to 10 eq) was then added to a stirring solution of 1 (30 mg, 0.043 mmol) in 
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benzene (10-15mL). A few drops of TFA were added and the mixture was refluxed for 
several days (3-5 days). The reaction progress was monitored by TLC and upon 
completion, the acid was neutralized with Et3N (1 drop), dried over anhydrous MgSO4, 
evaporated to dryness using rotary evaporation, and purified by flash column chromato-
graphy (CH2Cl2) or preparative plate to give 4a-Nmorph in 30% isolated yield (9 mg): Rf 
(silica–CH2Cl2) = 0.60; 1H NMR (300 MHz, CDCl3, δ): 8.52–8.54 (m, 1H), 8.45–8.47 
(m, 1H), 8.36–8.37 (m, 2H), 8.28–8.29 (m, 1H), 7.84–8.15 (m, 10H), 7.64–7.70 (m, 4), 
7.44 (s, 1H), 3.47–3.48 (m, 2H), 3.29–3.30 (m, 2H), 2.58–2.59 (m, 2H), 2.38–2.43 (m, 
2H), –0.44 (s, 1H), –0.86 (s, 1H) ppm; 13C NMR (100 MHz, CDCl3, δ): 166.5, 154.9, 
151.6, 150.6, 143.4, 142.0, 141.9, 141.2, 140.5, 139.2, 136.8, 135.2, 134.2, 134.0, 133.9, 
133.8, 133.3, 131.5, 130.1, 129.7, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 127.2, 127.1, 
126.93, 126.97, 126.1. 125.1. 121.6. 121.2. 111.6. 101.2. 99.7 ppm; UV-vis (CH2Cl2) 
λmax (log ε): 420 (5.08), 517 (3.91), 552 (3.91), 598 (3.16) 654 (4.34) nm; HR-MS (ESI+, 
100% CH3CN, TOF): m/z calc’d for C47H38N5O2 (MH+): 704.3026, found 704.3009. 
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Figure 5-16. 1H NMR spectrum (300 MHz, CDCl3) of 4a-Nmorph 
 
Figure 5-17. 13C NMR spectrum (100 MHz, CDCl3) of 4a-Nmorph 
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meso-Tetraphenyl-3-N-dibenzylamine-2-oxachlorin (4a-N(Bn)2). Prepared 
according to the general procedure from 1  (10.7 mg, 0.017 mmol) and dibenzylamine 
(1 mL) in 70% isolated yield (9.6 mg): Rf (silica–CH2Cl2) = 0.96; 1H NMR (300 MHz, 
CDCl3, δ): 8.54–8.56 (m, 1H), 8.39–8.44 (m, 2H), 8.34–8.35 (m, 1H), 8.26–8.28 (m, 1H), 
7.98–8.15 (m, 7H), 7.84–7.89 (m, 1H), 7.71–7.71 (m, 12H), 7.49–7.55 (m, 1H), 7.28 
(s,1H), 7.11–7.12 (br, 5H), 6.84–6.86 (m, 4H), 3.47–3.61 (m, 4H), –0.33 (s, 1H), –0.70 
(s, 1H) ppm; UV-vis (CH2Cl2) λmax (log ε): 420 (5.16), 518 (3.97), 555 (3.97), 600 (3.69) 
655 (4.39) nm; HR-MS (ESI+, 100% CH3CN, TOF): m/z calc’d for C57H44N5O (MH+): 
814.3546, found 814.3590. 
 
Figure 5-18. 1H NMR spectrum (300 MHz, CDCl3) of 4a-N(Bn)2 
meso-Tetraphenyl-3-ethioxy-2-oxachlorin (4a-SEt). General procedure for 
the conversion of hemiacetals  to RS-based thiaacetals. Excess ethanethiol (1 to 2 mL) 
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was added to a stirring solution of 1 (10 mg, 0.015 mmol) in CHCl3 (3-5 mL) at room 
temperature. Traces of TFA vapors (from a TFA bottle head space, delivered via pipette) 
were added, and the reaction was monitored by TLC. The reaction was complete within 
in 3 to 5 h.  Upon completion, the acid was neutralized with Et3N (1 drop), the solution 
washed, dried over anhydrous MgSO4, evaporated to dryness using rotary evaporation, 
and purified by silica gel flash column or preparative plate chromatography (CH2Cl2). 
Isolated yield 90% (9.6 mg): Rf (silica–CH2Cl2) = 0.96; 1H NMR (300 MHz, CDCl3, δ): 
8.50–8.52 (m, 1H), 8.43–8.44 (m, 1H), 8.33–8.35 (m, 2H), 8.26–8.27 (m, 1H), 7.99 (m, 
8H), 7.90–7.91 (m, 1H), 7.67–7.80 (m, 12H), 2.31–2.41 (m, 1H), 2.12–2.19 (m, 1H), 
0.89–0.93 (m, 3H), –0.30 (s, 1H), –0.65 (s, 1H) ppm; 13C NMR (100 MHz, CDCl3, δ): 
165.9, 154.9, 153.1, 151.9, 143.4, 141.9, 141.8, 141.4, 139.9, 138.7, 136.8, 135.5, 134.6, 
134.1, 133.9, 133.8, 133.3, 131.6, 131.1, 129.9, 128.5, 128.2, 128.0, 127.92, 127.94, 
127.97, 127.8, 127.7, 127.1, 126.95, 126.9, 126.3, 124.9, 121.8, 110.6, 100.1, 90.8 ppm; 
UV-vis (CH2Cl2) λmax (log ε): 420 (5.31), 457 (4.43), 518 (4.13), 555 (4.07), 608 (3.88), 
660 (4.51) nm; LR-MS (ESI+, 100% CH3CN, 30 V cone voltage): m/z 679.1 (MH+), 
upon exposure to ambient light and environment, significant peak of 695.7 (MHO+) is 
observed; HR-MS (ESI+, 100% CH3CN, TOF): m/z calc’d for C45H35N4OS (MH+): 
679.2532, found 679.2471. 
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Figure 5-19. 1H NMR spectrum (300 MHz, CDCl3) of 4a-SEt 
 
 
Figure 5-20. 13C NMR spectrum (100 MHz, CDCl3) of 4a-SEt 
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meso-Tetraphenyl-3-hexanethioxy-2-oxachlorin (4a-SnHex). Prepared 
according to the general procedure from 1 (10 mg 0.014 mmol) and hexanethiol (1 mL) 
in 50% isolated yields (5.8 mg): Rf (silica – CH2Cl2) = 0.92; 1H NMR (300 MHz, CDCl3, 
δ): 8.50–8.51 (m, 1H), 8.42–8.43 (m, 1H) 8.33–8.34 (m, 2H), 8.26–8.27 (m, 1H), 7.98–
8.23 (m, 8H), 7.89–7.91 (m, 1H), 7.65–7.75 (m, 13H), 2.35–2.42 (m, 1H), 2.15–2.18 (m, 
1H), 0.71–1.28 (m, 13H), –0.30 (s, 1H), –0.65 (s, 1H) ppm; UV-vis (CH2Cl2) λmax (log 
ε): 422 (5.17), 518 (3.99), 553 (3.93), 603 (3.65), 659 (4.35) nm; HR-MS (ESI+, 100% 
CH3CN, TOF): m/z calc’d for C49H43N4OS (MH+): 735.3153,  found 735.3097. 
 
Figure 5-21. 1H NMR spectrum (300 MHz, CDCl3) of 4a-SnHex 
Direct synthesis of meso-tetraphenyl-3-ethoxy-2-oxachlorins (4a-OEt) A 
general procedure for direct conversion of diols 5 to oxazolochlorins 4-OR/NR2. 
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Step 1: diolchlorin (110 mg) 5a was dissolved in amylene stabilized CHCl3 
(60 mL). To the solution was added Et3N (2 mL), ethanol (5 mL), and NaIO4 on silica 
(1 g). This mixture was stirred for ~18 h or until all the starting material was consumed. 
The starting material consumption was monitored using TLC and UV-vis. TLC showed a 
polar starting material 5a which was gradually converted to 8a of intermediate polarity 
(Rf = 0.5 in 30% Hexane in CH2Cl2). UV-vis showed the appearance of a distinct 
morpholinochlorin spectrum, which indicated full consumption of the diolchlorin. When 
the reaction was completed, oxidants were filtered out and the solvent was dried using 
rotary evaporation. The crude product was carried to the next step without any 
purification. Step 2: The crude product was dissolved in CHCl3 and to the stirring 
solution was added cetyltrimethylamonium permanganate (CTAP) (100 mg).  This 
reaction typically required 1-2 h. The reaction progress was monitored by TLC as the 
starting material 8a of intermediate polarity is converted to a nonpolar band (indicating 
the formation of 4). In some instances, additional oxidants may be added to push the 
reaction forward. Once full consumption of starting material was observed on TLC, the 
oxidants were filter out using a plug of silica before the solvent was dried by rotary 
evaporation. The column chromatography (eluent 30% Hexane in CH2Cl2) of the crude 
mixture gave 4a-OEt in 78% yields (87 mg). The spectroscopic data (1H NMR and 13C 
NMR) were consistent with the previously reported data. Compounds 4a-OMe (86%), 
4a-N(Bn)2 (33%), 4a-Nmorph (49%), were also synthesized following this method. 
meso-tetrakis(4-trifluoromethylphenyl)-3-ethoxy-2-oxachlorin (4b-OEt) 
4b-OEt was prepared in 73% yields (14.8 mg) from diolchlorin 4b (20 mg) as described 
Chapter 5: Oxazolochlorins 
 92 
for the synthesis of 4a-OEt. 1H NMR (400 MHz, CDCl3, δ): 8.58-8.56 (m, 1H), 8.49(dd, 
J = 4.8, 1.7 Hz, 1H), 8.45 (dd, J = 5.1, 1.5 Hz, 1H), 8.37 (d, J = 4.6 Hz, 1H), 8.30-8.18 
(m, 8H), 8.00 (t, J = 6.6 Hz, 8H), 7.54 (s, 1H), 3.83-3.79 (m, 1H), 3.59-3.55 (m, 1H), 
1.11 (t, J = 7.1 Hz, 3H), -0.740 (s, 1H), -1.10 (s, 1H) ppm. 13C NMR (100 MHz, CDCl3, 
δ): 165.01, 154.72, 151.64, 150.96, 145.35, 143.38, 142.86, 142.39, 140.66, 136.61, 
135.42, 134.23, 134.20, 134.16, 134.05, 133.95, 133.72, 132.05, 131.45, 129.96, 127.88, 
125.35, 125.97, 125.03, 124.99, 124.80, 124.23, 124.20, 124.10, 124.06, 122.18, 120.31, 
111.08, 105.84, 99.51, 65.59, 15.13 ppm; UV-vis (CH2Cl2) λmax (Rel. Int.): 415 (1), 513 
(0.10), 547 (0.11), 594 (0.08), 648 (0.23) nm; HR-MS (ESI+) m/z calc’d for 
C49H31F12N4O2, 935.2255, obs. 935.2253. 
 
Figure 5-22. 1H NMR spectrum (400 MHz, CDCl3) of 4b-OEt. 
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Figure 5-23. 13C NMR spectrum (100 MHz, CDCl3) of 4b-OEt. 
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Figure 5-24. UV-vis spectrum (CH2Cl2) of 4b-OEt. 
Synthesis of meso-tetrakis(pentafluorophenyl)-3-ethoxy-2-oxachlorin 
(4c-OEt). Prepared from diolchlorin 5c (110 mg, 1.1 × 10-4 mol) according to the 
procedure described for the synthesis of 4a-OEt in 76% yield.  Note: Step 2 for this 
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substrate only required 5-10 minutes for a full conversion. 1H NMR (400 MHz, CDCl3, 
δ): 8.69 (d, J = 4.6 Hz, 1H), 8.63 (d, J = 4.2 Hz, 1H), 8.53 (d, J = 4.8 Hz, 1H), 8.47 (d, 
J = 4.5 Hz, 1H), 8.38 (d, J = 4.5 Hz, 1H), 8.34 (d, J = 4.4 Hz, 1H), 7.77 (s, 1H), 3.67-3.59 
(m, 1H), 3.48 (dd, J = 16.0, 7.2 Hz, 1H) 1.16 (t, J = 7.0 Hz, 3H), -0.713 (s, 1H), -1.02 
(s, 1H) ppm. 13C NMR (100 MHz, CDCl3, δ): 165.74, 154.84, 153.00, 151.95, 143.03, 
137.06, 134.04, 133.50, 131.83, 129.75, 127.56, 125.51, 121.79, 109.46, 106.30, 105.24, 
95.97, 84.80, 63.22, 14.88 ppm; UV-vis (CH2Cl2) λmax (Rel. Int.): 402 (1), 500 (0.13), 
535 (0.09), 600 (0.09), 654 (0.35) nm; HR-MS (ESI+) m/z calc’d for C45H15F20N4O2, 
1023.0876, obs. 1023.0905. 
 
 
Figure 5-25. 1H NMR spectrum (400 MHz, CDCl3) of 4c-OEt. 
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Figure 5-26. 13C NMR spectrum (100 MHz, CDCl3) of 4c-OEt. 
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Figure 5-27. UV-vis spectrum (CH2Cl2) of 4c-OEt. 
meso-Tetrakis(pentafluorophenyl)-3-methoxy-2-oxachlorin (4c-OMe). 
Prepared from diolchlorin 5c (100 mg, 9.91 × 10-5 mol) according to the procedure 
described for the synthesis of 4a-OEt in 91% yield.  Note: Step 2 for this substrate only 
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required 5-10 minutes for a full conversion. 1H NMR (400 MHz, CDCl3, δ): 8.74 (dd, 
J = 4.74, 0.36 Hz, 1H), 8.68-8.67 (m, 1H), 8.57 (d, J = 4.8 Hz, 1H), 8.51(d, J = 4.5 Hz, 
1H), 8.42 (d, J = 4.5 Hz, 1H), 8.38-8.37 (m, 1H), 7.84 (s, 1H), 3.67-3.59 (m, 1H), 3.48 
(dd, J = 16.0, 7.2 Hz, 1H) 1.16 (t, J = 7.0 Hz, 3H), -0.713 (s, 1H), 3.25 (s, 3H), -0.68 
(s, 1H), -0.99 (s, 1H), ppm. 13C NMR (100 MHz, CDCl3, δ): 165.74, 154.84, 153.00, 
151.95, 143.03, 137.06, 134.04, 133.50, 131.83, 129.75, 127.56, 125.51, 121.79, 109.46, 
106.30, 105.24, 95.97, 84.80, 63.22, 29.90, 14.88 ppm; UV-vis (CH2Cl2) λmax (Rel. Int.): 
402 (1), 500 (0.13), 535 (0.09), 598 (0.09), 653 (0.33) nm; HR-MS (ESI+) m/z calc’d for 
C44H13F20N4O2, 1009.0719, obs. 1009.0712.  
 
Figure 5-28. 1H NMR spectrum (400 MHz, CDCl3) of 4c-OMe. 
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Figure 5-29. 13C NMR spectrum (100 MHz, CDCl3) of 4c-OMe. 
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Figure 5-30. UV-vis spectrum (CH2Cl2) of 4c-OMe. 
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5.6.3.  X-ray Crystallography Data 
X-ray crystallographic analysis (provided by Dr. Christopher Ziegler, University 
of Akron):  X-ray intensity data were measured at 100 K (Bruker KYRO-FLEX) on a 
Bruker SMART APEX CCD-based X-ray diffractometer system equipped with a Mo-
target X-ray tube (λ = 0.71073 Å) operated at 2000 W power.  The crystals were mounted 
on a cryoloop using Paratone N-Exxon oil and placed under a stream of nitrogen at 
100 K.  The detector was placed at a distance of 5.009 cm from the crystals. The data 
were corrected for absorption with the SADABS program.  The structures were refined 
using the Bruker SHELXTL Software Package (Version 6.1), and were solved using 
direct methods until the final anisotropic full-matrix, least squares refinement of F2 
converged. 
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Crystal Structure Report 4a-OMe 
 The oxazole unit is disordered with the pyrrole units in a 3:1 ratio. In addition the 
methoxy group is disordered over two alternative positions above or below the plane of 
the macrocycle. The methoxy groups of neighboring molecules are disordered around a 
four-fold rotinversion axis with a combined site occupancy of 0.5. The remainder of the 
site is taken up by a half occupied water molecule (located directly on the four-fold 
rotinversion axis).  
 
 
Figure 5-31. ORTEP representation and numbering scheme of the crystal structure of 
4a-OMe; only one of the possible eight positions and orientations of the oxazole unit is 
shown for clarity. 
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Table 5-1. Crystallographic and structure refinement data for 4a-OMe 
Chemical formula C44H33N4O2.5 
Mr 657.74 
Cell setting, space group Tetragonal, I4/m 
Temperature (K) 100 (2) 
a, b, c (Å) 13.460(3)  
13.460(3)  
9.7678(18) 
α, β, γ (°) 90  
90  
90 
V (Å3) 1769.6(6) 
Z 2 
Dx (Mg m–3) 1.234 
Radiation type Mo Ka 
m (mm–1) 0.078 
Crystal form, colour block, yellow 
Crystal size (mm) 0.38 × 0.22 × 0.18 
Diffractometer Bruker ApexII CCD area detector 
Data collection method φ and w scans 
Absorption correction Multi-scan  
 Tmin 0.6620 
 Tmax 0.7455 
No. of measured, independent  
& observed reflections 
7481, 1046, 832 
Criterion for observed reflections I > 2s(I) 
Rint 0.0268 
qmax (°) 27.12 
Refinement on F2 
R[F2 > 2s(F2)], wR(F2), S 0.0531, 0.1651, 0.1530 
No. of relections 1046 reflections 
No. of parameters 
No. of restraints 
95 
1 
H-atom treatment Constrained to parent site 
Weighting scheme Calculated    w =1/[s2(Fo2) + 
(0.0901P)2 + 0.8333P] where P = 
(Fo2 + 2Fc2)/3 
(D/s)max <0.01 
Drmax, Drmin (e Å–3) 0.309, –0.182 
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6.  Alkyl-Oxazolochlorins 
6.1.  Introduction 
One of the most challenging aspects of synthetic porphyrin chemistry is the 
stabilization of chlorin chromophores. Particularly, oxazolochlorin chromophores are 
highly unstable in oxidative conditions. For example, the α-position to the oxazoline 
oxygen of A (when in solution) is rapidly oxidized into B upon exposure to light. Further, 
OsO4-mediated dihydroxylation of porpholactol B surprisingly results only in the 
oxidation of hemiacetal to lactone. This instability toward oxidation severely limited the 
studies and utilizations of an otherwise intriguing class of chromophores. 
 
Scheme 6-1. Inadvertent oxidations at the α-carbon of oxazolochlorin. 
In the total syntheses of chlorins and bacteriochlorins, the group of Lindsey 
stabilized the chlorin and bacteriochlorin chromophores by incorporating geminal-
dimethyl moieties (Section 1.5). This prompted us to wonder whether the alkyl substi-
tuent can be added onto the oxazolochlorins as a stabilizer. Hence, can we reduce the 
carbonyl group of lactone via alkyl-Grignard addition? Further, can we gain control over 
mono- vs bis-alkylation? This chapter provides answers to these questions as well as the 
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details of their optical properties and structural conformation via single crystal X-ray 
diffraction structure elucidation.  
6.2.  Results and Discussion 
6.2.1.  Synthesis of Alkyloxazolochlorins  
Addition of alkyl (methyl, ethyl, i-propyl) Grignard reagents to the zinc(II) 
complex of porpholactone 1 under anhydrous conditions results in the formation of a 
more polar product. An aqueous acidic work-up using a strong enough acid to demetalate 
the zinc complexes provided free base porphyrinoids with a chlorin-like UV-visible 
spectra as the main products in good to satisfactory yields. The HR–MS (ESI+) of these 
compounds suggested their composition to be derived from the parent porpholactone to 
which a single equivalent of methane, ethane, and propane was added, respectively.  
Their 1H, 13C NMR, and IR spectra also confirmed the loss of the lactone functional 
group and the presence of an alkyl chain attached to the oxazole moiety. These spectros-
copic data and their similarity to those of the porpholactol identified these products as the 
alkylated hemiketals 2. The use of 2 to 3 equivalents of Grignard reagent was found to 
provide the highest yields of product. The reaction is rapid (5-20 mins at ambient 
temperature), and can be scaled up to 1.5 g of starting porpholactone 1Zn (2.15 mmol) 
(or 600 mg of 1FZn, 0.62 mmol, whereby the addition of the Grignard reagent at lower 
temperatures, –78°C for iPrMgBr and –45°C for EtMgCl, was found beneficial for this 
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substrate). The presence of the ‘protecting group’ zinc(II) is obligatory as the alkylation 
of free base porpholactones failed (Scheme 6-2).  
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Scheme 6-2. Synthesis of mono- and bis-alkyloxazolochlorins by alkyl-Grignard addition to 
porpholactones 1. 
Even the use of a large excess of Grignard reagent (e.g., 15-fold molar excess) did 
not generate more than traces of the corresponding bis-alkylated systems. The use of the 
more electron-withdrawing p-CF3Ph-derivatives also did not improve the yield of 
formation of the bisalkylated products. However, reaction of 1Zn/1FZn with an alkyl-
Grignard reagent, followed by reaction of the crude zinc complex of 2 with a Lewis acid 
and further addition of alkyl-Grignard reagent furnished the dialkyl-derivatives 4 in 
satisfying yields (Scheme 6-2). We screened a number of Lewis acids (BF3·OEt2, 
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TMSOTf, Sc(OTf)3, InCl3, Ti(OiPr)4, and TiCl4) for their ability to facilitate this reaction 
and found TMSOTf to be the best choice. The intermediacy of the TMS-ether of 2Zn was 
shown as it could be detected in the reaction mixture by ESI(+) LR-MS. 
We have also tested methyl and i-propyl lithium as alkylating agents. The 
reactions formed the expected mono-alkylated compounds. However, the experimental 
conditions (reaction temperatures of –78°C were required for both reagents) and the 
precautions associated with using alkyllithium reagents were not offset by higher yields, 
a larger fraction of bisalkylated products, or cleaner reactions when compared to the 
Grignard reactions. Thus, we did not develop this route toward alkyloxazolochlorins. 
Analogously to porpholactol, their alkylated analogues 2/2F can be hydro-
dehydroxylated using triethylsilane in the presence BF3·OEt2, forming mono-alkyl-
oxazolochlorin 3/3F (For hydro-dehydroxylation of porpholactol, refer to Chapter 2). The 
success of this reaction is indicated by the loss of one oxygen atom in the composition of 
the product 3 as determined by HR–MS, the appearance of one hydrogen signal in the 
pyrroline region of the spectrum (6.1–7.2 ppm) that is coupled with the corresponding 
alkyl group (CH3 of Me, CH2CH3 of Et, and CH(CH3)2 of iPr), and a similar ~20 nm red-
shift of the optical spectrum of alkyloxazolochlorin 3 as observed upon formation of 
oxazolochlorin1 by dehydroxylation of hemiacetal 5. The oxazolochlorins of types 2 and 
4 are distinguished by excellent solubilities but the mono-alkyloxazolochlorins of type 3 
possessed markedly reduced solubilities. Also, the dimethyl-substituted oxazolochlorins 
possess poor solubility (good quality 13C NMR spectra, for example, could not be 
Chapter 6: Alkyl-Oxazolochlorins 
 106 
recorded over 12 h acquisition times), particularly when compared to the excellent 
solubility of the bis-ethyl and bis-iPr derivatives. The generally improved solubility of 
the p-CF3Ph-derivatives was not enough to overcome these solubility issues.  
The hydroxy group of hemiketal 2 is susceptible to facile acid-catalyzed 
ketalization. This reaction is parallel to the reaction of its non-alkylated analogue. Under 
the right reaction conditions, this reaction is reversible, with no apparent destruction of 
the macrocycle, providing some evidence for the robust nature of the alkyloxazolo-
chlorins. Interestingly, after zinc(II) insertion into acetal 5c, a TMSOTf-mediated 
substitution of the methoxy group with an alkyl group gave rise to, after demetalation, an 
alternative synthesis of the bisalkylated product 4c (Scheme 6-3). 
 
Scheme 6-3. Ketalization and alternative pathway towards bis-alkyloxazolochlorins 
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6.2.2.  Optical Properties 
Benchmark compound free base porpholactol possesses a chlorin-type UV-visible 
absorption spectrum (λmax = 646 nm, Section 2.5.).1 The spectrum of the mono-alkylated 
analogues (2a: λmax = 647 nm, 2b: λmax = 648 nm, 2c: λmax = 649 nm, 2Fb: λmax = 
649 nm, 2Fc: λmax = 650 nm) are nearly indistinguishable from that non-alkylated species 
(porpholactol). Likewise, the optical spectra of the methyl, ethy, and i-propyl derivatives 
were indistinguishable from each other. The formal replacement of an alkyl group (as in 
3a: λmax = 667 nm, 3b: λmax = 667 nm,  3c: λmax = 668 nm, 3Fb: λmax = 669 nm, 3Fc: 
λmax = 670 nm) significantly red-shifts the spectrum. The corresponding profound effect 
of the hydroxy groups located at the chlorin-specific β,β’-bond on the optical properties 
of the chromophore and a qualitatively similar auxochromic effect upon removal of the 
hydroxy group was observed for non-alkylated oxazolochlorins and chlorins.1,2 The bis-
alkyloxazolochlorins 4 possess λmax values that are similar to those of the dehydroxylated 
monoalkyloxazolochlorins 3. However, the shapes of their Soret bands and the peak 
positions of the remaining Q-bands are distinctly different. Also, irrespective of whether 
bis-alkyloxazolochlorins 4a, 4b or 4c are concerned, the UV-visible spectra of the bis-
alkyloxazolochlorins possess almost 50% lower extinction coefficients compared to the 
corresponding mono-alkylated species 3a, 3b and 3c (Figure 6-1).  
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Figure 6-1. UV-visible spectra of porpholactol (green trace), α-i-propyl lactol 2c (blue trace), 
α-i-propyl oxazolochlorin 3c (magenta trace), and α,αʼ-bis-i-propyl oxazolochlorin 4c (red 
trace) (all in CHCl3 at ambient temperature).  
The fluorescence emission spectra of the alkyloxazolochlorins are all chlorin-like 
(Figure 6-2), with the small Stokes’ shift characteristic for porphyrins. The fluorescence 
yields are in the range of 0.19 to 0.30, consistent with those of regular dihydrochlorin 
derivatives previously reported.2 The presence of β-oxygen appears to have minimal 
effect on the florescence properties of alkyloxazolochlorins.  
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Figure 6-2. Fluorescne spectra of porpholactol (green trace), α-i-propyl lactol 2c (blue trace), 
α-i-propyl oxazolochlorin 3c (magenta trace), and α,αʼ-bis-i-propyl oxazolochlorin 4c (red 
trace) (all in CHCl3 at ambient temperature; λexcitation = λSoret).  
6.2.3.  Crystal Structures of Alkyloxazolochlorins 
The crystal structures of mono-i-propyloxazolochlorin hemiketal 2c, its methyl 
ketal zinc(II) complex 5cZn, and of the bis-i-propyloxazolochlorin 4c were determined 
by single crystal X-ray diffraction (Figure 6-3). These structures confirm the connectivity 
of the oxazolochlorins but more importantly, they prove the conformation of the macro-
cycles (in the solid state). The conformations of all three macrocycles are essentially 
planar. The small deviations from planarity that can be made out vary from chromophore 
to chromophore but are all not large enough to affect the optical properties in any major 
way. Hydroporphyrins are known to be conformationally somewhat more flexible than 
the corresponding porphyrins.3 The conformational analysis of the two halves of an 
oxazolochlorin dimer also showed small and distinct conformation differences of the two 
chromophores, suggestive of a somewhat flexible macrocycle.4 As will be shown below, 
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the optical spectra of all oxazolochlorins do not show any degree of broadening, further 
allowing us to conclude that the conformational flexibility of oxazolochlorins is not 
unusually high (as, for instance, observed in the morpholinochlorin that differ from the 
oxazolochlorins by the presence of an additional sp3-hybridized carbon atom in the non-
pyrrolic moiety).5,6 
 
Figure 6-3. Single crystal X-ray structures of 2c, 4c, and 5cZn. All hydrogen atoms attached 
to aromatic carbons and the minor disorder contribution of 2c have been omitted for clarity.  
Unlike many of the structures of the corresponding porpholactones, 1 the 
structures of 4c and 5cZn are not disordered. The structure of 2c exhibits a small degree 
of disorder in the oxazole ring, which adopts two orientations with in an approximately 
80/20 ratio. In all three cases, bond distances, angles and overall porphyrin planarity can 
be unambiguously observed.  The Cβ-O bond in the oxazole ring is significantly 
lengthened in all three compounds (1.4483(18) Å in 4c, 1.461(5) Å in 5cZn and 
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1.457(4) Å for the primary orientation of 2c) versus a typical Cβ-­‐Cβ’	  bond length of 
~1.36 Å in a normal porphyrin. The Cα-­‐O	  bond distance is appreciably shorter, however, 
with distances of (1.3594(17) Å in 4c, 1.374(4) Å in 5cZn and 1.351(3) Å for the primary 
orientation in 2c, indicative of a significant degree of double bond character. The Cα-Cβ 
bonds in the oxazole rings are clearly single in bond character, with observed bond 
lengths of (1.545(2) Å in 4c, 1.518(5) Å in 5cZn and 1.578(4) Å for the primary 
orientation in 2c.  In all three compounds, the N-C bonds in the oxazole moiety are 
asymmetric, with one measuring a typical distance of ~1.36-1.37 Å, and the second being 
shorter at 1.34 Å. 
All three porphyrinoids exhibit primarily planar conformations in the solid state 
with some small and varying deviations. In 2c, the largest deviation from the mean 24 
atom plane of the porphyrinoid is 0.27 Å, with an average deviation of 0.09 Å. In 4c, the 
maximum deviation is 0.23 Å with an average deviation of 0.11 Å. The zinc complex 
5cZn also exhibits a predominantly planar porphyrinoid macrocycle (maximum deviation 
0.27 Å, average deviation 0.10 Å); the presence of the zinc ion does not distort the 
conformation of the ring, although the greatest deviations from planarity are observed in 
the oxazole unit.  The zinc ion is five coordinate with an axial pyridine, and the Zn(II) ion 
is pulled away from the plane of the porphyrinoid macrocycle by 0.38 Å, as is commonly 
observed for penta-coordinated zinc porphyrin complexes.7  
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6.3.  Conclusions 
The addition of Grignard reagents to the porphyrin-like meso-tetraarylporpho-
lactones resulted in the formation of mono- and bis-alkylated oxazolochlorins. The mono-
alkylated hemiketals can be deoxygenated or converted to ketals. As previously demons-
trated for the corresponding porpholactol (Chapter 5),1 this allows the facile derivati-
zation of these chromophores. The oxazolochlorins possess chlorin-like optical properties 
that are slightly modulated depending on the nature of the substituents located on the sp3-
hybridized carbon α to the oxazole oxygen. Since porpholactones are readily accessible 
in gram-scales and the key reactions were demonstrated at gram or half-gram scales, this 
methodology offers straightforward access to significant quantities of a class of stable 
chlorin-like chromophores that are endowed with somewhat tunable optical spectra.  
6.4.  Experimental Section 
6.4.1.  Instruments and Materials 
 [meso-Tetraphenyl-3-oxo-2-oxaporphyrinato]Zn(II) was prepared as described in 
the literature.1 Flash column chromatography was performed on an automated flash 
chromatography system, on normal-phase silica columns (sizes of columns and solvents 
used are indicated; isochratic elution modes). The crude products were dry-packed onto 
silica gel in a pre-column unless noted otherwise. The fluorescence quantum yields (φ) 
were determined relative to those of meso-tetraphenylporphyrin (φ = 0.11 in benzene, 
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calculated to be 0.09 in CH2Cl2); λexcitiation = λSoret. For details of the instruments used, see 
List of Instruments.  
6.4.2.  Preparation and Characterization 
meso-Tetraphenyl-3-hydroxy-3-methyl-2-oxachlorin (2a). General procedure 
for the conversion of lactone 1Zn to hemiketal 2. For a typical reaction, a N2-flushed, 
oven-dried 50 mL round bottom flask was loaded with [meso-tetraphenyl-2-oxa-3-
oxoporphyrinato]Zn(II) (1Zn, 100 mg, 0.145 mmol) dissolved in dry THF (15 mL). 
Then, 5 equivalents of MeMgBr (3M solution in Et2O, 0.24 mL) was slowly added at 
ambient temperature. The reaction progress was monitored using UV-vis spectroscopy 
(disappearance of the band at ~600 nm and development of a band at ~625 nm). The 
reaction was completed within 15 min. Upon completion, the reaction was quenched by 
addition of a saturated aq NH4Cl solution (2-3 mL). The mixture was transferred into a 
250 mL separatory funnel and washed with a saturated aq NH4Cl, and the chlorin was 
extracted with CH2Cl2. Note: it appears critical to assure that all Grignard reagent is 
quenched; repeated aq NH4Cl washes may be necessary. Crude 2aZn was dissolved in 
THF (15 mL) and stirred, and 6 M aq HCl (2-3 mL) is added. The reaction was stirred for 
~2 hrs. The reaction progress was monitored by UV-vis spectroscopy. Upon 
disappearance of the metallochlorin spectrum of a neutralized aliquot, the green reaction 
mixture was transferred into a separatory funnel and a saturated aq NaHCO3 solution is 
added (Caution, foam!). CH2Cl2 was added and the organic layer was extracted. The aq 
NaHCO3 wash was repeated until the organic layer was pure purple in color. The organic 
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phase was isolated and dried over K2CO3. The product was isolated by flash 
chromatography (silica-CH2Cl2) to afford product 2a as a purple solid in good yield 
(76%, 72 mg). MW = 648.8 g/mol; Rf = 0.55 (silica-CH2Cl2); UV-vis (CHCl3) λmax (log 
ε): 419 (5.29), 516 (4.08), 551 (4.14), 594 (3.86), 647 (4.53) nm; Fl λmax (CHCl3, λexc = 
420 nm): 652, 704 nm, φ = 0.28; 1H NMR (300  MHz, CDCl3, δ): 8.57 (d, 3J = 5.0 Hz, 
1H), 8.46 (d, 3J = 5.0 Hz, 1H), 8.41–8.39 (m, 2H), 8.33 (d, 3J = 4.4 Hz, 1H), 8.15–7.60 
(m, 21H), 3.72 (s, 1H), 1.96 (s, 3H), –0.67 (s, 1H), –1.1 (s, 1H) ppm; 13C NMR (100  
MHz, CDCl3, δ): 162.6, 155.1, 153.5, 151.6, 143.1, 142.1, 141.9, 141.8, 139.2,139.1, 
137.1, 134.8, 134.7, 134.4, 134.1, 133.9, 133.9, 133.6, 131.6, 129.7, 128.2, 128.0, 127.9, 
127.6, 127.5, 127.1, 127.0, 126.9, 126.9, 126.4, 126.3, 125.5, 122.6, 121.2, 111.5, 109.2, 
100.3, 27.6 ppm; HR-MS (ESI+ of MH+, 100% CH3CN, TOF): m/z calc’d for 
C44H33N4O2: 649.2604, found 649.2579. 
 
Figure 6-4. 1H NMR spectrum (400 MHz, CDCl3) of 2a 
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Figure 6-5. 13C NMR spectrum (100 MHz, CDCl3) of 2a 
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Figure 6-6. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 2a 
(CHCl3) 
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meso-Tetraphenyl-3-ethyl-3-hydroxy-2-oxachlorin (2b). Prepared from [meso-
tetraphenyl-2-oxa-3-oxoporphyrinato]Zn(II) (1Zn, 100 mg, 0.145 mmol) according to the 
reaction procedure described for the preparation of 2a, except the reaction was performed 
using 5 equivalents of EtMgBr (2M solution in THF, 0.145 mL). The product 2b was 
isolated by flash chromatography (silica-CH2Cl2) as a purple solid in 65% (61.5mg) 
yield. MW = 662.78 g/mol; Rf = 0.55 (silica-CH2Cl2); UV-vis (CHCl3) λmax (log ε): 420 
(5.59), 516 (4.16), 552 (4.45), 593 (4.19), 648 (4.84) nm; Fl λmax (CHCl3, λexc = 420 nm): 
652, 710 nm, φ = 0.31; 1H NMR (300  MHz, CDCl3, δ): 8.59 (d, 3J = 4.4 Hz, 1H), 8.48 
(d, 3J = 3.0 Hz, 1H), 8.43–8.34 (m, 2H), 8.35 (d, 3J = 4.0 Hz, 1H), 8.17–7.59 (m, 21H), 
3.75 (s, 1H), 2.38–2.32 (m, 1H), 1.99–1.94 (m, 1H), 0.75 (t, 3J = 7.1 Hz, 3H), –0.64 (s, 
1H), –1.04 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ): 163.2, 155.1, 152.1, 151.6, 
143.1, 142.1, 141.9, 141.8, 139.4, 138.9, 137.1, 134.9, 134.4, 134.2, 134.1, 133.9, 133.8, 
133.6, 131.5, 129.7, 128.3, 128.0, 127.9, 127.9, 127.7, 127.5, 127.1, 126.9, 126.9, 126.8, 
126.3, 126.2, 125.5, 122.5, 121.2, 112.2, 111.6, 100.1, 32.5, 8.67 ppm; HR-MS (ESI+ of 
MH+, 100% CH3CN, TOF): m/z calc’d for C45H35N4O2: 663.2760, found 663.2754 
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Figure 6-7. 1H NMR spectrum (400 MHz, CDCl3) of 2b 
 
Figure 6-8. 13C NMR spectrum (100 MHz, CDCl3) of 2b 
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Figure 6-9. UV-vis(solid red trace) and fluorescence (broken black trace) spectra of 2b 
(CHCl3)  
meso-Tetraphenyl-3-hydroxy-3-isopropyl-2-oxachlorin (2c). Prepared from 
[meso-tetraphenyl-2-oxa-3-oxoporphyrinato]Zn(II) (1Zn, 1.5 g, 2.15 mmol) according to 
the reaction procedure described for the preparation of 2a, except the reaction was 
performed using 2 equivalents of i-PrMgBr (2M solution in THF, 2.15 mL). The product 
2c was isolated by flash chromatography (silica-CH2Cl2) as a purple solid in 75% yield 
(1090 mg). MW = 676.80 g/mol; Rf = 0.50 (silica-CH2Cl2); UV-vis (CHCl3) λmax (log ε): 
420 (5.22), 516 (4.13), 550 (4.14), 592 (3.92), 649 (4.49) nm; Fl λmax (CHCl3, λexc 
= 420 nm): 653, 710 nm, φ = 0.35; 1H NMR (300  MHz, CDCl3, δ) 8.59 (d, 3J = 5.0 Hz, 
1H), 8.45–8.47 (m, 3H), 8.34 (d, 3J = 4.5 Hz, 1H), 7.95–8.17 (m, 7H), 7.85 (m, 1H), 
7.65–7.72 (m, 11H), 7.48–7.57 (m, 3H), 2.17–2.26 (m, 1H), 1.28 (d, 3J = 6.7 Hz, 3H), 
0.67 (d, 3J = 6.7 Hz, 3H), –0.60 (s, 1H), –0.99 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, 
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δ): 163.4, 155.2, 153.6, 151.7, 143.2, 142.2, 142.0, 139.4, 139.0, 137.2, 134.9, 134.4, 
134.2, 134.1, 133.9, 133.6, 131.6, 131.0, 129.8, 128.9, 128.3, 128.0, 127.9, 127.6, 127.2, 
127.0, 126.9, 126.3, 125.6, 122.67, 121.3, 113.6, 111.4, 100.2, 36.4, 30.0, 17.8, 16.1 
ppm; LR-MS (ESI+, 30 V, CH3CN): m/z = 677 (MH+); HR-MS (ESI+ of MH+, 100% 
CH3CN, TOF): m/z calc’d for C46H37N4O2: 676.2917, found 677.2918. 
 
Figure 6-10. 1H NMR spectrum (400 MHz, CDCl3) of 2c 
 
Figure 6-11. 13C NMR spectrum (100 MHz, CDCl3) of 2c  
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Figure 6-12. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 2c 
(CHCl3) 
meso-Tetrakis(4-trifluoromethylphenyl)-3-ethyl-3-hydroxy-2-oxachlorin 
(2Fb). Prepared from [meso-tetrakis(trifluoromethylphenyl)-2-oxa-3-oxoporphyrinato]-
Zn(II) (1FZn, 113 mg, 0.117 mmol) according to the reaction procedure described for the 
preparation of 2a, except the reaction was performed at –45°C using 2 equivalents of 
EtMgBr (2M solution in THF, 117 µL). For best yield, the reaction should be maintained 
at –45°C until it is quenched. The product 2Fb was isolated by column chromatography 
(silica-50% petroleum ether/CH2Cl2) as a purple solid in 78% (85 mg) yield. MW = 
934.8 g/mol; Rf = 0.26 (silica-50% petroleum ether 30-60/CH2Cl2); UV-vis (CHCl3) λmax 
(log ε): 419 (5.13), 513 (4.00), 548 (3.99), 595 (3.75), 649 (4.45) nm, Fl λmax (CHCl3, 
λexc = 419 nm): 654, 702 nm, φ = 0.29; 1H NMR (300  MHz, CDCl3, δ): 8.59 (d, 3J = 5.1 
Hz, 1H), 8.45 (d, 3J = 3.9 Hz, 1H), 8.42 (d, 3J = 5.0 Hz, 1H), 8.39 (d, 3J = 4.6 Hz, 1H), 
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8.32 (d, 3J = 4.6 Hz, 1H), 8.18–7.99 (m, 15H), 7.87 (d, 3J = 8.0 Hz, 1H), 7.77 (d, 3J = 8.0 
Hz, 1H), 3.84 (s, 1H), 2.38–2.29 (m, 1H), 1.92–1.86 (m, 1H), 0.74 (t, 3J = 7.3 Hz, 3H), –
0.63 (s, 1H), –0.99 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ): 163.2, 154.9, 152.3, 
151.4, 145.4, 145.2, 142.9, 142.7, 142.3, 141.6, 136.9, 135.3, 134.2, 134.2, 134.0, 134.0, 
133.9, 133.8, 131.8, 130.0, 129.9, 127.7, 126.0, 125.7, 125.1, 125.1, 125.0, 124.3, 124.3, 
124.1, 124.1, 124.0, 123.9, 123.9, 123.3, 123.3, 123.3, 123.3, 122.8, 120.1, 112.3, 110.7, 
99.2, 32.7, 8.57; HR-MS (ESI+ of MH+, 100% CH3CN, TOF): m/z calc’d for 
C49H31F12N4O2: 935.2255, found 935.2236. 
 
 
Figure 6-13. 1H NMR spectrum (400 MHz, CDCl3) of 2Fb 
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Figure 6-14. 13C NMR spectrum (100 MHz, CDCl3) of 2Fb 
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Figure 6-15. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 2Fb 
(CHCl3)  
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meso-Tetrakis(4-trifluoromethylphenyl)-3-hydroxy-3-isopropyl-2-oxachlorin 
(2Fc). Prepared from [meso-tetrakis(trifluoromethylphenyl)-2-oxa-3-oxoporphyrinato]-
Zn(II) (1FZn, up to 500 mg scale) according to the reaction procedure described for the 
preparation of 2a, except the reaction was performed using i-PrMgCl (2M solution in 
THF, 0.515 mL for 500 mg scale) maintained at –78°C. The product 2Fc was isolated by 
chromatography (silica-50% petroleum ether 30-60/CH2Cl2) as a purple solid in 80-85% 
yield (up to 415 mg). MW = 948.8  g/mol; Rf = 0.32 (silica-50% petroleum ether 30-
60/CH2Cl2); UV-vis (CHCl3) λmax (log ε): 420 (5.24), 513 (4.10), 548 (4.09), 595 (3.88), 
650 (4.55) nm; Flλmax (CHCl3, λexc = 420 nm): 655, 703 nm, φ = 0.36; 1H NMR (300  
MHz, CDCl3, δ): 8.57 (d, 3J = 4.9 Hz, 1H), 8.42 (m, 2H), 8.36 (d, 3J = 4.5 Hz, 1H), 8.15–
7.95 (m, 19H), 3.87 (s, 1H), 2.14–2.08 (m, 1H), 1.28 (d, 3J = 6.5 Hz, 3H), 0.65 (d, 3J = 
6.7 Hz, 3H), –0.63 (s, 1H), –0.99 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ): 163.2, 
154.8, 153.7, 151.3, 145.4, 145.1, 142.8, 142.7, 142.7, 142.4, 141.8, 136.9, 135.3, 134.2, 
134.1, 134.0, 133.9, 133.9, 133.9, 133.7, 131.7, 129.8, 127.7, 125.7, 125.0, 124.3, 124.2, 
124.2, 124.1, 124.0,124.0, 123.9, 123.8, 123.3, 123.3, 123.2, 122.8, 120.1, 113.6, 110.4, 
99.1, 36.4, 17.5, 15.9; HR-MS (ESI+ of MH+, 100% CH3CN, TOF): m/z calc’d for 
C50H33F12N4O2: 949.2412, found 949.2431. 
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Figure 6-16. 1H NMR spectrum (400 MHz, CDCl3) of 2Fc 
 
Figure 6-17. 13C NMR spectrum (100 MHz, CDCl3) of 2Fc 
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Figure 6-18. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 2Fc 
(CHCl3) 
meso-Tetraphenyl-3-methyl-2-oxachlorin (3a). General procedure for the 
conversion of hemiketal 9 to mono-alkyl oxazolochlorin 10. meso-Tetraphenyl-3-
hydroxy-3-methyl-2-oxachlorin (2a, 54 mg, 0.083 mmol), was dissolved in CH2Cl2 and 
stirred at room temperature. To this solution, excess BF3·OEt2 (20 eq, 0.2 mL) and 
Et3SiH (20 eq, 0.26 mL) were added slowly. The reaction was mixture was left stirring 
overnight. Reaction progress was monitored using UV-visible spectroscopy (formation of 
the diagnostic peak at ~660 nm in a neutralized aliquot). Upon completion, the reaction 
mixture was quenched by addition of a saturated aq NaHCO3 solution. The mixture was 
transferred into a separatory funnel. The aq NaHCO3 wash was repeated until the organic 
layer was purple/green in color. The organic layer was isolated, dried over Na2SO4, and 
the solvent was evaporated by rotary evaporation. The crude product was purified by 
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flash chromatography (silica–CH2Cl2) to afford the product 3a as a purple solid in 88% 
yield (46 mg). MW = 632.8 g/mol; Rf = 0.89 (silica–CH2Cl2); UV–vis (CHCl3) λmax (log 
ε): 424 (5.25), 519 (4.05), 557 (3.94), 610 (3.79), 667 (4.61) nm; Fl λmax (CHCl3, 
λexc = 424 nm): 672, 718 nm, φ = 0.29; 1H NMR (300  MHz, CDCl3, δ): 8.47 (s, 1H), 
8.40 (s, 1H), 8.31–8.24 (m, 3H), 8.16–7.95 (m, 10H), 7.71 (s, 12H), 7.10 (d, 3J = 5.6 Hz, 
1H), 1.60 (d, 3J = 5.4 Hz, 3H), 0.09 (s, 1H), –0.29 (s, 1H) ppm; 13C NMR (100  MHz, 
CDCl3, δ): 167.9, 159.7, 154.7, 151.4, 143.9, 142.1, 141.9, 141.8, 140.4, 139.2, 136.7, 
134.9, 134.2, 134.0, 133.9, 133.8, 133.7, 132.9, 131.1, 129.8, 129.1, 128.2, 128.1, 128.0, 
127.97, 127.91 127.8, 127.6, 127.1, 126.99, 126.94, 126.4, 124.62, 121.61, 121.1, 108.7, 
99.3, 83.0, 21.8 ppm; HR–MS (ESI+ of MH+, 100% CH3CN, TOF): m/z calc’d for 
C44H33N4O: 633.2654, found 633.2646. 
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Figure 6-19. 1H NMR spectrum (400 MHz, CDCl3) of 3a 
 
Figure 6-20. 13C NMR spectrum (100 MHz, CDCl3) of 3a 
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Figure 6-21. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 3a 
(CHCl3)  
meso-Tetraphenyl-3-ethyl-2-oxachlorin (3b). Prepared from meso-tetraphenyl-
3-ethyl-3-hydroxy-2-oxachlorin (2b, 45 mg, 0.07 mmol) according to the reaction 
procedure described for the preparation 3a. The product 3b was isolated by flash 
chromatography (silica–CH2Cl2) as a purple solid in 85% (38 mg) yield. MW = 
646.8 g/mol; Rf = 0.92 (silica–CH2Cl2); UV–vis (CHCl3) λmax (log ε): 425 (5.36), 520 
(4.18), 556 (4.06), 610 (3.92), 667 (4.70) nm; Fl λmax (CHCl3, λexc = 424 nm): 673, 718 
nm, φ = 0.20; 1H NMR (300  MHz, CDCl3, δ): 8.45 (dd, 3J = 4.8, 4J = 0.8 Hz, 1H), 8.38 
(dd, 3J = 4.4, 4J = 1.2 Hz, 1H), 8.29 (d, 3J = 4.5 Hz, 1H), 8.23 (m, 2H), 8.15–7.92 (m, 
9H), 7.70–7.65 (m, 12H), 7.08 (dd, 3J = 7.9, 4J = 3.5 Hz, 1H), 2.06–1.99 (m, 1H), 1.75–
1.69 (m, 1H), 0.69 (t, 3J = 7.4 Hz, 3H), 0.08 (s, 1H), –0.31 (s, 1H) ppm; 13C NMR (100  
MHz, CDCl3, δ): 168.7, 157.9, 154.7, 151.4, 143.9, 142.1, 141.9, 141.8, 140.5, 139.3, 
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136.7, 134.5, 134.2, 133.99, 133.92, 133.8, 133.75, 133.70, 133.6, 132.9, 131.1, 130.8, 
129.8, 129.1, 128.22, 128.18, 128.0, 127.99, 127.96, 127.92, 127.8, 127.7, 127.1, 127.0, 
126.9, 126.4, 124.6, 121.6 121.1, 108.9, 99.1, 87.5, 27.7, 8.1 ppm; HR–MS (ESI+ of 
MH+, 100% CH3CN, TOF): m/z calc’d for C45H35N4O: 647.2811, found 647.2814. 
 
Figure 6-22. 1H NMR spectrum (400 MHz, CDCl3) of 3b 
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Figure 6-23. 13C NMR spectrum (100 MHz, CDCl3) of 3b 
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Figure 6-24. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 3b 
(CHCl3)  
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meso-Tetraphenyl-3-isopropyl-2-oxachlorin (3c). Prepared from meso-
tetraphenyl-3-hydroxy-3-isopropyl-2-oxachlorin (2c, 100 mg, 0.14 mmol) according to 
the reaction procedure described for the preparation of 3a. The product 3c was isolated 
by flash chromatography (silica–CH2Cl2) as a purple solid in 76% (75 mg) yield. MW = 
660.8 g/mol; Rf = 0.90 (silica–CH2Cl2); UV-vis (CHCl3) λmax (log ε): 423 (5.27), 519 
(4.14), 556 (4.03), 611 (3.93), 668 (4.63) nm; Fl λmax (CHCl3, λexc = 423 nm): 674, 728 
nm, φ = 0.26; 1H NMR (300  MHz, CDCl3, δ): 8.45 (dd, 3J = 4.7, 4J = 1.5 Hz, 1H), 8.38 
(dd, 3J = 4.7, 4J = 1.8 Hz, 1H), 8.29 (d, 3J = 4.5 Hz, 1H), 8.27 (dd, 3J = 5.0, 4J = 1.7 Hz, 
1H), 8.21 (d, 3J = 4.5 Hz, 1H), 8.13–8.17 (m, 2H), 7.92–8.02 (m, 6H), 7.64–7.72 (m, 
13H), 6.90 (d, 3J = 2.3 Hz, 1H), 1.95–2.25 (m, 1H), 1.10 (d, 3J = 6.8 Hz, 3H), 0.50 (d, 3J 
= 6.8 Hz, 3H), 0.11 (s, 1H), –0.28 (s, 1H ) ppm; 13C NMR (100  MHz, CDCl3, δ): 168.9, 
158.0, 154.6, 151.3, 143.8, 142.0, 141.9, 141.8, 140.5, 139.2, 136.6, 134.5, 134.1, 133.9, 
133.8, 133.7, 133.6, 133.3, 132.8, 130.9, 130.6, 129.8, 129.0, 128.1, 127.9, 127.8, 127.7, 
127.5, 127.1, 126.9, 126.8, 126.3, 124.6, 121.5, 121.0, 108.9, 98.8, 91.1, 32.9, 31.8, 20.4, 
14.4 ppm; HR–MS (ESI+ of MH+, 100% CH3CN, TOF): m/z calc’d for C46H37N4O: 
661.2967, found 661.2932. 
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Figure 6-25. 1H NMR spectrum (400 MHz, CDCl3) of 3c 
 
Figure 6-26. 13C NMR spectrum (100 MHz, CDCl3) of 3c 
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Figure 6-27. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 3c 
(CHCl3) 
meso-Tetrakis(4-trifluoromethylphenyl)-3-ethyl-2-oxachlorin (3Fb). Prepared 
from meso-tetrakis(trifluoromethylphenyl)-3-ethyl-3-hydroxy-2-oxachlorin (2Fb, 80 mg, 
8.5 × 10–5 mol) according to the reaction procedure described for the preparation of 3a. 
The product 3Fb was isolated by flash chromatography (silica–CH2Cl2) as a purple solid 
in 71% (56 mg) yield. MW = 918.7 g/mol; Rf = 0.93 (silica–50% petroleum ether 30-
60/CH2Cl2); UV–vis (CHCl3) λmax (log ε): 424 (5.12), 518 (3.96), 553 (3.78), 613 (3.71), 
669 (4.53) nm; Fl λmax (CHCl3, λexc = 424 nm): 675, 720 nm, φ = 0.27; 1H NMR (300  
MHz, CDCl3, δ): 8.41 (dd, 3J = 5.0, 4J = 1.5 Hz, 1H), 8.33 (dd, 3J = 4.7, 4J = 1.7 Hz, 1H), 
7.95–8.25 (m, 20H), 7.05–7.07 (m, 1H), 1.99–2.06 (m, 1H), 1.66–1.73 (m, 1H), 0.70 (t, 
3J = 7.4 Hz, 3H), 0.09 (s, 1H), –0.29 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ): 
168.6, 158.1, 154.4, 151.1, 145.4, 145.2, 143.9, 143.7, 142.7, 141.5, 136.5, 134.7, 134.0, 
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133.9, 133.8, 133.7, 133.1, 131.3, 131.2, 130.9, 130.7, 130.4, 130.28, 130.17, 129.9, 
129.8, 128.1, 126.3, 126.2, 126.1, 126.0, 125.8, 125.3, 125.28, 125.22, 125.17, 125.14, 
125.10, 125.06, 125.0, 124.9, 124.3, 124.27, 124.24, 124.20, 124.1, 124.09, 124.0, 123.4, 
123.3, 123.1, 121.2, 120.5, 107.9, 98.2, 87.5, 27.9, 8.1 ppm; HR-MS (DART+, 100% 
CH3CN, orifice voltage 20 V, TOF, of MH+): m/z calc’d for C49H31F12N4O: 919.2306, 
found 919.2331. 
 
 
Figure 6-28. 1H NMR spectrum (400 MHz, CDCl3) of 3Fb 
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Figure 6-29. 13C NMR spectrum (100 MHz, CDCl3) of 3Fb 
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Figure 6-30. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 3Fb 
(CHCl3) 
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meso-Tetrakis(4-trifluoromethylphenyl)-3-isopropyl-2-oxachlorin (3Fc). 
Prepared from meso-tetrakis(4-trifluoromethylphenyl)-3-hydroxy-3-isopropyl-2-
oxachlorin (2Fc, 52 mg, 6.0 × 10–5 mol) according to the reaction procedure described for 
the preparation of 3a. The product 3Fc was isolated by flash chromatography (silica–
CH2Cl2) as a purple solid in 84% (43 mg) yield. MW = 932.8 g/mol; Rf = 0.93 (silica–
50% petroleum ether 30-60/CH2Cl2); UV–vis (CHCl3) λmax (log ε): 425 (5.14), 519 
(3.98), 555 (3.81), 615 (3.74), 670 (4.54) nm; Fl λmax (CHCl3, λexc = 424 nm): 676, 722 
nm, φ = 0.24; 1H NMR (300  MHz, CDCl3, δ): 8.41 (d, 3J = 4.7 Hz, 1H), 8.32 (d, 3J = 4.8 
Hz, 1H), 8.07 (m, 20H), 6.95 (s, 1H), 1.90–1.95 (m, 1H), 1.11 (d, 3J = 6.6 Hz, 3H), 0.48 
(d, 3J = 6.0 Hz, 3H), 0.10 (s, 1H), –0.27 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ): 
168.9, 158.2, 154.4, 151.1, 145.4, 145.2, 144.1, 143.7, 142.7, 141.6, 135.6, 134.7, 133.9, 
133.8, 133.7, 133.1, 131.2, 130.9, 130.6, 130.4, 130.3, 130.1, 139.9, 128.1, 126.2, 126.1, 
126.0, 125.3, 125.2, 125.1, 124.9, 124.3, 124.2, 124.1, 123.3, 121.2, 120.4, 107.9, 98.0, 
91.3, 33.3, 20.4, 14.4 ppm; HR–MS (ESI+ of MH+, 100% CH3CN, TOF): m/z calc’d for 
C50H33F12N4O: 933.2463, found 933.2433. 
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Figure 6-31. 1H NMR spectrum (400 MHz, CDCl3) of 3Fc 
 
Figure 6-32. 13C NMR spectrum (100 MHz, CDCl3) of 3Fc 
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Figure 6-33. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 3Fc 
(CHCl3) 
meso-Tetraphenyl-3,3-dimethyl-2-oxachlorin (4a). General procedure for the 
conversion of porpholactone 4Zn to bis-alkyloxazolochlorin 11. Step 1: Lactone zinc(II) 
complex 1Zn (103 mg, 0.15 mmol) was dissolved in dry THF and stirred under N2 at 
room temperature and 3 equivalents of MeMgBr (3 M solution in THF, 0.15 mL) were 
added. The reaction progress was monitored using UV-visible spectroscopy (develop-
ment of an intense peak at ~625 nm indicates the formation of the acetal moiety). Upon 
completion (~30 min), the reaction was quenched and washed with distilled H2O in a 
separatory funnel. The organic phase was extracted with CH2Cl2, the organic phase 
isolated, and reduced to dryness using a rotary evaporator. The residue was then 
dissolved in dry THF (10 mL), and passed through a plug of Na2SO4 and dried using 
rotary evaporation. Step 2: The round bottom flask containing the dried residue from part 
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1 was purged with N2 prior to adding dry THF (10 mL). Under N2, 2.5 equivalents of 
TMSOTf (0.067 mL) was added and stirred for 5-10 min, followed by 5 equivalents of 
MeMgBr (0.25 mL of a 3 M solution in THF). In order to avoid incomplete reaction, the 
molar equivalents of alkyl-Grignard should double that of TMSOTf in this step. The 
reaction progress was monitored by UV-visible spectroscopy (a small aliquot is being 
treated with drops of 6 M HCl and neutralizing with aq NaHCO3, the formation of a peak 
at ~665 nm indicates the formation of the product). Step 3: Upon completion, the reaction 
was quenched with water (1-2 mL), then 6M HCl (10 mL) was added to the reaction 
mixture to affect demetalation. The reaction mixture was stirred until the demetalation 
was complete (as monitored by UV-visible spectroscopy; formation of a free-base chlorin 
spectrum upon neutralization indicates the formation of the product). Once demetalation 
was achieved, the mixture was neutralized with a saturated aq NaHCO3 solution in a 
separatory funnel. CH2Cl2 (10 mL) were added and the organic phase was isolated and 
dried using rotary evaporator. Product 4a was isolated and purified by column chromato-
graphy (silica–CH2Cl2) as a purple solid in 74% yield (71 mg). MW = 646.8 g/mol; Rf = 
0.96 (silica–CH2Cl2); UV–vis (CHCl3) λmax (log ε): 424 (5.10), 519 (3.93), 556 (3.87), 
607 (3.75), 666 (4.42) nm; Fl λmax (CHCl3, λexc = 425 nm): 668, 715 nm, φ = 0.19; 
1H NMR (300  MHz, CDCl3, δ): 8.42 (dd, 3J = 5.2, 4J = 1.4 Hz, 1H), 8.28 (dd, 3J = 4.5, 4J 
= 1.9 Hz, 1H), 8.25 (d, 3J = 4.5, 1H), 8.22–8.20 (m, 1H), 8.18 (d, 3J = 4.5, 1H), 8.06–7.58 
(m, 21H), 1.85 (s, 6H), 0.06 (s, 1H), –0.33 (s, 1H) ppm; due to its poor solubility, high-
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quality 13C NMR spectra could not be obtained; HR–MS (ESI+ of M+, 100% CH3CN, 
TOF): m/z calc’d for C45H34N4O: 646.2733, found 646.2729. 
 
Figure 6-34. 1H NMR spectrum (400 MHz, CDCl3) of 4a 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0
200
400
600
800
400 500 600 700 800
ε 
x 1
0-5
/M
-1
cm
-1
Flu
or
es
ce
nc
e I
nte
ns
ity
/a.
u.
Wavelength/nm  
Figure 6-35. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 4a 
(CHCl3) 
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meso-Tetraphenyl-3,3-diethyl-2-oxachlorin (4b). Prepared from [meso-
tetraphenyl-2-oxa-3-oxoporphyrinato]Zn(II) (1Zn, 103 mg, 0.15 mmol) and EtMgCl 
according to the reaction procedure described for the preparation of 4a except for the 
following: In Step 1, 1.5 equivalents of EtMgCl (3 M solution in THF, 0.075 mL) was 
used with the reaction time of ~5 min at room temperature. In Step 2, 2 equivalents of 
TMSOTf (0.054 mL) were added at room temperature and stirred for ~5 min, then 4 
equivalents of EtMgCl (3M solution in THF, 0.198 mL) were added and the solution 
stirred for additional ~5 min at room temperature. (Note: increased reaction time does not 
result in better yield, in fact, the opposite effect was noticed.) The product 4b was 
isolated by flash chromatography (silica–CH2Cl2) as a purple solid in 45% (45 mg) yield. 
MW = 674.8 g/mol; Rf = 0.9 (silica-CH2Cl2); UV-vis (CHCl3) λmax (log ε): 425 (5.10), 
517 (3.87), 556 (3.76), 608 (3.66), 664 (4.45) nm; Fl λmax (CHCl3, λexc = 425 nm): 669, 
719 nm, φ = 0.30; 1H NMR (300  MHz, CDCl3, δ): 8.43 (d, 3J = 4.9 Hz, 1H), 8.30 (d, 3J = 
4.2 Hz, 1H), 8.27 (d, 3J = 4.4 Hz, 1H), 8.20 (d, 3J = 4.4 Hz, 2H), 8.06 (d, 3J = 6.1 Hz, 4H) 
7.96–7.91 (m, 4H), 7.69–7.56 (m, 14H), 2.15–2.04 (m, 4H), 0.78 (t, 3J = 7.2 Hz, 6H), 
0.11 (s, 1H), –0.32 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ): 167.6, 157.9, 154.8, 
150.9, 143.8, 142.8, 142.2, 141.8, 139.9, 139.4, 137.0, 133.9, 133.8, 133.7, 133.6, 133.5, 
132.9, 130.6, 129.6, 128.4, 127.9, 127.8, 127.5, 127.4, 127.1, 126.8, 126.6, 126.5, 125.0, 
121.5, 120.9, 109.0, 99.1, 97.4, 34.0, 8.3; HR–MS (ESI+ of MH+, 100% CH3CN, TOF): 
m/z calc’d for C47H38N4O: 674.3046, found 674.3031. 
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Figure 6-36. 1H NMR spectrum (400 MHz, CDCl3) of 4b 
 
 
Figure 6-37. 13C NMR spectrum (100 MHz, CDCl3) of 4b 
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Figure 6-38. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 4b 
(CHCl3) 
meso-Tetraphenyl-3,3-diisopropyl-2-oxachlorin (4c). Prepared from [meso-
tetraphenyl-2-oxa-3-oxoporphyrinato]Zn(II) (1Zn, 250 mg, 0.36 mmol) and i-PrMgCl 
according to the reaction procedure described for the preparation of 4a except for the 
following: In Step 1, 2 equivalents i-PrMgCl (2M solution in THF, 0.36 mL) were added 
slowly and stirred for 5 min at r.t. In Step 2, 2 equivalents of TMSOTf (0.13 mL) were 
added at r.t. and stirred for 5 min, then 4 equivalents of i-PrMgCl (2 M solution in THF, 
0.72 mL) were added and stirred for ~5min. Product 4c was isolated by flash chromato-
graphy (silica–CH2Cl2) as a purple solid in 61% (152 mg) yield. MW = 702.3 g/mol; Rf = 
0.9 (silica–CH2Cl2); UV–vis (CHCl3) λmax (log ε): 424 (5.06), 516 (3.88), 554 (3.75), 
609 (3.66), 667 (4.38) nm; Fl λmax (CHCl3, λexc 425 nm): 670, 726 nm, φ = 0.31; 
1H NMR (300  MHz, CDCl3, δ): 8.43 (d, 3J = 4.8 Hz, 1H), 8.24–8.27 (m, 3H), 8.17 (m, 
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1H), 8.03–8.06 (m, 4H), 7.91–7.96 (m, 4H), 7.57–7.69 (m, 13H), 2.55–2.59 (m, 2H), 1.07 
(d, 3J = 6.6 Hz, 6H), 0.66 (d, 3J = 6.8 Hz, 6H), 0.08 (s, 1H), –0.30 (s, 1H) ppm; 13C NMR 
(100  MHz, CDCl3, δ): 167.6, 161.1, 154.8, 150.8, 143.5, 142.4, 141.8, 140.3, 140.1, 
137.1, 134.8, 134.1, 133.9, 133.7, 133.6, 133.4, 132.9, 130.5, 129.5, 128.4, 127.9, 127.8, 
127.7, 127.5, 127.4, 127.2, 126.9, 126.8, 126.7, 126.4, 125.1, 122.1, 120.7, 108.9, 100.9, 
99.2, 36.9, 19.3, 18.9; HR–MS (ESI+ of MH+, 100% CH3CN, TOF): m/z calc’d for 
C49H43N4O: 703.3437, found 703.3459. 
 
Figure 6-39. 1H NMR spectrum (400 MHz, CDCl3) of 4c 
 
Chapter 6: Alkyl-Oxazolochlorins 
 145 
 
Figure 6-40. 13C NMR spectrum (100 MHz, CDCl3) of 4c 
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Figure 6-41. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 4c 
(CHCl3) 
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meso-Tetrakis(4-trifluoromethylphenyl)-3,3-diethyl-2-oxachlorin (4Fb). 
Prepared from [meso-tetrakis(4-trifluoromethylphenyl)-2-oxa-3-oxoporphyrinato]Zn(II) 
(1FZn, 40 mg, 4.1 × 10–5 mol) and EtMgCl according to the reaction procedure described 
for the preparation of 4a, except for the following: In Step 1, 2 equivalents of EtMgCl 
(2M solution in THF, 0.041 mL) were added at –45 °C. In Step 2, 3 equivalents of 
TMSOTf (0.022mL) were added and the solution was stirred for ~90 min at –45 °C. Into 
the reaction mixture, 10 equivalents of EtMgCl (2M solution in THF, 0.205 mL) were 
added at -45 °C. The reaction was then stirred for ~4 h at –45°C while the progress was 
closely monitored as described in the preparation of 4a. The product 4Fb was isolated by 
chromatography (silica–60% petroleum ether 30-60/CH2Cl2) as a purple solid in 51% 
(20 mg) yield. MW = 946.8 g/mol; Rf = 0.97 (silica–50% petroleum ether 30-60/CH2Cl2); 
UV-vis (CHCl3) λmax (log ε): 423 (5.15), 516 (3.99), 553 (3.86), 609 (3.82), 666 (4.56) 
nm; Fl λmax (CHCl3, λexc = 424 nm): 671, 721 nm, φ = 0.29; 1H NMR (300  MHz, CDCl3, 
δ): 8.41 (d, 3J = 4.29 Hz, 1H), 8.26 (d, 3J = 3.40 Hz, 1H), 8.2–7.08 (m, 19H), 7.61 (d, 3J = 
3.60 Hz, 1H), 2.20–2.17(m, 2H), 2.01–1.97 (m, 2H), 0.79 (t, 3J = 7.18 Hz, 6H), 0.10 (s, 
1H), –0.31 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ): 167.4, 158.2, 154.6, 150.7, 
145.5, 145.5, 143.6, 143.26, 143.25, 142.98, 142.97, 142.5, 136.9, 134.0, 133.9, 133.71, 
133.66, 133.5, 133.2, 130.9, 129.8, 127.7, 125.33, 125.29, 124.34, 124.31, 124.27, 124.1, 
124.04, 124.01, 123.8, 123.7, 121.8, 119.8, 108.0, 98.2, 97.7, 34.1, 8.2 ppm; HR–MS 
(ESI+ of MH+, 100% CH3CN, TOF): m/z calc’d for C51H35F12N4O: 947.2619, found 
947.2603. 
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Figure 6-42. 1H NMR spectrum (400 MHz, CDCl3) of 4Fb 
 
 
Figure 6-43. 13C NMR spectrum (100 MHz, CDCl3) of 4Fb 
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Figure 6-44. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 4Fb 
(CHCl3) 
meso-Tetrakis(4-trifluoromethylphenyl)-3,3-diisopropyl-2-oxachlorin (4Fc). 
Prepared from [meso-tetrakis(4-trifluoromethylphenyl)-2-oxa-3-oxo-porphyrinato]Zn(II) 
(4FZn, 53 mg, 5.5 × 10–5 mol) and i-PrMgCl according to the reaction procedure 
described for the preparation of 4a except for the following: In Part 1, 3 equivalents of 
i-PrMgCl (2M solution in THF, 0.083 mL) were added and the solution stirred for ~1 h at 
–78°C. In Step 2, 3 equivalents of TMSOTf (0.03 mL) were added and the reaction was 
stirred for ~1 h at –78°C. Next, 6 equivalents of i-PrMgCl (2M solution in THF, 0.164 
mL) was added at –78°C, then the reaction was stirred for about ~1 h at this temperature. 
The product 4Fc was isolated by column chromatography (silica–60% petroleum ether 
30–60/CH2Cl2) as a purple solid in 56% (30 mg) yield. MW = 974.3 g/mol; Rf = 0.97 
(silica-50% petroleum ether 30-60/CH2Cl2); UV-vis λmax (log ε): 425 (5.29), 517 (4.11), 
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554 (3.95), 610 (3.92), 668 (4.67) nm; Fl λmax (CHCl3, λexc = 425 nm): 673, 718 nm, φ = 
0.27; 1H NMR (300  MHz, CDCl3, δ): 8.41 (d, 3J = 4.4 Hz, 1H), 8.22–7.88 (m, 20H), 
7.53 (d, 3J = 2.5 Hz, 1H), 2.55–2.48 (m, 2H), 1.09 (d, 3J = 6.2 Hz, 6H), 0.67 (d, 3J = 6.6 
Hz, 6H), 0.08 (s, 1H), –0.03 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ): 167.5, 161.4, 
154.6, 150.5, 145.6, 145.0, 143.9, 143.5, 143.3, 143.0, 136.9, 134.2, 134.0, 133.7, 133.6, 
133.4, 133.2, 130.9, 130.7, 129.7, 127.7, 125.3, 125.2, 124.98, 124.95, 124.33, 124.30, 
124.0, 123.9, 123.8, 123.7, 122.3, 119.7, 107.9, 101.4, 98.2, 37.0, 19.3, 19.0; HR–MS 
(ESI+ of MH+, 100% CH3CN, TOF): m/z calc’d for C53H39F12N4O: 975.2932, found 
975.2901. 
 
Figure 6-45. 1H NMR spectrum (400 MHz, CDCl3) of 4Fc 
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Figure 6-46. 13C NMR spectrum (100 MHz, CDCl3) of 4Fc 
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Figure 6-47. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 4Fc 
(CHCl3) 
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meso-Tetraphenyl-3-isopropyl-3-methoxy-2-oxachlorin (5c). General 
procedure for the conversion of hemiketals 2 to ketals 5. Hemiacetal meso-tetra-
phenyl-3-hydroxy-3-isopropyl-2-oxachlorin (2c, 190 mg, 0.28 mmol) was dissolved with 
30% MeOH in THF (v/v), and stirred at r.t. A catalytic amount (few small drops) of TFA 
was added. Reaction progress was monitored using TLC and complete conversion 
typically required overnight stirring (15–18 h). Upon completion, the reaction was 
quenched by addition of Et3N (~2-3 mL, added drop-wise until solution turns to 
pink/red). The neutralized solution was evaporated by rotary evaporation. The bright 
pink, non-polar product 5c was isolated by column chromatography (silica–CH2Cl2) as a 
purple solid in excellent yield (181 mg, 93%). MW = 690.83 g/mol; Rf = 0.88 (silica-
CH2Cl2); UV-vis (CHCl3) λmax (log ε): 421 (4.94), 516 (3.76), 551 (3.77), 595 (3.52), 650 
(4.19) nm; Fl λmax (CHCl3, λexc = 420 nm): 653, 702 nm, φ = 0.36; 1H NMR (300  MHz, 
CDCl3, δ): 8.61 (d, 3J = 4.9 Hz, 1H), 8.49 (d, 3J = 4.9 Hz, 1H), 8.45 (d, 3J = 5.0 Hz, 1H), 
8.43 (d, 3J = 4.5 Hz, 1H), 8.36 (d, 3J = 4.5 Hz, 1H), 8.18–7.99 (m, 8H), 7.86–7.55 (m, 
13H), 3.04 (s, 3H), 2.19 (m, 1H), 1.22 (d, 3J = 6.5 Hz, 3H), 0.67 (d, 3J = 6.5 Hz, 3H), –
0.56 (s, 1H), –0.99 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ): 164.1, 155.1, 151.6, 
150.9, 143.0, 142.2, 142.0, 141.8, 139.4, 138.8, 137.0, 134.2, 134.1, 133.9, 133.8, 133.5, 
133.4, 131.5, 129.7, 128.2, 128.0, 127.9, 127.6, 127.5, 127.1, 126.9, 126.2, 126.1, 125.5, 
122.6, 121.2, 117.5, 111.4, 99.8, 50.9, 35.8, 17.4, 16.5, ppm; HR–MS (ESI+ of MH+, 
100% CH3CN, TOF): m/z calc’d for C47H39N4O2: 691.3073, found 691.3062. 
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General procedure for the reversion of ketals 5 to hemiketals 2. Ketal 5c 
(100 mg, 0.145 mmol) was dissolved in 10% 3 M HCl in THF (v/v) and stirred overnight 
at 45 °C. The reaction was washed with aq. NaHCO3 solution and the organic layer was 
extracted using CH2Cl2. The organic layer was evaporated by rotary evaporation and the 
product was isolated by flash chromatography (CH2Cl2) as a purple solid in 90-95% yield 
(88-93 mg). 
 
Figure 6-48. 1H NMR spectrum (400 MHz, CDCl3) of 5c 
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Figure 6-49. 13C NMR spectrum (100 MHz, CDCl3) of 5c 
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Figure 6-50. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 5c 
(CHCl3) 
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meso-Tetrakis(4-trifluoromethylphenyl)-3-isopropyl-3-methoxy-2-oxachlorin 
(5Fc). Prepared from meso-tetrakis(4-trifluoromethylphenyl)-3-hydroxy-3-isopropyl-2-
oxachlorin (2Fc, 51 mg, 5.4 × 10–5 mol) according to the procedure described for the 
preparation 5c. The product 5Fc was isolated by flash chromatography (silica-CH2Cl2) as 
a purple solid in 70% (36 mg) yield. MW = 962.8 g/mol; Rf = 0.88 (silica–30% 
petroleum ether 30-60/CH2Cl2); UV-vis (CHCl3) λmax (log ε): 420 (5.22), 514 (4.11), 548 
(4.11), 595 (3.60), 652 (4.54) nm; Fl λmax (CHCl3, λexc 420 nm): 655, 703 nm, φ = 0.35; 
1H NMR (300  MHz, CDCl3, δ): 8.56 (d, 3J = 3.8 Hz, 1H), 8.42 (t, 3J = 3.9 Hz, 2H), 8.34 
(d, 3J = 4.5 Hz, 1H), 7.85–8.28 (m, 18H), 3.04 (s, 3H), 2.04–2.09 (m, 1H), 1.19 (d, 3J = 
6.4 Hz, 3H), 0.63 (d, 3J = 6.8 Hz, 3H), –0.62 (s, 1H), –1.02 (s, 1H) ppm; 13C NMR (100  
MHz, CDCl3, δ): 164.0, 154.8, 151.4, 151.3, 145.4, 145.1, 142.9, 142.8, 142.3, 141.7, 
136.9, 134.2, 133.95, 133.92, 133.88, 133.81, 133.7, 133.6, 131.7, 130.6, 130.4, 130.3, 
129.9, 127.8, 126.1, 125.7, 125.2, 125.1, 125.05, 125.00, 124.98, 124.96, 124.4, 124.3, 
124.2, 124.1, 123.4, 123.3, 123.2, 122.8, 120.1, 117.7, 110.4, 98.8, 51.0, 36.0, 17.3, 16.5 
ppm; HR–MS (ESI+ of MH+, 100% CH3CN, TOF): m/z calc’d for C51H35F12N4O2: 
963.2568, found 963.2539. 
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Figure 6-51. 1H NMR spectrum (400 MHz, CDCl3) of 5Fc 
 
Figure 6-52. 13C NMR spectrum (100 MHz, CDCl3) of 5Fc 
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Figure 6-53. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 5Fc 
(CHCl3) 
[meso-Tetraphenyl-3-isopropyl-3-methoxy-2-oxachlorinate]Zn(II) (5cZn). 
meso-Tetraphenyl-3-isopropyl-3-methoxy-2-oxachlorin (5c, 67 mg, 9.7 × 10–5 mol), was 
dissolved in 30% MeOH/CHCl3 (v/v) and heated to reflux. A solution of Zn(OAc)2·H2O 
(~5-7 eq, 100-150 mg) in MeOH (5–10 mL) was added and the mixture was stirred and 
heated overnight. The reaction progress was monitored by TLC (silica–CH2Cl2; the bright 
pink non-polar starting material is converted to a more polar green spot). Upon comple-
tion, the product was isolated by rotary evaporation, followed by flash chromatography 
(silica–CH2Cl2). The material was obtained as crystalline material by crystallization using 
a slow solvent exchange from CH2Cl2 to MeOH or pentane as a green crystalline solid 
(65%, 47 mg). MW = 754.2 g/mol; Rf = 0.50 (silica–CH2Cl2); UV-vis (CHCl3) λmax (log 
ε): 417 (5.36), 455 (4.07), 516 (3.76), 581 (3.88), 622 (4.58) nm; Fl λmax (CHCl3, λexc = 
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420 nm): 626, 679 nm, φ = 0.19; 1H NMR (300  MHz, CDCl3, δ): 8.58 (d, 3J = 4.7 Hz, 
1H), 8.49 (d, 3J = 3.3 Hz, 1H), 8.41–8.33 (m, 3H), 8.13–7.88(m, 9H), 7.78–7.58 (m, 
12H), 3.1 (s, 3H), 2.26–2.17 (m, 1H), 1.25 (d, 3J = 6.4 Hz, 3H), 0.75 (d, 3J = 6.6 Hz, 3H) 
ppm; 13C NMR (100  MHz, CDCl3, δ): 162.2, 156.0, 155.1, 149.9, 147.9, 146.6, 145.3, 
145.2, 142.4, 139.6, 139.3, 134.2, 133.9, 133.8, 133.7, 133.65, 133.60, 133.5, 133.1, 
132.0, 130.3, 128.5, 128.4, 128.1, 128.0, 127.98, 127.87, 127.82, 127.7, 127.3, 127.0, 
126.9, 126.8, 126.3, 126.2, 122.9, 117.6, 112.5, 98.5, 50.9, 36.1, 17.5, 16.2 ppm; HR–MS 
(ESI+ of MH+, 100% CH3CN, TOF): m/z calc’d for C47H36N4O2Zn: 752.2130, found 
752.2120. 
 
Figure 6-54. 1H NMR spectrum (400 MHz, CDCl3) of 5cZn 
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Figure 6-55. 13C NMR spectrum (100 MHz, CDCl3) of 5cZn 
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Figure 6-56. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 5cZn 
(CHCl3) 
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6.4.3.  X-ray Crystallography Data  
X-ray crystallographic analysis (provided by Dr. Christopher Ziegler and James 
T. Engle, University of Akron):  Single crystals of 2c, 4c, and 5cZn were coated in 
Fomblin® oil, mounted on a CryoLoop™ and placed on the goniometer head under a 
stream of nitrogen cooled to 100 K.  The data were collected on a Bruker APEX2 CCD 
diffractometer with either IµS microfocus Cu source Kα radiation (λ = 1.54178 Å, 4c) or 
IµS microfocus Mo source Kα radiation (λ = 0.71073, 2c and 5cZn). The frames were 
integrated with the Bruker SAINT software package using a narrow-frame algorithm. 
Data were corrected for absorption effects using the multi-scan method (SADABS) and 
the structure was solved and refined using the Bruker SHELXTL Software Package until 
the final anisotropic full-matrix, least squares refinement of F2 converged. 
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Crystal Structure Report for 2c  
A purple plate-like specimen of 2c, approximate dimensions 0.09 mm × 0.19 mm 
× 0.25 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data 
were measured. The total exposure time was 15.15 hours.  
 
Figure 6-57. ORTEP representation of the single crystal X-ray structures of 2c including the 
numbering system used. Thermal ellipsoids have been rendered at the 35% level. 
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Crystal Structure Report for 4c 
A purple plate-like specimen of 4c, approximate dimensions 0.21 mm × 0.29 mm 
× 0.56 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data 
were measured. The total exposure time was 16.87 hours.  
 
Figure 6-58. ORTEP representation of the single crystal X-ray structures of 4c including the 
numbering system used. Thermal ellipsoids have been rendered at the 35% level. 
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Crystal Structure Report for 5cZn  
A red rod-like specimen of 5cZn, approximate dimensions 0.07 mm × 0.16 mm × 
0.27 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data were 
measured. The total exposure time was 15.15 hours.  
 
 
Figure 6-59. ORTEP representation of the single crystal X-ray structures of 5cZn including 
the numbering system used. Thermal ellipsoids have been rendered at the 35% level. 
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Table 6-1. Crystallographic and structure refinement data for 2c, 4c and 5cZn. 
Identification code  2c 4c 5cZn 
Empirical formula  C47H40N4O3 C49H42N4O C52H41N5O2Zn 
Formula weight  708.83 702.87 833.27 
Temperature (K) 100(2)  100(2)  100(2)  
Wavelength (Å) 0.71073  1.54178  0.71073  
Crystal system  Triclinic Monoclinic Monoclinic 
Space group  P-1 P2(1)/n P2(1)/n 
a, b, c, (Å) 9.2644(17) 
9.7808(18)  
20.850(4)  
10.6322(11)  
12.8331(13)  
26.909(3) 
13.2442(13)  
18.7070(19)  
17.9647(18)  
α, β, γ (°) 
 
88.078(2) 
86.288(2) 
88.819(2) 
90 
90.658(5) 
90 
90 
91.7930(10) 
90 
Volume [Å3] 1883.9(6)  3671.4(7)  4448.7(8)  
Z 2 4 4 
Density (calcʼd) [mg/m3] 1.250  1.272  1.244  
Abs coefficient [mm-1] 0.079  0.591  0.598  
F(000) 748 1488 1736 
Crystal size [mm3] 0.25 × 0.19 × 0.09  0.56 × 0.29 × 0.21  0.27 × 0.16 × 0.07  
Theta range for  
data collection 
1.96 to 27.57°. 3.82 to 65.42°. 1.57 to 26.58°. 
Index ranges -12<=h<=12 
-12<=k<=12 
-26<=l<=27 
-11<=h<=12 
-14<=k<=12 
-31<=l<=31 
-16<=h<=16,  
-23<=k<=23,  
-22<=l<=22 
Reflections collected 16351 20769 35192 
Independent reflections 8427 [R(int) = 
0.0473] 
6067 [R(int) = 
0.0253] 
9224 [R(int) = 
0.0741] 
Completeness to theta =  27.57°, 96.7 %  65.42°, 96.0 %  26.58°, 99.2 %  
Absorption correction Multi-scan Multi-scan Multi-scan 
Max. and min.  
transmission 
0.9930 and 0.9806 0.8859 and 0.7315 0.9594 and 0.8553 
Refinement method Full-matrix least-
squares on F
2
 
Full-matrix least-
squares on F
2
 
Full-matrix least-
squares on F
2
 
Data / restraints 
/ parameters 
8427 / 33 / 530 6067 / 0 / 491 9224 / 0 / 544 
Goodness-of-fit on F2 0.822 0.823 0.912 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0652 
wR2 = 0.1939 
R1 = 0.0408 
wR2 = 0.1127 
R1 = 0.0609 
wR2 = 0.1463 
R indices (all data) R1 = 0.1201 
wR2 = 0.2545 
R1 = 0.0429 
wR2 = 0.1153 
R1 = 0.1079 
wR2 = 0.1679 
Largest diff.  
peak & hole [e x Å-3] 
0.410 & -0.424  0.438 & -0.270  0.915 and -0.315  
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7.  Oxabacteriochlorins and Dioxabacteriochlorins 
7.1.  Introduction 
The syntheses of alkyloxazolochlorins described in the preceding chapter allowed us 
access to a number of oxidatively stable oxazolochlorin chromophores.  In principle, this 
meant that we could now shift our focus onto modulating the pyrrole unit on the opposite 
side, without altering the pre-existing oxazole moiety, to create various bis-pyrrole 
modified macrocycles. Although there are few exceptions, bis-pyrrole modified 
porphyrinoids generally possess bacteriochlorin-like chromophores with high extinction 
coeffecients and significant bathochromic shifts compared to their parent porphyrins.1,2 In 
fact, these two properties are often the essential key elements to the development of 
successful porphyrinoid photo-medicinal agents. For this reason, we became particularly 
interested in knowing whether bisoxazolobacteriochlorins can be generated. Further, can 
the option to modulate the tunable optical properties of the oxazolochlorins by variation 
of the α-substituent be extended to the bisoxazole-systems?  Presented herein are the 
answers to these questions. This chapter describes the systematic evaluation of the scope 
and limits of the synthesis of bacteriochlorin-type chromophores possessing a single or 
double carbon-to-oxygen replacements at opposite ring positions, their optical properties, 
and the crystal structures of select members. 
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7.2.  Nomenclature Conventions 
Herein we define oxazolochlorins (2-oxachlorins) to be chlorin-type 
porphyrinoids in which a single pyrrole was replaced by an oxazoline moiety and 
oxazolobacteriochlorins (2-oxabacteriochlorins) to be bacteriochlorin-type porphyrinoids 
in which a single pyrrole was replaced by an oxazoline moiety. Correspondingly, 
bisoxazolochlorins (2,12- or 2,13-dioxachlorins) are chlorin-type porphyrinoids in which 
two pyrroles were replaced by oxazoline and oxazole moieties. This double replacement 
can also result in the formation of bacteriochlorin-like chromophores; consequenty, they 
are named bisoxazolobacteriochlorins (2,12/13-dioxabacteriochlorins).  
In cases in which two oxygens are present in the chromophore of 
bisoxazolochlorins and -bacteriochlorins, two regioisomers are possible, designated cis 
(2,13-isomer) and trans (2,12-isomer) (Figure 7-1). If a mixture of isomers is present, the 
compound is designated as a 3,12/13 isomer mixture.  
 
Figure 7-1. Nomenclature conventions for the regio- and stereo-isomeric bisoxazolo- 
chromophores. 
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The sp3-hybridized carbons of the pyrroline or oxazoline moieties are chiral 
centers. Moreover, the substituents on these centers can be positioned relative to each 
other on opposite sides defined by the macrocycle mean plane, or on the same side 
(Figure 7-1). Following the nomenclature chosen for these type of stereoisomers that are 
also observed in the tetrahydroxybacteriochlorins, we name them E and Z isomers, 
respectively.3 
7.3.  Results and Discussion 
7.3.1  Synthesis of Oxazolobacteriochlorins 
The highly regioselective OsO4-mediated conversion of free base chlorins to form 
β,β’-dihydroxylated bacteriochlorin is well established for β-octaalkyl- as well as meso-
di- and tetraarylchlorins.3-13 This reaction can also be applied to the green, non-polar 
alkyloxazolochlorin 1 (Scheme 7-1). Thus, dihydroxylation followed by H2S-reductive 
cleavage of the intermediate osmate ester produced a single major pink product in overall 
34% isolated yield (with ~50% recovered starting material; the reaction was much slower 
than observed for the oxidation of diolchlorins but neither extended reaction times nor an 
excess of oxidant improved the yield significantly). Based on its composition 
(C49H45N4O3 for MH+ as per ESI+ HR-MS) and diagnostic bacteriochlorin spectrum (with 
a λmax of 750 nm; see Figure 7-5 and below for a more detailed description of the UV-
visible spectra of all chromophores prepared) it was identified as 12,13-dihydroxy-2-
oxabacteriochlorin 2. The 1H NMR spectrum of 2 showed inter alia the presence of two 
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non-equivalent pyrroline hydrogens. The compound is chiral and presumably is found as 
a racemate.  
 
Scheme 7-1. Syntheses of oxazolobacteriochlorin 2 and bisoxazolochlorins 3. 
7.3.2.  Synthesis of Bisoxazolochlorins 
The oxidative conversion of a dihydroxychlorin to a porpholactone was described 
in Chapter 2.14-17 This reaction could also be applied to dihydroxyoxazolobacteriochlorin 
2. Thus, oxidation of 2 using MnO4– (in the form of CTAP) converted the diol functiona-
lity into a lactone moiety, as indicated by the appearance of a carbonyl stretch at 
1724 cm-1 in the IR of the product 3. In comparison, the stretching frequency is 1742 cm-1 
for the parent porpholactone. The observed shift to lower wavenumbers for 3 likely 
reflects the higher HOMO level for hydroporphyrins compared to porphyrins.18-20 The 
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bacteriochlorin-type spectrum of the pink, polar starting material was replaced by a (red-
shifted) chlorin-like spectrum of the much less-polar grey-colored product 3 (Figure 7-3). 
 
Figure 7-2. Stick representation of the molecular structures of (A) 3-cis, (B) 6-cis, and (C) 
6Zn-cis (top and side views). All hydrogens, disorder and solvents, when present, omitted 
for clarity.  
The 1H NMR spectrum of the product indicated the presence of two diastereomers 
in a 7:1 ratio (see ESI), assigned to the two isomers 3-cis and 3-trans that differ in their 
relative orientation of the lactone moiety. The absorption spectrum of this mixture 
possessed equally intense λmax peaks at 695 and 705 nm. No flash column or preparative 
plate chromatographic separation methods were found to completely separate the two 
isomers but repeated column chromatography (50% hexane/CH2Cl2 on silica gel) 
enriched the mixture to a ~10:1 isomer ratio. Crystallization of this mixture resulted in 
the formation of a crystal of the slightly less polar majority product that was suitable for 
investigation by single crystal X-ray diffractometry. The structure of the compounds were 
determined to be of type 3, though due to disorder in the crystal, the cis-regiochemistry 
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could not be assigned with absolute certainty (Figure 7-2). However, the UV-visible 
spectra of 3 and 9-cis (derived from 6-cis) are very similar, much like the way 8 and 6 
posses near-identical spectra. This information lead us to believe that the major compo-
nent of the 10:1 mixture of 3 is the cis-regioisomer. 
With small amounts of the separated isomers in hand, it allowed us to identify 
their surprisingly different UV-visible spectra. Isomer 3-cis possesses a λmax peak at 
695 nm, while 3-trans possessed a much more intense λmax peak at 705 nm. Thus, the 
non-axial symmetric electron distribution within the oxazole moiety also affects the MOs 
of the oxazolone moiety across the macrocycle. 
The dihydroxylation/oxidative diol cleavage reaction sequence applied to 
alkyloxazolochlorin 1 to generate bisoxazolochlorin 3 can also be applied to both the 
hydroxy-substituted alkyloxazolochlorin 10 and its alkoxy derivative 4, to generate, via 
the intermediates 7 and 5, respectively, the bisoxazolochlorins 8 and 6, respectively. 
However, the presence of a chiral center in these starting materials increased the 
complexity of the product isomer mixtures: each cis/trans isomer is formed as a racemic 
mixture (Scheme 7-2). 
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Scheme 7-2. Syntheses of alkylbisoxazolochlorins 6, 6Zn,7, 8 and 9.  
All products possessed the expected spectroscopic and analytical properties with 
some notable features. Intermediate bacteriochlorin diol 5 formed as a separable mixture 
of E/Z isomers. However, since NMR spectroscopy does not allow an assignment of the 
isomers, their assignment remained, citing the relative polarity of related bacteriochlorin 
E/Z isomers for which crystal structure analyses confirmed their relative stereochemistry, 
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speculative.3 The UV-visible spectra of the intermediate diols 5 and 7 possess identical 
UV-visible spectra that are ~30 nm blue-shifted (λmax = 720 nm) as compared to the 
spectrum of the corresponding dihydroxydialkyloxazolobacteriochlorin 2. Thus, the 
α-hydroxy/methoxy-induced blue-shifts that were observed in the monooxazolochlorins 
(shifts of ~20 nm) are also present in the oxazolobacteriochlorin series but the shifts are 
somewhat more pronounced. 
The MnO4–-mediated oxidation of either isomer of 5 converts the bacteriochlorin-
like chromophore into a diastereomeric mixture of chlorin-type chromophores, 6. While, 
as expected, the sp2 -hybridized lactone carbon mimics the effect of a β,β’-double 
bond,17,21 the chlorin-type UV-visible spectrum of bisoxazole 6 is significantly red-
shifted compared to that of the corresponding mono-oxazolochlorin 4 (Figure 7-3). As 
per 1H NMR spectrum of the regioisomeric mixture of 6-cis/trans, the formation of the 
2,13-dioxachlorin 6-cis isomer was slightly favored (cis/trans diastereomeric ratio is 5:2). 
Again, the majority diastereomer could be enriched to ~10:1 by column chromatography 
and purified by fractional cryctallization. The UV-visible spectrum of 6-cis (10:1 
mixture) exhibited a λmax peak at 675 nm while the 5:2 cis/trans diasteromeric mixture 
possessed equally intense λmax peaks at 675 nm and 695 nm. Thus, the latter band was 
assigned to the 2,12-dioxa-substituted trans-isomer 6-trans. The structure and regio-
chemistry of 6-cis was confirmed using single crystal X-ray diffractometry (Figure 7-2).  
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Zinc insertion into the regioisomeric mixture of grey non-polar 6 proceeded 
smoothly to form the more polar green product 6Zn of identical diastereomeric ratio. The 
product showed, as expected, a metallochlorin-type spectrum (see ESI). 
Treatment of 6 with 2 M aq HCl in THF hydrolyzed its ketal moiety to form 
hemiketal 8 in near-quantitative yield. The replacement of the methoxy proton peak (at 
3.1 ppm) in the 1H NMR spectrum of the reactant with a hydroxy peak at 3.9 ppm 
(exchangeable with D2O) in the 1H NMR spectrum of the product, with no further 
significant differences in their spectra, confirmed the transformation. This reaction is 
reversible. Thus, hemiacetal 8 is swiftly converted back into 6 in the presence of 
methanol with catalytic amount of TFA at ambient temperature (Scheme 7-2).17,22 The 
UV-visible spectra of 6 and 8 are near-identical (see ESI). The pathway towards 8 ( 4 → 
5 → 6 → 8) proved to be overall higher yielding compared to the shorter alternative 
sequence (10 → 7 → 8) previously communicated.23 This is because the presence of the 
acetal moiety in 4 significantly improved the yield of the dihydroxylation reaction as well 
as the MnO4–-mediated oxidation step. 
Hemiketalchlorins of type 10 could be hydro-dehydroxylated to the corresponding 
oxazolochlorin (Chapter 6).17 Likewise, treatment of 8 with Et3SiH/BF3·OEt2 produce the 
less polar bisoxazolochlorin 9 in acceptable yield (Scheme 7-2). This transformation was 
expressed in the 1H NMR spectrum of the product by the replacement of the hydroxy 
peak in spectrum of 8 by a diagnostic singlet for the oxazoline hydrogen (at 6.7 ppm). 
Once again, the removal of the α-hydroxy group caused a bathochromic shift in the UV-
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visible spectrum of 9 when compared to the spectrum of 8 and, not surprisingly, its 
spectrum is very similar to that of 3 (Figure 7-3). 
 
Figure 7-3. (top) full and (bottom) λmax normalized UV-visi spectra of chlorins 1 (grey), 4 
(purple), 3 (of -cis, blue), 6 (of -cis, lime-green), 8 (of -cis, light-blue), 9 (of -cis, red) in CH2Cl2 
at ambient temperature. 
Much to our disappointment, none of the bisoxazolochlorins 6 (as its free base or 
zinc complex 6Zn), 8, or 9 were susceptible to an alkylation of the lactone moiety using 
Grignard reagents under a variety of reaction conditions without extensive decompo-
sition. Likewise, the double-alkylation of bisporpholactone 11 21,24,25 failed to provide 
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any isolatable product (Scheme 7-3). Thus, alkylation pathways did not allow the 
generation of bisoxazolobacteriochlorins.  
 
Scheme 7-3. Failed routes towards dioxazolobacteriochlorins 21. 
On the contrary, an exhaustive hydride-reduction (using DIBAl-H or Et3SiH) of 
11 appeared to be reducing both lactones of 11 to methylene groups as the crude mixture 
showed a strongly red-shifted bacteriochlorin-type spectrum (λmax = 815 nm) and the 
HR-MS indicated the presence of a product of the desired composition (signal indicative 
of a MH+ of the composition C42H31N4O2). However, the product appeared to be 
extremely light- and acid sensitive and could not be isolated in a quantity allowing an 
unambiguous characterization. We observed the sensitivity of unsubstituted oxazolo-
chlorins before.17 Moreover, bis-pyrrole modified bacteriochlorin  proved also to be 
significantly more fragile than the corresponding mono-pyrrole modified morpholino-
chlorins (Section 1.5.).1 Nonetheless, the discovery of a fortuitous transformation 
eventually led to the isolation of bisoxazolobacteriochlorins. 
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7.3.3.  Synthesis of Bisoxazolobacteriochlorins 
The oxidative cleavage of a dihydroxychlorin with NaIO4/silica gel generates the 
corresponding secochlorin bisaldehyde (Chapter 1).26 Performed in ROH/CHCl3, this 
bisaldehyde is converted in situ to a dialkoxymorpholinochlorin.14,27 When we submitted 
polar dihydroxyoxazolobacteriochlorin 2 to these reaction conditions, the resulting non-
polar product 13 showed the expected red-shifted UV-visible spectrum (λmax = 770 nm) 
but it possessed a composition (as per ESI+-HR-MS) of C49H45N4O3 (for MH+), i.e., short 
of a C2H4O fragment to the composition of the expected morpholinooxazolobacterio-
chlorin. Further, the 1H NMR spectrum of the product confirmed the loss of the 
diagnostic pyrroline hydrogen peaks of the β,β’-dihydroxy moiety but revealed the 
appearance of a new signal for only a single methoxy group (3.1 ppm, s, 3H) in a 
compound that appeared as a 3:2 mixture of two diastereomers that could not be 
separated by chromatography. These findings are consistent with the formation of 
bisoxazolobacteriochlorin 13 (Scheme 7-4).  
 
Scheme 7-4. Syntheses of bis-alkylbisoxazolobacteriochlorins 13. 
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The one-step conversion of β,β’-dihydroxypyrroline to α-methoxy-oxazoline 
conversion can also be applied to bacteriochlorin diol 5 (Scheme 7-5). However, the 
spectroscopic analysis of the resulting bisoxazolobacteriochlorin 14 is complicated by the 
presence of several regio- and stereoisomers. The molecule contains two chiral α-
oxazoline carbons. Their relative orientation to each other give rise to E/Z diastereomers. 
In addition, the second oxazole can be arranged such that the ring oxygens are on the 
same side (cis) or on opposite sides (trans).  
 
Scheme 7-5. Syntheses of mono-alkylbisoxazolobacteriochlorin isomers 14. 
All diastereomers are formed with little to no regioselectivity (as per 1H NMR 
spectrum of the crude mixture). The diastereomer mixture of 14 can be further purified 
into the E- and Z- isomers using an automated flash chromatography system (on silica 
gel, 50% hexane/CH2Cl2) though this process also causes some decomposition of 
products on the stationary phase (alumina did not allow any separation). Both fractions 
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possess identical UV-visible absorption spectra and compositions (C47H41N4O4 as per 
ESI+-HR-MS).  
Based on the relative polarity of the E/Z isomers of the tetrahydroxy-
bacteriochlorins,3 we presume that the less polar fraction contains the E-isomers while 
the more polar fraction contains the Z-isomers. This was confirmed by the single crystal 
X-ray structure elucidation of the two fractions; the non-polar fraction contained 14-
cis/trans-E isomers while the more polar fraction contained 14-cis/trans-Z isomers. Due 
to disorder problems in the asymmetric unit however, we could not unequivocally 
determine the regiochemistry (cis vs. trans) of the major product (Figure 7-4). 
 
Figure 7-4. Stick representation of the molecular structures of (A) 14-trans-E and (B) 
14-trans-Z, and (C) 13-cis (top and side views). All hydrogens, disorder and solvents, when 
present, omitted for clarity.  
The UV-visible spectra of the starting oxazolobacteriochlorin diols (2 and 5) and 
the bisozaxolobacteriochlorins are typical bacteriochlorin-type spectra (Figure 7-5). Once 
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again, the trend that the λmax of a given chlorin or bacteriochlorin red-shifts upon 
replacement of a pyrroline by an oxazoline is maintained. 
 
Figure 7-5. UV-vis spectra of 2 (red), 5 (light-blue), 14 (mixture of all isomers, blue), 13 
(cis/trans mixture, lime-green) in CH2Cl2 at ambient temperature. 
The above findings demonstrate that the α,α-dialkyl-bis-oxazolobacteriochlorins, 
such as 13, are chemically more robust than their mono-alkyl- or alkoxy-analogues. This 
further suggested to us a renewed take at the initially fruitless attempts to reduce 
bisoxazolochlorin (such as 6/8/9/11) to the corresponding bisoxazolobacteriochlorin. 
Indeed, reduction of α,α-dialkyloxazole-substituted lactone 3 could be achieved using an 
approx. 30-fold large excess of Et3SiH/BF3·OEt2. The reaction was slow and full 
conversion (determined by the development of the diagnostic product λmax peak at 
815 nm) to form bisoxazolobacteriochlorin 15 took nearly 48 h at room temp and its 
isolated yield were relatively low (Scheme 7-6).  
Chapter 7: Oxabacteriochlorins and Dioxabacteriochlorins 
 180 
 
Scheme 7-6. Synthesis of bis-alkylbisoxazolobacteriochlorins 15. 
The disappearance of the carbonyl νC=O in the IR of the product, its composition 
of C48H43N4O2 (as per ESI+ HR-MS), and the presence of the diagnostic oxazoline peak 
(6.4 ppm, s, 2H) confirmed the structure of 15. Product 15 was diastereomerically pure 
when a 3-cis isomer-enriched (~10:1 mixture) was used as the starting material. In 
addition, the lack of chiral centers in 15 also greatly simplified its 1H NMR spectrum. As 
expected, the UV-visible spectrum for 15 is a red-shifted bacteriochlorin-type spectrum 
(Figure 7-6). 
 
Figure 7-6. UV-vis spectra comparison (normalized at λsoret) of the starting material 3 (red) 
and 15 (blue) in CH2Cl2 at ambient temperature. 
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In part, the low yield of product is because of a pronounced (light-induced) 
oxidation sensitivity of the non-alkylated oxazole moiety, forming the lactol derivative 
(indicated by the presence of the parent mass of the MH+ ion at m/z 737 and possessing 
an UV-visible spectrum that is blue-shifted to 770 nm), or even regenerating the starting 
material.17 Its stability on silica gel was also limited (and alumina proved unsuitable to 
separate the product from the reactant). Thus, we resorted to a fractional crystallization 
method (in the cold and dark) to purify product 15. 
7.3.4.  Fluorescence Properties of Oxazolochlorins and -bacteriochlorins  
The fluorescence emission spectra of the dioxazolochlorins 3, 6, 8 are all chlorin-
type (Figure 7-7) with the small Stoke’s shift typical for porphyrinoids, and with 
fluorescence quantum yields ranging between 0.11 to 0.19. The dihydroxyoxazolo-
bacteriochlorins 2 and 5 showed also similar fluorescence emission spectra, with yields in 
the range of 0.07 to 0.14, but the dioxazolobacteriochlorins show a much lower 
fluorescence yield (0.07, 0.03, to under 0.01 respectively), as is also typical for regular 
bacteriochlorins.1 Thus, as far as the fluorescence properties of the oxazole-derived 
chromophores is concerned, the replacement of one and two carbons in the chromophore 
framework by oxygen(s) is comparable to the effects a reduction of one or two β,β’-bond 
have.  
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Figure 7-7. Normalized fluorescence spectra of 2 (grey), 3 (lime-green), 5 (purple), 6 (light-
blue) 8 (red) and 9 (blue) (all in CH2Cl2 at ambient temperature λexcitation = λsoret).  
7.4.  Conclusions 
The step-wise replacement of a pyrroline moiety in a bacteriochlorin 
chromophore by one or two oxazolone or oxazoline moieties was described. Depending 
on the presence of an oxazolone or oxazoline moiety, the resulting chromophores possess 
chlorin (when one oxazolone moiety is present) or bacteriochlorin characteristics (when 
either one pyrroline and oxazoline or two oxazoline moieties are present) (Figure 7-8). 
The chromophores possess UV-visible spectra that are predictably tuned based on the 
regioisomer and the number and position of the substituents. Thus, a stepwise modify-
cation of the porphyrin chromophore with oxazolines (variously substituted) in combi-
nation with oxazolines, oxazolones and (dihydroxy-substituted) pyrrolines allows a fine-
tuning of their λmax from 650 nm to 810 nm in small increments. Thus this study defines 
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the structure-optical properties relationships in oxazole-derived chlorins and 
bacteriochlorins.  
 
Figure 7-8. Oxazole-based chromophores sorted according to chromophore class and plot 
of their λmax band (spectrum of porpholactone is not shown). 
As a number of crystal structures of the bisoxazole-based chromophores demon-
strate that the replacement of one or two β-carbons by oxygen does not change the 
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overall planarity of the macrocycle. In fact, most chromophores are more planar than, for 
instance, the chromophore of the parent tetrahydroxybacteriochlorin (Section 1.5),3 
implying that the tuning of the UV-visible spectra observed is an electronic substituent 
effect that is to no or minimal degree affected by conformational effects. Thus, the results 
we derived earlier for mono-oxazolochlorins can be transferred to mono- and bis-
oxazolobacteriochorin series except that the bathochromic shifts that are observed in the 
UV-visible spectra upon replacement of a pyrroline with oxazoline are significantly more 
pronounced than in the chlorin series.17,28 
The relatively facile preparation of the novel bacteriochlorin analogues alkyl-
oxazolobacteriochlorins, the oxidative stability of select members of this compound class, 
and the ability to tune their optical spectra suggests their further study with respect to 
their applicability as PDT agent, fluorescence tags, or in light-harvesting systems.  
7.5.  Experimental Section 
7.5.1.  Instruments and Materials 
 meso-Tetraphenyl-2-oxachlorins 1, 4, and 10 were synthesized as reported in the 
literature.28 Flash column chromatography was performed manually in glass columns or 
on an automated flash chromatography system, via dry-packing or liquid injection, on 
normal-phase silica (solvents used are indicated; isochratic elution modes). The fluores-
cence quantum yields (φ) were determined relative to those of meso-tetraphenylporphyrin 
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(φ = 0.11 in benzene, calculated to be 0.09 in CH2Cl2); λexcitiation = λsoret. For details of the 
instruments used, see List of Instruments. 
7.5.2.  Preparation and Characterization 
meso-Tetraphenyl-12,13-cis-dihydroxy-3,3-diisopropyl-2-oxabacteriochlorin 
(2). General procedure for the conversion of 2-oxachlorins to 2-oxabacteriochlorins. 
To a solution of 1 (1.1 g, 1.57 mmol) dissolved in CHCl3 was added a solution of OsO4 in 
pyridine (2 eq., 796 mg). (CAUTION: OsO4 is volatile and extremely toxic, use with 
care; perform in fume hood and wear protective gear at all times!) Reaction progress was 
monitored by TLC and UV-visible spectroscopy. The conversion of starting material to 
product can be identified by the formation of a sharp peak at ~750 nm in the UV-visible 
spectrum of an aliquot of the reaction mixture. The reaction was left stirring until no 
further reaction was detectable (2 to 3 days). The reaction vessel was then purged with 
gaseous H2S for 5 min. (CAUTION: fume hood; use of a bleach filled H2S scrubber is 
recommended.) The reaction was stirred for approximately 15-30 min under an H2S 
atmosphere. The excess H2S was purged out using N2 overnight and the remaining 
solvent (if any) was evaporated by rotary evaporation. Product 2 was isolated by column 
chromatography (silica-1% MeOH/CH2Cl2) in 34% yield (550 mg of the starting material 
1 was also recovered). MW = 736.3 g/mol; Rf = 0.10 (silica-CH2Cl2); UV-vis (CH2Cl2) 
λmax (log ε) 360 (4.65), 386 (4.74), 462 (3.49), 492 (3.66), 526 (4.28), 619 (3.31), 680 
(3.69), 750 (4.39) nm; Fl λmax (CH2Cl2, λexc 385 nm): 687, 760 nm, φ = 0.07; 1H NMR 
(300  MHz, CDCl3, δ) 8.07 (m, 2H), 7.95-8.00 (m, 2H), 7.86-7.87 (m, 5H), 7.51-7.64 (m, 
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15H), 6.03 (d, 3J = 7.1 Hz, 1H), 5.91 (d, 3J = 7.1 Hz, 1H), 2.46-2.49 (m, 2H), 1.06 (d, 3J 
= 6.6 Hz, 3H), 0.96 (d, 3J = 6.6 Hz, 3H), 0.74 (d, 3J = 6.8 Hz, 3H), 0.60 (d, 3J = 6.8 Hz, 
3H), 0.36 (s, 1H), -0.21 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ) 165.3, 161.9, 
154.2, 152.9, 149.8, 141.6, 141.1, 140.5, 140.4, 140.1, 139.6, 138.2, 133.9, 133.6, 133.3, 
133.1, 131.9, 131.6, 128.1, 128.0, 127.9, 127.8, 127.8, 127.6, 127.5, 127.4, 126.5, 126.5, 
126.4, 125.6, 123.9, 120.3, 119.0, 118.6, 113.9, 112.1, 102.6, 100.1, 74.5, 72.8, 70.7, 
36.7, 36.6, 32.1, 29.8, 29.5, 29.4, 24.9, 22.8, 19.0, 18.9, 18.5, 14.3 ppm; HR-MS (ESI+ of 
MH+, 100% CH3CN): m/z calc’d for C49H45N4O3: 737.3492, found 736.3490. 
 
Figure 7-9. 1H NMR spectrum (400 MHz, CDCl3) of 2. 
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Figure 7-10. 13C NMR spectrum (100 MHz, CDCl3) of 2. 
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Figure 7-11. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 2 
(CH2Cl2). 
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Figure 7-12. FT-IR spectrum (neat, diffuse reflectance) of 2. 
meso-Tetraphenyl-12,13-cis-dihydroxy-3-isopropyl-3-methoxy-2-
oxabacteriochlorin (5). A diastereomeric mixture of 5 (178 mg) was prepared in 56% 
yield from meso-tetraphenyl-3-isopropyl-3-methoxy-2-oxachlorin (4) (300 mg, 
0.44 mmol) according to the general procedure described for the formation of 2. The two 
diastereomers were separated using automated chromatography (silica, CH2Cl2). MW = 
724.84 g/mol; Rf = 0.30 (silica-CH2Cl2); UV-vis (CH2Cl2) λmax (log ε) 374 (4.94), 383 
(5.00), 494 (3.74), 525 (4.48), 657 (3.77), 722 (4.63) nm; Fl λmax (CHCl3, λexc = 385 nm): 
729 nm, φ = 0.12; 1H NMR (300  MHz, CDCl3, δ) 8.26 (dd, 3J = 4.9, 4J = 1.4 Hz, 1H), 
8.12 (dd, 3J = 4.7, 4J = 1.4 Hz, 1H), 8.12-7.69 (m, 8H), 7.66-7.51 (m, 14H), 6.08 (m, 2H), 
3.05 (s, 3H), 2.07 (m, 1H), 1.11 (d, 3J = 6.5 Hz, 3H), 0.58 (d, 3J = 6.8 Hz, 3H), -0.38 (s, 
1H), -0.88 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ) 162.1, 161.9, 154.5, 145.1, 
141.4, 140.8, 140.7, 139.9, 138.9, 138.8, 137.1, 134.7, 133.7, 133.5, 133.4, 133.2, 132.7, 
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132.1, 131.7, 128.2, 128.1, 127.8, 126.7, 126.1, 125.8, 120.9, 120.4, 118.2, 116.9, 114.8, 
114.5, 102.9, 74.6, 73.2, 70.8, 50.7, 35.6, 31.8, 22.9, 17.4, 16.3, 14.3 ppm; HR-MS (ESI+ 
of MH+, 100% CH3CN): m/z calc’d for C47H41N4O4: 725.3123, found 725.3126.  
 
Figure 7-13. 1H NMR spectrum (400 MHz, CDCl3) of 5. 
 
Figure 7-14.13C NMR spectrum (100 MHz, CDCl3) of 5. 
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Figure 7-15. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 5 
(CH2Cl2). 
meso-Tetraphenyl-12,13-cis-dihydroxy-3-hydroxy-3-isopropyl-2-
oxabacteriochlorin (7).  A diastereomeric mixture (1:3) of 7 was prepared in 32% yield 
from meso-tetraphenyl-3-hydroxy-3-isopropyl-2-oxachlorin (10) (300 mg, 0.44 mmol) 
according to the general procedure described for the synthesis of 2. The diagnostic peak 
of product 7 was observed at ~720 nm. MW = 710.80 g/mol; Rf = 0.10 (silica-CH2Cl2); 
UV-vis (CH2Cl2) λmax (log ε) 371 (4.94), 383 (5.01), 460 (3.66), 491 (3.84), 524 (4.50), 
597 (3.46), 654 (3.85), 719 (4.60) nm, Fl λmax (CH2Cl2, λexc = 383 nm): 663, 731 nm, φ = 
0.14; 1H NMR (300  MHz, CDCl3, δ) 8.26 (d, 3J = 4.0 Hz, 0.33H), 8.23 (d, 3J = 4.2 Hz, 
1H), 8.16 (d, 3J = 7.5 Hz, 1H), 8.11 (m, 1.33H), 8.01-8.06 (m, 2.3H), 7.94 (m, 4H), 7.76-
7.78 (m, 3.33H), 7.50-7.78 (m, 16H), 6.14 (d, 3J = 6.9 Hz, 1H), 5.99 (d, 3J = 6.9 Hz, 1H), 
2.31 (m, 0.33H), 2.07 (m, 1H), 1.22 (d, 3J = 6.5 Hz, 3H), 0.74 (d, 3J = 6.7 Hz, 3H), -0.31 
Chapter 7: Oxabacteriochlorins and Dioxabacteriochlorins 
 191 
(s, 1H), -0.38 (s, 0.33H), -0.79 (s, 1H), -0.85 (s, 0.33H) ppm; 13C NMR (100  MHz, 
CDCl3, δ) 162.3, 161.9, 161.3, 161.3, 154.6, 154.0, 148.0, 141.5, 141.4, 140.8, 140.8, 
140.8, 140.7, 140.1, 139.9, 138.9, 138.9, 138.9, 137.1, 137.0, 134.7, 134.7, 134.3, 134.3, 
133.8, 133.6, 133.5, 133.4, 133.2, 133.2, 132.1, 132.0, 131.8, 131.7, 128.2, 128.2, 128.1, 
128.0, 127.8, 127.8, 127.7, 127.6, 126.8, 126.8, 126.7, 126.7, 126.2, 126.1, 125.8, 121.0, 
120.9, 120.3, 120.2, 118.5, 114.7, 114.7, 114.5, 114.3, 113.1, 113.0, 103.2, 103.2, 102.9, 
75.1, 75.1, 74.6, 73.2, 72.8, 70.8, 51.1, 36.2, 36.1, 32.2, 29.9, 29.9, 22.9, 17.9, 17.7, 15.9, 
14.3 ppm; HR-MS (ESI+ of MH+, 100% CH3CN): m/z calc’d for C46H39N4O4: 711.2966, 
found 711.2958. 
 
 
Figure 7-16. 1H NMR spectrum (400 MHz, CDCl3) of 7. 
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Figure 7-17. 13C NMR spectrum (100 MHz, CDCl3) of 7. 
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Figure 7-18. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 7 
(CHCl3). 
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meso-Tetraphenyl-3,3-diisopropyl-2,12-dioxa-13-oxochlorin (3-trans) and 
meso-tetraphenyl-3,3-diisopropyl-2,13-dioxa-12-oxochlorin (3-cis). General 
procedure for the conversion of diolbacteriochlorin to bisoxazolochlorin. Into a 
stirring solution of meso-tetraphenyl-12,13-cis-dihydroxy-3,3-diisopropyl-2-oxa-
bacteriochlorin (2, 350 mg) in CHCl3 (20 ml) were added 3 equiv of cetyltrimethyl-
ammonium permanganate (CTAP). The reaction was left stirring for ~4 h. Reaction 
progress was monitored using UV-visible spectroscopy and TLC. The bacteriochlorin 
spectrum of 2 disappeared as the formation of a chlorin spectrum (λmax ~695 nm) was 
observed. Product 3 was isolated as diasteromeric mixture in 67% yield (231 mg) using 
column chromatography (silica-CH2Cl2). 1H NMR indicated a diastereomeric ratio of 7:1 
favoring the formation of meso-tetraphenyl-3,3-diisopropyl-2,13-dioxa-12-oxochlorin. 
Repeated chromatography (silica-50% hexane/CH2Cl2) enriched the diastereomeric 
mixture to about ~10:1. MW = 720.86 g/mol; Rf = 0.95 (silica-CH2Cl2); UV-vis (CH2Cl2) 
λmax (log ε): 419 (5.15), 510 (4.02), 632 (3.87), 693 (4.35) nm; Fl λmax (CH2Cl2, λexc = 
409 nm): 703 nm, φ = 0.11; 1H NMR (300  MHz, CDCl3, δ, minority product peaks not 
listed) 8.23 (dd, 3J = 5.2, 4J = 1.7 Hz, 1H), 8.09 (dd, 3J = 5.2, 4J = 1.8 Hz, 1H), 7.90 -7.92 
(m, 2H), 7.78-7.87 (m, 7H), 7.55-7.71 (m, 10H), 7.53-7.57 (m, 2H), 7.19 (dd, 3J = 4.6, 4J 
= 2.1 Hz, 1H), 2.486 (m, 2H), 1.57 (s, 1H), 1.03 (d, 3J = 6.6 Hz, 6H), 0.71 (d, 3J = 6.9 Hz, 
6H), 0.69 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ) 167.9, 167.3, 157.6, 154.2, 
143.9, 141.6, 141.5, 139.7, 138.4, 136.7, 133.6, 133.6, 133.2, 132.9, 131.7, 129.4, 128.6, 
128.3, 128.2, 128.1, 127.9, 127.8, 127.7, 126.9, 126.5, 125.0, 123.5, 120.1, 112.1, 104.4, 
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103.3, 100.8, 36.7, 19.1, 18.7 ppm; HR-MS (ESI+ of MH+, 100% CH3CN): m/z calc’d for 
C48H41N4O3: 721.3179, found 721.3161. 
 
Figure 7-19. 1H NMR spectrum (400 MHz, CDCl3) of 3-cis. 
 
Figure 7-20. 13H NMR spectrum (100 MHz, CDCl3) of 3-cis. 
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Figure 7-21. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 3-cis 
(CH2Cl2). 
 
Figure 7-22. FT-IR spectrum (neat, diffuse reflectance) of 3-cis. 
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meso-Tetraphenyl-3-isopropyl-3-methoxy-2,13-dioxa-12-oxochlorin (6-cis) 
and meso-tetraphenyl-3-isopropyl-3-methoxy-2,12-dioxa-13-oxochlorin (6-trans). A 
diastereomeric mixture of 6 (237 mg) was prepared in 81% yield from 5 (300 mg, 
0.41 mmol) according to the general procedure described for the synthesis of 3. 1H NMR 
of the crude reaction mixture indicated the product to be in 5:2 diastereomeric ratio 
favoring the isomer 6-cis. The major isomer 6-cis can be further purified (up to ~10:1 
d.r.) by repeated column chromatography (50% hexane in CH2Cl2). MW = 708.8 g/mol; 
Rf = 0.90 (silica-CH2Cl2); UV-vis (CH2Cl2) λmax (log ε): 414 (5.12), 505 (3.89), 538 
(3.67), 614 (3.71), 672 (4.26) nm; Fl λmax (CH2Cl2, λexc = 415 nm): 683nm, φ = 0.19; 
1H NMR (300  MHz, CDCl3, δ(minority product peaks not listed)) 8.38 (dd, 3J = 5.2, 4J = 
1.5 Hz, 1H), 8.28 (dd, 3J = 5.2, 4J = 1.6 Hz, 1H), 8.01-7.87 (m, 8H), 7.72-7.60 (m, 14 H), 
3.08 (m, 3H), 2.05 (m, 1H), 1.13 (d, 3J = 6.6 Hz, 3H), 0.89 (s, 1H), 0.69 (d, 3J = 6.8 Hz, 
3H), 0.05 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ) 167.2, 164.8, 162.6, 154.4, 
152.5, 147.8, 143.7, 141.8, 141.3, 140.4, 139.9, 138.1, 138.0, 137.9, 137.5, 136.8, 136.7, 
136.6, 133.9, 133.8, 133.7, 133.3, 133.1, 133.0, 132.8, 132.5, 131.8, 131.7, 131.1, 129.5, 
129.0, 128.5, 128.4, 128.3, 128.3, 128.0, 127.9, 127.9, 127.8, 127.0, 126.9, 126.3, 126.0, 
125.1, 124.6, 124.3, 120.8, 117.7, 117.2, 115.1, 107.3, 104.8, 103.4, 102.7, 50.8, 35.8, 
35.6, 31.1. 17.4, 17.4, 16.4, 16.3 ppm; HR-MS (ESI+ of MH+, 100% CH3CN): m/z calc’d 
for C46H37N4O4: 709.2815, found 709.2825. 
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Figure 7-23. 1H NMR spectrum (400 MHz, CDCl3) of 6-cis.  
 
Figure 7-24. 13C NMR spectrum (100 MHz, CDCl3) of 6-cis. 
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Figure 7-25. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 6-cis 
(CH2Cl2). 
 
Figure 7-26. FT-IR spectrum (neat, diffuse reflectance) of 6-cis. 
Chapter 7: Oxabacteriochlorins and Dioxabacteriochlorins 
 199 
[meso-Tetraphenyl-3-isopropyl-3-methoxy-2,13-dioxa-12-oxochlori-
nato]Zn(II) (6Zn-cis). Freebase 6 (100 mg of 10:1 mixture, 0.14 mol) was dissolved in 
30% MeOH/CHCl3 (v/v, 30 mL) and heated to reflux. A solution of Zn(OAc)2·H2O (~3-5 
eq, 90-150 mg) in warm MeOH (~5 mL) was added and the mixture was refluxed 
overnight. The reaction progress was monitored by TLC. Upon completion, the product 
was isolated by rotary evaporation, followed by flash chromatography (silica–CH2Cl2). 
The material was obtained as a green crystalline solid by crystallization using a slow 
solvent exchange from CH2Cl2 to MeOH or pentane (73%, 79 mg). MW = 772.17 g/mol; 
Rf = 0.45 (silica-CH2Cl2); UV-vis (CH2Cl2) λmax (log ε): 424 (458), 520 (3.73), 572 
(3.65), 613 (3.81), 663 (4.33) nm; Fl λmax (CHCl3, λexc = 414 nm): 677nm, φ = 0.08; 
1H NMR (300  MHz, CDCl3, δ) 8.38 (m, 1H), 8.27 (m, 1H), 8.04 (m, 1H), 7.82-7.98 (m, 
6 H), 7.47-7.77 (m, 16H), 2.99 (s, 3H), 2.00 (m, 1H), 1.09 (m, 3H), 0.88 (m, 3H) ppm; 
13C NMR (100  MHz, CDCl3, δ) 166.7, 162.5, 156.5, 153.3, 151.9, 151.3, 144.7, 144.4, 
140.4, 139.4, 139.3, 139.1, 137.9, 137.6, 134.1, 134.0, 133.9, 133.3, 133.2, 132.5, 132.0, 
131.9, 131.5, 128.6, 127.9, 127.8, 127.7, 127.5, 127.34, 127.32, 127.30, 126.8, 126.1, 
124.5, 123.7, 118.3, 117.8, 116.3, 104.7, 101.4, 50.5, 35.7, 17.1, 17.0, 16.1; HR-MS 
(ESI+ of MH+, 100% CH3CN): m/z calc’d for C46H35N4O4Zn: 771.1950, found 771.1950. 
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Figure 7-27. 1H NMR spectrum (400 MHz, CDCl3) of 6Zn-cis. 
 
Figure 7-28. 13C NMR spectrum (100 MHz, CDCl3) of 6Zn-cis. 
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Figure 7-29. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 6Zn-
cis (CH2Cl2). 
 
Figure 7-30. FT-IR spectrum (neat, diffuse reflectance) of 6Zn-cis. 
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meso-Tetraphenyl-3-hydroxy-3-isopropyl-2,13-dioxa-12-oxochlorin (8-cis) 
and meso-tetraphenyl-3-hydroxy-3-isopropyl-2,12-dioxa-13-oxochlorin (8-trans). A 
10:1 diastereomeric mixture of 6 (0.08 mmol, 57 mg) was dissolved in 10% 2M HCl in 
THF (25 ml) and stirred overnight at 45°C. The reaction progress was monitored using 
TLC and the product was isolated through column chromatography (silica, CH2Cl2) to 
give 7 in 96% yield (53 mg). MW = 694.78 g/mol; Rf = 0.60 (silica-CH2Cl2); UV-vis 
(CH2Cl2) λmax (log ε): 413 (5.03), 506 (3.83), 540 (3.60), 613 (3.63), 672 (4.16) nm; Fl 
λmax (CH2Cl2, λexc = 414 nm): 680 nm, φ = 0.19; 1H NMR (300  MHz, CDCl3, δ, minority 
product peaks not listed) 8.36-8.34 (dd, 3J = 5.2, 4J = 1.9 Hz, 1H), 8.25-8.26 (dd, 3J = 5.2, 
4J = 1.9 Hz, 1H), 7.88-8.00 (m, 6H), 7.54-7.77 (m, 16H), 3.93 (s, 1H), 2.05 (m, 1H), 1.17 
(d, 3J = 6.8 Hz, 3H), 0.71 (m, 4H), -0.12 (s, 1H) ppm; 13C NMR (100  MHz, CDCl3, δ) 
167.2, 164.2, 154.2, 150.7, 143.7, 141.3, 140.1, 138.1, 138.0, 136.7, 134.4, 133.9, 133.9, 
133.8, 133.2, 131.9, 131.7, 129.6, 128.6, 128.4, 128.3, 128.1, 127.9, 127.8, 127.7, 127.1, 
126.4, 125.9, 125.0, 124.4, 120.8, 115.0, 113.1, 104.7, 103.8, 35.9, 17.8, 17.7, 15.8 ppm; 
HR-MS (ESI+ of MH+, 100% CH3CN): m/z calc’d for C45H35N4O4: 695.2658, found 
695.2645. 
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Figure 7-31. 1H NMR spectrum (400 MHz, CDCl3) of 8-cis. 
  
Figure 7-32. 13C NMR spectrum (100 MHz, CDCl3) of 8-cis. 
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Figure 7-33. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 8-cis 
(CH2Cl2).  
 
Figure 7-34. FT-IR spectrum (neat, diffuse reflectance) of 8-cis. 
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meso-Tetraphenyl-3-isopropyl-2,13-dioxa-12-oxochlorin (9-cis) and meso-
tetraphenyl-3-isopropyl-2,12-dioxa-13-oxochlorin (9-trans). A 10:1 diastereomeric 
mixture of meso-tetraphenyl-3-hydroxy-3-isopropyl-2,13-dioxa-12-oxochlorin and meso-
tetraphenyl-3-hydroxy-3-isopropyl-2,12-dioxa-13-oxochlorin (8, 100 mg,) was dissolved 
in CH2Cl2 (30 mL) and stirred at room temperature. To this solution, excess BF3·OEt2 
(10 eq, 0.17 ml of 98%+ solution) and Et3SiH (10 eq, 0.23 ml) were added slowly. 
Reaction progress was monitored using UV-visible spectroscopy (formation of the 
diagnostic peak at ~695 nm in a neutralized aliquot). Upon completion (~2-3 h reaction 
time), the reaction mixture was quenched by addition of a sat. aq. NaHCO3 solution. The 
mixture was transferred to a separatory funnel. The aqueous NaHCO3 wash was repeated 
until all acids were removed. The organic layer was isolated, dried using Na2SO4, and the 
solvent was evaporated by rotary evaporation. The crude product was purified by flash 
chromatography (silica-CH2Cl2) to afford the product 9 in good yield (71%, 69 mg). The 
product was isolated as a diastereomeric mixture (10:1 based on 1H NMR) reflecting the 
diastereomeric mixture of the starting material. For the sake of simplicity, only the 
spectroscopic data of 9-cis are listed here. MW = 678.78 g/mol; Rf = 0.95 (silica-
CH2Cl2); UV-vis (CH2Cl2) λmax (log ε): 418 (5.02), 483 (3.41), 510 (3.82), 544 (3.45), 
633 (3.66), 695 (4.25) nm, Fl λmax (CH2Cl2, λexc 414 nm): 709 nm, φ = 0.13; 1H NMR 
(300  MHz, CDCl3, δ) 8.27 (dd, 3J = 5.2, 4J = 1.9 Hz, 1H), 8.14 (dd, 3J = 5.2, 4J = 1.9 Hz, 
1H), 8.93-7.78 (m, 8H), 7.69-7.62 (m, 14 H), 6.73 (d, 3J = 2.6 Hz, 1H), 1.92 (m, 1H), 
1.44 (s, 1H), 1.05 (d, 3J = 6.8 Hz, 3H), 0.68 (s, 1H), 0.59 (d, 3J = 6.7 Hz, 3H) ppm; 
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13C NMR (100  MHz, CDCl3, δ) 169.4, 169.2, 154.5, 154.1, 144.4, 144.1, 139.9, 139.8, 
138.3, 138.2, 137.9, 136.8, 133.9, 133.6, 133.5, 133.3, 132.9, 132.4, 132.0, 131.8, 131.7, 
130.4, 129.9, 129.6, 129.2, 128.6, 128.4, 128.3, 128.0, 127.7, 127.7, 127.7, 127.5, 126.4, 
125.3, 124.1, 123.8, 123.1, 118.9, 112.1, 105.1, 102.9, 90.5, 90.5, 33.1, 32.7, 20.3, 20.1, 
20.0, 14.4, 14.3 ppm; HR-MS (ESI+ of MH+, 100% CH3CN): m/z calc’d for C45H34N4O3: 
679.2709, found 679.2689. 
 
Figure 7-35. 1H NMR spectrum (400 MHz, CDCl3) of 9-cis. 
 
Figure 7-36. 13C NMR spectrum (100 MHz, CDCl3) of 9-cis.  
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Figure 7-37. UV-vis (solid red trace) and fluorescence (broken black trace) spectra of 9-cis 
(CH2Cl2). 
 
Figure 7-38. FT-IR spectrum (neat, diffuse reflectance) of 9-cis. 
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meso-Tetraphenyl-3-isopropyl-3,12/13-dimethoxy-2,12/13-dioxabacterio-
chlorin (14-cis/trans-E/Z). General procedure for conversion of diolbacteriochlorins 
to dioxazolobacteriochlorins. 5 (56 mg, 0.77 mmol) was dissolved in CHCl3 (7 mL) at 
r.t. in a round-bottom flask equipped with a magnetic stirring bar, a N2 inlet and bubbler, 
was shielded from ambient light with aluminum foil. Excess MeOH (3mL) was added to 
the solution in which was purged with N2. NaIO4-silica- (~ 0.5 g) was added to the stirring 
reaction mixture and allowed to react for ~16 h. The reaction progress was monitored 
using UV-visible spectroscopy (product peak ~740 nm). A full conversion of the starting 
material was never observed and  ~25-30 % recovery of starting material was generally 
observed. The mixture was then filtered (glass frit M) and the filter cake washed with 
CH2Cl2. The filtrate was evaporated to dryness by rotary evaporation. The products were 
isolated by automated flash chromatography (silica, CH2Cl2). The non-polar red-pink 
product was isolated in 31% yield (17.5 mg, adjusted yield = 45%) as a diastereomeric 
mixture. MW = 724.84 g/mol; Rf = 0.85 (silica-CH2Cl2); UV-vis (CH2Cl2) λmax (log ε): 
348 (4.86), 377 (4.96), 518 (4.34), 743 (4.37) nm; Fl λmax (CH2Cl2, λexc = 377 nm): 
747 nm, φ = 0.07; 1H NMR (300  MHz, CDCl3, δ, mixture of 14-cis/trans-E/Z) 8.28 (m, 
2H), 8.23 (m, 2H), 8.17 (m, 2H), 7.77-8.11 (m, 33H), 7.51-7.72 (m, 44H), 3.26 (s, 3H) 
3.25 (s, 3H), 3.25 (s, 2H), 3.24 (s, 2H), 3.06 (s, 2H), 3.02 (s, 2H), 3.01 (s, 3H), 2.94 (s, 
3H), 2.08 (m, 2H), 1.94 (m, 2H), 1.06 (m, 5H), 0.99 (m, 2H), 0.71 (m, 2H), 0.68 (m, 6H), 
0.61 (m, 3H), -1.22 (m, 2H), -1.34 (m, 2H) ppm; 13C NMR (100  MHz, CDCl3, δ); 162.7, 
163.0, 161.0, 160.9, 160.6, 160.5, 147.9, 147.8, 147.3, 147.1, 143.0, 142.9, 142.7, 142.3, 
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142.2, 139.7, 139.6, 139.5, 139.4, 139.10, 139.09, 138.8, 138.63 138.60, 138.5, 138.4, 
137.94, 137.91, 137.6, 137.46, 137.45, 137.16, 137.14, 135.7, 135.6, 134.4, 134.3, 143.1, 
133.9, 133.8, 133.6, 133.54, 133.52, 133.3, 133.20, 133.19, 133.0, 132.8, 132.6, 132.5, 
131.2, 131.1, 130.6, 130.4, 128.1, 128.0, 127.96, 127.90, 127.74, 127.69, 127.6, 127.51, 
127.49, 127.40, 127.38, 126.9, 126.8, 126.7, 126.1, 126.0, 123.7, 123.6, 123.2, 123.1, 
122.64, 122.62, 118.4, 117.9, 117.8, 117.4, 117.20, 117.19, 116.6, 116.5, 116.3, 116.2, 
113.97, 113.94, 113.44, 113.38, 106.24, 106.19, 105.6, 103.7, 103.6, 103.34, 103.33, 
103.30, 103.27, 103.09, 103.05, 54.66, 54.5, 54.42, 54.38, 35.75, 35.73, 35.49, 35.42, 
34.88, 34.73, 32.14, 25.5, 20.9, 17.6, 17.5, 16.5, 16.4, 16.3, 16.2 ppm; HR-MS (ESI+ of 
MH+, 100% CH3CN): m/z calc’d for C47H41N4O4: 725.3128, found 725.3145. 
  
Figure 7-39. 1H NMR spectrum (400 MHz, CDCl3) of 14 (mixture of all isomers).  
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Figure 7-40. 13C NMR spectrum (100 MHz, CDCl3) of 14 (mixture of all isomers).  
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Figure 7-41. UV-vis spectrum of 14 (CH2Cl2, mixture of all isomers). 
Chapter 7: Oxabacteriochlorins and Dioxabacteriochlorins 
 211 
meso-Tetraphenyl-3,3-diisopropyl-12-methoxy-2,13-dioxabacteriochlorin 
(13-cis) and meso-tetraphenyl-3,3-diisopropyl-13-methoxy-2,12-dioxabacteriochlorin 
(13-trans). Prepared from diolbacteriochlorin 2 (48 mg) in 21 % yield (10 mg, with 
~25% of 2 recovered) according to the general procedure described for the synthesis of 
14. The diagnostic peak of 23 in UV-visible spectroscopy was observed at ~770 nm. MW 
= 736.89 g/mol; Rf = 0.85 (silica-CH2Cl2); UV-vis (CH2Cl2) λmax (log ε): 390 (5.09), 356 
(5.00), 528 (4.50), 774 (4.81) nm; Fl λmax (CH2Cl2, λexc = 380 nm): 776 nm, φ = 0.03; 
1H NMR (300  MHz, CDCl3, δ, contains 13-cis and 13-trans at a 3:2 ratio) 8.12 (m, 1H), 
8.05 (m, 3H), 7.78-8.02 (m, 15H), 7.53-7.71 (m, 23H), 3.22 (s, 3H), 3.20 (s, 2H) 2.51 (m, 
2H), 2.38 (m, 1H), 1.08 (m, 3H), 1.03 (m, 3H), 0.99 (m, 2H), 0.96 (m, 2H), 0.73 (m, 2H), 
0.70 (m, 3H), 0.67 (m, 2H), 0.60 (m, 3H) -0.76(s, 1H), -0.92 (s, 1H) ppm;13C NMR (100  
MHz, CDCl3, δ) 166.0, 164.1, 163.5, 160.2, 157.7, 152.2, 146.6, 143.1, 142.7, 140.9, 
140.4, 140.3, 139.9, 139.6, 139.42, 139.36, 139.1, 137.9, 137.8, 137.4, 137.1, 136.5, 
134.2, 133.9, 133.79, 133.78, 133.6, 133.4, 133.3, 133.2, 133.1, 132.8, 131.2, 130.4, 
128.4, 128.1, 128.0, 127.9, 127.8, 127.79, 127.76, 127.68, 127.6, 127.5, 127.4, 127.3, 
126.6, 126.5, 126.4, 122.98, 122.94, 122.4, 122.1, 117.7, 117.3, 117.1, 113.8, 113.2, 
111.3, 105.9, 105.4, 103.7, 103.4, 102.9, 102.3, 100.6, 99.6, 54.25, 54.1, 37.0, 36.6, 36.5, 
29.9, 19.4, 19.3, 19.1, 19.0, 18.9, 18.59, 18.57; HR-MS (ESI+ of MH+, 100% CH3CN): 
m/z calc’d for C49H45N4O3: 737.3492, found 737.3504. 
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Figure 7-42. 1H NMR spectrum (400 MHz, CDCl3) of 13-cis/trans (mixture, 3:2). 
 
Figure 7-43. 13C NMR spectrum (100 MHz, CDCl3) of 13-cis/trans (mixture, 3:2). 
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Figure 7-44. UV-vis spectrum of 13-cis/trans (CH2Cl2, mixture, 3:2). 
meso-Tetraphenyl-3,3-diisopropyl-12,12-dihydro-2,13-dioxabacteriochlorin 
(15). In the dark or low light environment (important to avoid adventitious oxidation), a 
10:1 diastereomeric mixture of meso-tetraphenyl-3,3-diisopropyl-2,12-dioxa-13-oxo-
chlorin and meso-tetraphenyl-3,3-diisopropyl-2,13-dioxa-12-oxochlorin (3-cis/trans, 
80 mg, 0.11 mmol) was dissolved in CH2Cl2 and stirred at room temperature. To this 
solution, excess BF3·OEt2 (30 eq, 0.4 ml of 98+% solution) and Et3SiH (30 eq, 0.53 ml) 
were added slowly. Reaction progress was monitored using UV-visible spectroscopy (a 
band ~820 nm in a neutralized aliquot, indicated the appearance of the product). The 
reaction was left stirring until all starting materials were consumed and additional 
reductants were added as necessary until the UV-visible spectrum of the reaction mixture 
only displayed a the bacteriochlorin spectrum with a λmax of ~820 nm. Upon completion, 
Chapter 7: Oxabacteriochlorins and Dioxabacteriochlorins 
 214 
the reaction mixture was quenched by addition of a sat. aq. NaHCO3 solution. The 
mixture was transferred to a separatory funnel. The aq. NaHCO3 wash was repeated until 
all acids were removed. The organic layer was isolated, dried using Na2SO4, and the 
solvent was evaporated by rotary evaporation. The dark residue was re-dissolved in 
minimal CH2Cl2 and crystallized via slow solvent exchange with MeOH to give 15 in 
18 % yield (14 mg). MW = 706.87 g/mol; UV-vis (CH2Cl2) λmax (log ε): 353 (4.65), 389 
(4.79), 529 (4.24), 815 (4.6) nm; Fl λmax (CH2Cl2, λexc = 379 nm): 819nm, φ = < 1%; 
1H NMR (500  MHz, CDCl3, δ,) 8.02 (dd, 3J = 4.7, 4J = 2.0 Hz, 1H), 7.87-7.93 (m, 6H), 
7.82 (dd, 3J = 4.5, 4J = 2.0 Hz, 1H), 7.76-7.78 (m, 2H), 7.41-7.68 (m, 14H), 6.4 (s, 2H), 
2.47 (m, 2H), 1.04 (d, 3J = 6.6 Hz, 6H), 0.67 (d, 3J = 6.9 Hz, 6H), -0.33 (s, 1H), -0.48 (s, 
1H) ppm; 13C NMR (100  MHz, CDCl3, δ) 164.9, 163.6, 156.0, 152.4, 140.4, 140.2, 
140.1, 139.4, 138.5, 137.9, 137.7, 136.8, 133.7, 133.2, 132.9, 131.6, 128.8, 128.2, 128.1, 
127.8, 127.6, 127.5, 127.2, 126.4, 122.8, 122.2, 121.8, 120.1, 111.8, 109.8, 102.8, 101.9, 
100.1, 36.9, 19.3, 18.8; HR-MS (ESI+ of MH+, 100% CH3CN): m/z calc’d for 
C48H43N4O2: 707.3386, found 707.3402. 
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Figure 7-45. 1H NMR spectrum (500 MHz, CDCl3) of 15. 
 
Figure 7-46. 13C NMR spectrum (100 MHz, CDCl3) of 15. 
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Figure 7-47. UV-vis spectrum of 15 (CH2Cl2). 
7.5.3.  X-Ray Crystallography Data  
X-ray crystallographic analyses (provided by Dr. Christopher Ziegler and James 
T. Engle, University of Akron):  Single crystals of 3-cis, 6-cis, 6-Zn-cis, 14-trans-E, 14-
trans-Z and 13-cis were coated in Fomblin® oil, mounted on a pin and placed a 
goniometer head under a stream of nitrogen cooled to 100 K. The data were collected on 
an APEX2 CCD diffractometer with Cu source Kα radiation (λ = 1.54178). The frames 
were integrated with the Bruker SAINT software package using a narrow-frame algo-
rithm. Data were corrected for absorption effects using the multi-scan method (SADABS) 
and the structure was solved and refined using the Bruker SHELXTL Software Package 
until the final anisotropic full-matrix, least-squares refinement of F2 converged.  
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Crystal Structure Report for 3-cis  
A red block-like specimen of 3-cis, approximate dimensions 0.13 mm x 0.14 mm 
x 0.19 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data 
were measured.  
 
 
Figure 7-48. ORTEP Representation of the crystal structure of 3-cis, side and top views. 
Hydrogens and disorder removed for clarity. 
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Crystal Structure Report for 6-cis  
A red plate-like specimen of 6-cis, approximate dimensions 0.08 mm × 0.22 mm 
× 0.28 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data 
were measured.  
 
 
Figure 7-49. ORTEP Representation of the crystal structure of 6-cis, side and top views. 
Hydrogens and disorder removed for clarity. 
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Crystal Structure Report for 6Zn-cis  
A green specimen of 6Zn-cis, approximate dimensions 0.27 mm × 0.47 mm × 
0.55 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data were 
measured. 
 
 
Figure 7-50. ORTEP Representation of the crystal structure of 6Zn-cis, side and top views. 
Hydrogens and disorder removed for clarity. 
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Crystal Structure Report for 14-trans-E  
An orange plate-like specimen of 14-trans-E, approximate dimensions 0.09 mm × 
0.10 mm × 0.21 mm, was used for the X-ray crystallographic analysis. The X-ray 
intensity data were measured. The total exposure time was 33.52 hours.  
 
 
Figure 7-51. ORTEP Representation of the crystal structure of 14-trans-E, side and top 
views. Hydrogens and disorder removed for clarity. 
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Crystal Structure Report for 14-trans-Z 
A orange specimen of 14-trans-Z, approximate dimensions 0.18 mm × 0.24 mm × 
0.28 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data were 
measured. The total exposure time was 38.48 hours. 
 
 
Figure 7-52. ORTEP Representation of the crystal structure of 14-trans-Z, side and top 
views. Hydrogens and disorder removed for clarity. 
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Crystal Structure Report for 13-cis  
A red specimen of 13-cis, approximate dimensions 0.38 mm × 0.42 mm × 
0.55 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data were 
measured.  
 
 
Figure 7-53. ORTEP Representation of the crystal structure of 13-cis, side and top views. 
Hydrogens and disorder removed for clarity. 
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Table 7-1. Crystallographic and structure refinement data for 3-cis,1-cis and 6-cis-Zn. 
Identification Code 3-cis 6-cis 6-Zn-cis 
Empirical formula  C48H40N4O3 C97H77N9O8 C47H38N4O5Zn 
Formula weight  720.84 1496.68 804.18 
Temperature (K) 100(2)  100(2)  100(2)  
Wavelength (Å) 1.54178  1.54178  1.54178  
Crystal system  Monoclinic Monoclinic Triclinic 
Space group  P2(1)/c C2/c P1 
a, b, c, (Å) 11.4410(5) 
21.8550(10) 
18.5306(8) 
23.6921(5)  
13.7480(3)  
25.7494(8) 
12.5921(4) 
12.9701(4) 
14.8500(5)  
α, β, γ (°) 90 
126.626(3) 
90 
90 
117.2340(10) 
 90 
111.9920(10) 
96.5610(10) 
97.7270(10) 
Volume [Å3] 3718.6(3)  7457.3(3) 2192.36(12)  
Z 4 4 2 
Density (calcʼd) [Mg/m3] 1.288 1.333 1.218 
Abs coefficient [mm-1] 0.640  0.684  1.163  
F(000) 1520 3144 836 
Crystal size [mm3] 0.19 x 0.14 x 0.13  0.28 x 0.22 x 0.08 0.55 x 0.47 x 0.27  
Theta range for data 
collection 
3.59° to 62.99° 3.84° to 64.61° 3.26° to 61.00° 
Index ranges -13<=h<=11  
-25<=k<=22 
-21<=l<=20 
-27<=h<=26  
-16<=k<=16  
-30<=l<=29 
-14<=h<=14  
-14<=k<=11 
-16<=l<=16 
Reflections collected 20276 21363 23334 
Independent reflections 5807  
[R(int) = 0.0480] 
6046  
[R(int) = 0.0303] 
6348  
[R(int) = 0.0272] 
Completeness to theta 96.5% 96.4% 94.7% 
Absorption correction SADABS SADABS SADABS 
Max. and min. transmission 0.9220 & 0.8892 0.9473 & 0.8320 0.7434 & 0.5661 
Refinement method Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Data / restraints / 
parameters 
5807 / 0 / 573 6046 / 0 / 518 6348 / 0 / 522 
Goodness-of-fit on F2 1.082 0.967 0.968 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0874,  
wR2 = 0.2245 
R1 = 0.0516,  
wR2 = 0.1466 
R1 = 0.0629,  
wR2 = 0.1734 
R indices (all data) R1 = 0.0987,  
wR2 = 0.2324 
R1 = 0.0607,  
wR2 = 0.1551 
R1 = 0.0645,  
wR2 = 0.1748 
Largest diff.  
peak & hole [e x Å-3] 
0.328 & -0.226  0.797 & -0.386  1.736 & -0.441 
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Table 7-2. Crystallographic and structure refinement data for 14-trans-E, 14-trans-Z and 13-cis.  
Identification Code 14-trans-E 14-trans-Z 13-cis 
Empirical formula  C47H40N4O4 C47H40N4O4 C49H44N4O3 
Formula weight  724.83 724.83 736.88 
Temperature (K) 100(2)  100(2)  100(2)  
Wavelength (Å) 1.54178  1.54178  1.54178  
Crystal system  Orthorhombic Monoclinic Monoclinic 
Space group  P2(1)2(1)2(1) P2(1)/c P2(1)/c 
a, b, c, (Å) a = 9.4468(2)  
b = 13.2846(3)  
c = 30.4999(7)  
a = 20.5804(4)  
b = 9.5370(2)  
c = 19.1964(4)  
a = 20.3320(5)  
b = 11.1841(3)  
c = 18.4019(5)  
α, β, γ (°) 90 
90 
90 
90 
91.8000(10) 
90 
90 
109.5870(10) 
90 
Volume [Å3] 3827.64(15)  3765.92(13)  3942.36(18)  
Z 4 4 4 
Density (calcʼd) [mg/m3] 1.258  1.278  1.242  
Abs coefficient [mm-1] 0.644  0.654  0.613  
F(000) 1528 1528 1560 
Crystal size [mm3] 0.21 x 0.10 x 0.09  0.28 x 0.24 x 0.18 0.55 x 0.42 x 0.38  
Theta range 2.90° to 63.00° 4.30° to 61.98° 2.31° to 64.45° 
Index ranges -9<=h<=10 
-15<=k<=15 
-35<=l<=35 
-23<=h<=223 
-10<=k<=10 
-21<=l<=20 
-23<=h<=22 
-12<=k<=11 
-20<=l<=19 
Reflections collected 42976 37579 23323 
Independent reflections 6168  
[R(int) = 0.0720] 
5901  
[R(int) = 0.0498] 
6350  
[R(int) = 0.0315] 
Completeness to theta 100.0% 99.8% 96.1% 
Absorption correction SADABS SADABS SADABS 
Max. and min. transmission 0.9437 & 0.8772 0.8891 & 0.8401 0.8006 & 0.7297 
Refinement method Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Data / restraints / 
parameters 
6168 / 24 / 519 5901/ 0 / 519 6350 / 6 / 585 
Goodness-of-fit on F2 0.945 0.894 1.037 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0808,  
wR2 = 0.2144 
R1 = 0.0814,  
wR2 = 0.2308 
R1 = 0.0825,  
wR2 = 0.2563 
R indices (all data) R1 = 0.0876,  
wR2 = 0.2213 
R1 = 0.0970,  
wR2 = 0.2549 
R1 = 0.0904,  
wR2 = 0.2674 
Largest diff.  
peak & hole [e x Å-3]  
1.354 & -0.389  1.444 & -0.439  1.341 & -0.423  
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